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Summary 
Wound care is a challenging task in our daily lives. Therefore, it would be highly 
desirable to have simple, acceptable dressing materials that can be used directly to 
cover wounds and accelerate wound healing. Birch bark triterpene extract (TE) has the 
ability to accelerate the wound healing process. Thus, the main goal of this work was 
to develop novel electrospun wound dressings with TE as the active principal. The 
underlying concept was to blend colloidal dispersions of TE with polyvinyl alcohol 
(PVA) matrix and produce wound dressings by electrospinning. However, TE particles 
exhibit unique structures which cannot be crushed by common techniques to reach 
particles in the colloidal size range even when high energy dispersion techniques are 
used. This represents an obstacle for a simple incorporation of TE into the PVA matrix 
through electrospinning.  
In the first part of this PhD thesis, the colloidal dispersions were designed to contain 
TE, sunflower oil, phospholipids (PL90H) and water. First, an interfacial tension 
analysis was performed to investigate and understand the potential influence of PL90H 
in the dispersion process and its interaction with TE. A synergistic interaction between 
PL90H and TE was also discussed. An optimized stepwise homogenization process 
made it feasible to produce colloidal dispersions with particle sizes below 1 µm. 
In order to design and develop novel wound dressings as delivery devices capable of 
releasing TE, we focused on emulsion electrospinning technique for bioactive scaffold 
production. Electrospinning parameters to fabricate the dressings were investigated 
and optimized. In particular, the varying of concentration and molecular weight of the 
polymer had a significant effect on spinnability, rheological properties of polymer 
solution and the resulting fiber properties. We showed that bioactive wound dressings 
with smooth and uniform fibers can be produced.  
Cumulative in vitro drug release and ex vivo permeation profiles showed that TE-
loaded scaffolds can release Betulin in a sustained release manner. By adjusting 
components of the colloidal dispersions, namely PL90H and sunflower oil, the release 
of Betulin can be controlled. Amazingly, ex-vivo wound healing results indicated that 
treatment with nanofibrous wound dressings especially with low TE amounts achieved 
superlative and accelerated wound healing recovery. 
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In the last phase of this thesis, films containing colloidal dispersions were produced 
using the solvent casting method, for possible alternative formulations towards wound 
therapy. From the in vitro drug release and ex vivo wound healing studies, these films 
gave positive insights to serve as additional wound dressings. Nevertheless, TE-
loaded electrospun wound dressings were superior to such cast films in wound healing. 
With the current developments in electrospinning technology, it is possible to 
manufacture electrospun dressings at industrial level within shorter times. On the other 
hand, fabrication of such cast films could also serve as efficient dressings for covering 
wounds. 
In vivo studies could be essential for future translation of the developed TE dressings 
while utilizing the basis of this work. 
This project clearly shows that through an innovative approach we have developed 
bioactive wound dressings that present an alternative pharmaceutical formulation 
potential for wound therapy in the near future. 
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Zusammenfassung 
Ein effizientes und einfach zu handhabendes Wundmanagement ist immer noch eine 
große Herausforderung. In unserem täglichen Leben wäre es äußerst wünschenswert, 
einfache, akzeptable Verbandmaterialien zu haben, die einerseits direkt zur 
Abdeckung von Wunden und andererseits zur Beschleunigung der Wundheilung 
verwendet werden können. Ein Triterpentrockenextrakt (TE) aus der Birkenrinde kann 
nachgewiesenermaßen den Wundheilungsprozess beschleunigen. Daher war das 
Hauptziel dieser Arbeit die Entwicklung von elektrogesponnenen Wundauflagen mit 
TE als aktiver Komponente. Das Grundkonzept bestand darin, kolloidale Dispersionen 
von TE in eine Polyvinylalkohol (PVA)-Matrix einzuarbeiten und Wundauflagen durch 
Elektrospinnen herzustellen. Die TE-Partikel weisen jedoch einzigartige Strukturen 
auf, die mit herkömmlichen Verfahren nicht zerkleinert werden können. Selbst wenn 
hochenergetische Dispersionstechniken eingesetzt werden, lassen sich in öligen oder 
wässrigen Dispersionen keine Partikel im kolloidalen Größenbereich herstellen. Dies 
stellt ein Hindernis für eine einfache Verwendung des TE in die PVA-Matrix beim 
Elektrospinnen dar.  
Im ersten Teil dieser Doktorarbeit wurden kolloidale Dispersionen konzipiert, die TE, 
Sonnenblumenöl, Phospholipide (PL90H) und Wasser enthalten. Zunächst wurde eine 
Bestimmung der Grenzflächenspannung durchgeführt, um den potenziellen Einfluss 
von PL90H im Dispersionsprozess und seine Wechselwirkung mit TE zu untersuchen 
und zu verstehen. Es wurde eine synergistische Wechselwirkung zwischen PL90H und 
TE beobachtet. Durch ein optimiertes stufenweises Homogenisierungsverfahren war 
es möglich, kolloidale Dispersionen mit Partikelgrößen unter 1 µm herzustellen. 
Im zweiten Teil wurden bioaktive elektrogesponnene Wundauflagen entwickelt und 
charakterisiert, die TE kontrolliert freisetzen können. Elektrospinnparameter zur 
Herstellung von Wundauflagen wurden untersucht und optimiert. Insbesondere die 
Variation von Konzentration und Molekulargewicht des Polymers hatte einen 
signifikanten Einfluss auf die Spinnbarkeit, die rheologischen Eigenschaften der 
Polymerlösung und die resultierenden Fasereigenschaften. Wir konnten zeigen, dass 
bioaktive Wundauflagen mit glatten und gleichmäßigen Fasern hergestellt werden 
können. 
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In-vitro-Freisetzungs- und Ex vivo-Permeationsuntersuchungen ergaben, dass 
elektrogesponnene Wundauflagen Betulin über einen Zeitraum von 72 Stunden 
freisetzen können. Durch die Veränderung der Komponenten von kolloidalen 
Dispersionen, nämlich PL90H und Sonnenblumenöl, kann die Freisetzung von Betulin 
gesteuert werden. Ex-vivo-Wundheilungsergebnisse deuten darauf hin, dass die 
Behandlung mit nanofaserigen Wundauflagen, insbesondere mit niedrigen TE-
Mengen, eine überragende und beschleunigte Wundheilung erzielte. 
Als alternative Formulierung zur Wundtherapie wurden in der letzten Phase der Arbeit 
TE-haltige Filme mittels Solvent Casting Methode hergestellt. Aus den in-vitro-
Freisetzungs- und ex vivo-Wundheilungsstudien ergaben diese Filme positive 
Erkenntnisse, sodass diese ebenfalls als Wundauflagen dienen können. Dennoch 
waren TE-basierte elektrogesponnene Wundauflagen im Vergleich zu den 
gegossenen Filmen bei der Wundheilung überlegen. Mit den aktuellen Entwicklungen 
in der Elektrospinntechnologie ist es möglich, elektrogesponnene Wundauflagen 
innerhalb kürzerer Zeit auf industrieller Ebene herzustellen. Andererseits könnte die 
Herstellung gegossener Filme auch als einfache Alternative zur Abdeckung von 
Wunden dienen. 
In-vivo-Studien könnten für die zukünftige Umsetzung der entwickelten TE-
Wundauflagen unter Nutzung der Grundlage dieser Arbeit von wesentlicher Bedeutung 
sein. 
Dieses Projekt zeigt deutlich, dass wir durch einen innovativen Ansatz bioaktive 
Wundauflagen entwickelt haben, die ein alternatives pharmazeutisches 
Formulierungspotenzial für die Wundtherapie in naher Zukunft darstellen. 
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 Chapter 1: General introduction 
1.1 Motivation 
The human skin serves as a barrier to protect the body from the outside environment. 
Therefore, it is vulnerable to microbial, thermal, mechanical and chemical threats which 
can cause acute or chronic wounds. Acute wounds include, mechanical injuries caused 
by knives, gun shots and surgical wounds including burns and chemical injuries. Acute 
wounds usually take short period (8-12 weeks) to heal completely whereas chronic 
wounds such as from diabetic foot ulcers, decubitis ulcers heal slowly and take beyond 
12 weeks to recover [1]. Wound healing is a complex process and several biological 
pathways are involved in three major phases-inflammation, proliferation, and 
maturation to restore damaged tissues. Globally, the management of wounds is a 
serious problem and a huge burden to the healthcare where in each year high costs 
are invested in. For instance, in Germany alone, the number of wound patients in 2012 
was around 2.7 million patients whereas in USA chronic wounds were reported to affect 
6.5 million patients and an excess of US$25 billion spent on treatment [2, 3]. Therefore, 
various materials have been widely used as wound dressings to assist the wound 
healing process. Traditionally, honey, plant extracts, animal products were used as 
dressing materials for covering wounds [4, 5]. An ideal wound dressing material should 
maintain a moist environment, allow removal of exudates, gaseous exchange, protect 
the wound from bacterial infection, non-toxic and need less frequent dressing changes 
at an affordable cost [6]. In wound care management, wound dressing materials for 
covering wounds have been manufactured in form of nanofibrous meshes. Techniques 
such as 3D printing, phase separation, self-assembly, melt blowing, drawing, 
electrospinning and centrifugal spinning are used to fabricate nanofibers. Among these 
fabrication techniques, electrospinning is the most widely used for production of 
nanofibrous materials [7-9]. Electrospinning as the name suggests, is a process by 
which nanofibers are generated from a polymer solution or melt in the presence of an 
electric field. It was known back in 1934 when A. Formhals patented this process 
describing the production of cellulose acetate based fibers using an acetone/alcohol 
solution as the solvent [10]. Thereafter, many researchers like Reneker and others 
especially in the 1990s stepped up further in using electrospinning technology to 
produce nanofibers and now we know that a wide range of polymers can be 
electrospun into nanofibers [11-17]. Since then, the technology has gained a lot of 
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momentum and interest in the recent years and nowadays it is widely used to generate 
nanofibers for various applications from tissue engineering to wound healing [18]. 
Besides, considerable publications have recently emerged based on electrospinning 
technology. Electrospinning technique is a simple, cost-effective and versatile process 
for preparing fibers having a diameter from few micrometers down to several 
nanometers [19, 20]. Beyond that, the obtained nanofiber mats possess not only good 
mechanical properties but also exhibit unique properties, such as high porosity, high 
encapsulation efficiency and high surface area to volume ratio thus high drug loading. 
These features make electrospun mats perfect materials for wound dressing. Besides 
mimicking the native extracellular matrix in human tissues, their high surface area and 
high porosity allow efficient gaseous exchange including removal of exudate, facilitate 
cell proliferation, act as a physical barrier against entry of microorganisms while 
preventing dehydration during wound healing [5, 21-23].  
1.2 Significance of research 
Polymeric nanofibers made from biodegradable and biocompatible synthetic or natural 
polymers have been utilized to develop drug delivery systems to treat various ailments 
and one of the potential areas to use them is medicated wound dressing [5, 21]. Many 
wound dressings based on electrospun fibrous mats have been developed and loaded 
with diverse active ingredients [1, 24, 25]. In particular, the incorporation of active 
ingredients with antibacterial properties in the electrospun wound dressing would 
prevent infection of the wound and accelerates the healing process. However, some 
wound dressings in the market containing active agents like hydrocolloids or silver 
dressings often used on wound healing have been reported to shown negative effects 
like allergic contact dermatitis [26] and use of dressings loaded with antibiotics has risk 
of developing antimicrobial resistance [27]. Therefore, it is crucial to develop bioactive 
wound dressings for not only covering wounds but at the same time accelerate the 
wound healing process with effective therapy even after long term usage. 
Triterpenes from the outer bark of birch are known for various pharmacological effects 
including enhanced wound healing [28]. However, the low solubility of these triterpenes 
in polar and non-polar solvents makes formulation a challenging task which might limit 
their therapeutic application [29, 30]. For topical application only few formulation 
concepts are known. These include cosmetic water-in-oil creams, water-in-oil foams 
[31, 32] and an oleogel consisting of birch bark triterpene extract (TE) and sunflower 
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oil which received the European marketing authorization in January 2016 [33]. Hence, 
this research focuses on design and development of novel dressing materials that can 
provide alternative formulations of birch bark extract which are suitable for wound 
healing applications. In addition, we ensured that all the components used in this study 
are biocompatible and biodegradable when the dressing is applied to the human body, 
such that an invasive and / or traumatic intervention for dressing removal like in deep 
wounds is unnecessary resulting to a better patient compliance. Furthermore, water 
was used as the common solvent for the processing of the wound dressing which is 
non-toxic and affordable. This is eco-friendly and such type of electrospinning can also 
be regarded as green electrospinning. 
In electrospinning, different strategies like coaxial method and the most commonly 
used principle, the blending, have been used for incorporation of therapeutic agents 
into the electrospun scaffolds [34]. By using the coaxial electrospinning principle, it is 
possible to electrospin two immiscible solutions using arranged nozzles. However, in 
most cases, where blend electrospinning is necessary, this may pose a challenge to 
produce fibers as a proper stabilizing agent is needed to stabilize the interface between 
immiscible phases. With the help of two types of dispersions systems oil-in-water 
(O/W) and water-in-oil (W/O), it is possible to manufacture nanofibers containing small 
drug enriched compartments and to modulate drug release rate by regulating the oil 
and water phase of the dispersions. For instance, the use of W/O dispersion 
electrospinning could improve the release of hydrophilic drugs whereas with O/W 
dispersions encapsulation of lipophilic components to electrospun fibers can be useful 
[35]. In this case, colloidal dispersions can be utilized in dispersion electrospinning to 
create core shell fibers even in blend electrospinning without further modification of the 
nozzle. However, encapsulation of birch bark dry extract into nanofibers by blend 
electrospinning may present a challenge. For instance, earlier studies showed that due 
to their unique structure the particle sizes of the dry triterpene extract cannot be grinded 
by common techniques to reach sufficiently small particles even when high energy 
dispersion techniques, e.g. sonication or high-pressure homogenization were used 
with aqueous and organic suspensions of the material [36]. This could be solved 
through processing of colloidal dispersions with birch bark dry extract as the active 
substance through homogenization and use of phospholipids as stabilizer. This 
phenomenon presumably seems to be directly linked to the use of phospholipids as 
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stabilizers. In this context, it was found by chance that the interfacial tension of mixtures 
of the triterpene extract and the phospholipids reveal cooperative effects [21, 22]. 
However, this interaction has not been studied systematically so far. There are first 
hints from previous PhD theses, that processing mixtures of triterpene extract, 
phospholipid, and oil with a high-pressure homogenizer yielded submicron-sized 
dispersions [36, 37]. Therefore, in the initial phase of this research, was to develop a 
suitable workflow for production of aqueous (O/W) colloidal dispersions consisting four 
constituents, the active substance (TE), sunflower oil, phospholipids (PL) as a 
stabilizer and water phase. Composition and processing conditions are expected to 
have a significant impact on the characteristics of these colloidal dispersions. Also, an 
interaction between PL and TE was studied systematically with the main goal to 
produce colloidal dispersions (particle sizes <1 µm) for better encapsulation into 
nanofibers. Consequently, the colloidal dispersions were blended with a polyvinyl 
alcohol polymer and electrospun to produce wound dressings. PVA was used because 
it’s a biocompatible and biodegradable hydrophilic polymer with good chemical and 
mechanical properties, and has been approved by the FDA for different biomedical and 
pharmaceutical applications [38, 39]. Possibilities of electrospinning TE-loaded / PVA 
nanofibers from their solutions was explored together with effects of variables 
associated with the polymer and electrospinning process. Various electrospinning 
parameters such as- molecular weight, solution concentration, applied voltage, tip-to-
collector distance and flow rate are expected to influence overall fiber morphology and 
diameter [40, 41]. Besides, a controlled drug release can be gained through variation 
of the dispersion constituents and polymer associated properties. After 
electrospinning, fiber morphologies as well as the presence of TE was assessed using 
a combination of scanning electron microscopy and confocal laser scanning 
microscopy. Ex-vivo permeation and in vitro drug release studies were performed, and 
the efficacy of the developed wound dressings evaluated through ex-vivo wound 
healing assay. 
To our knowledge, there are no reports focusing on the development of this kind of 
wound dressing so this will be the first polymer based wound dressing containing birch 
bark dry extract aimed for future potential use in wound therapy. Apart from that, 
electrospinning of dispersions containing phospholipids has not been commonly 
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practiced so this study covers innovative aspects in all three fields, namely use of 
phospholipids, electrospinning and wound care. 
 
1.3 General basics 
1.3.1 The structure and function of human skin 
The skin as the outermost organ of the human body, is the primary protective barrier 
against the external environment. It offers protection against physical, chemical and 
thermal injuries, micro-organisms invasion and dehydration. The skin is composed of 
two recognisable layers: epidermis and dermis (Figure 1). Together with the 
subcutaneous fat tissue it builds the outer integument. The epidermis is the outermost 
layer and act as a barrier to micro-organism invasion. The epidermal barrier attached 
to the underlying dermis, has a thickness of 50-100 µm in depth and comprises of 
stratum corneum (SC), stratum lucidum, stratum granulosum, stratum spinosum and 
stratum basale. Keratinocytes are the most common cell type in the epidermis and full 
of keratin filaments. In addition, keratinocytes produce cytokines in case of an injury. 
Melanocytes are part of the lower epidermis and are involved in skin pigmentation. The 
dermis has a thickness ranging from 1 to 2 mm which varies depending on the body 
site. It is made up of tough, supportive cell matrix which mainly consist collagen and 
fibrous proteins embedded in a proteoglycan-rich matrix. Collagen fibers secreted by 
fibroblasts, makes up to 70% of the dermis, providing the skin its flexibility and strength. 
It also contains nerve endings, hair follicles, and sebaceous and sweat glands. Beyond 
that, dermis is a highly vascularized tissue which provides nutrition to the epidermis. 
The subcutaneous layer (hypodermis) (1-2 mm) is the innermost layer of the outer 
integument located underneath the dermis. It consists of loose connective tissue and 
fat tissue, larger blood vessels and nerve cells which helps insulate the body from heat 
and cold and thus serves as energy reserve [42-44]. 
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Figure 1. Schematic showing the three layers of the skin: epidermis, dermis, hypodermis 
and potential causes of skin wounds. 
1.3.2  Wound healing 
The main goal of the wound healing process is to restore the integrity of the damaged 
skin. This occurs through several sequential stages such as haemostasis, 
inflammation, cell proliferation and tissue remodelling. Haemostasis occurs 
immediately after tissue damage which leads to fibrin clot formation (initiated by 
platelets) to stop bleeding. Platelets release other mediators to recruit other functional 
cells to the injured area. Haemostasis is simultaneous to inflammation stage. During 
inflammation stage, blood neutrophils followed by phagocyte immune cells enter the 
injury site to remove dead cells and prevent invasive infection. In the proliferation 
phase, new blood vessels are formed (angiogenesis). Also, it is during proliferation 
phase where synthesis of extracellular matrix (ECM) and re-epithelialization is 
accomplished. In the remodelling stage as the final stage of wound healing, the 
development of new epithelium with eventual scar formation occurs. This brief 
description of wound healing phases clearly illustrate that the wound healing process 
is a very complex process cascaded by a series of biological processes and has been 
discussed extensively [45-50]. 
1.3.3 Triterpene composition of birch bark extracts and their characteristics 
Birch bark is widely available in wood-processing industry as a low-value waste 
product which is generated in huge amounts. Therefore, birch bark extract is easily 
available at low costs. Purified triterpene-rich dry extract can be derived from the bark 
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of Betula pendula and Betula pubescens, or hybrids of both tree species [33]. Outer 
birch bark extracts have a high content of triterpenes which are known for various 
pharmacological properties such as anti-inflammatory, anti-viral, anti-cancer activity 
and wound healing effects [28, 29, 31, 51-55]. Triterpenes are widely found in plants 
but only the outer bark of the white barked birches contains up to 34 % (w/w) Betulin. 
A well characterized triterpene dry extract from the outer bark of birch contains about 
80 % (w/w) Betulin. This TE is obtained by accelerated solvent extraction with n-
heptane. It is also possible to use other extraction fluids or to use supercritical CO2 for 
extraction [56]. Other minor constituents of the dry extract are lupeol (LU), erythrodiol 
(ER), Betulinic acid (BA), oleanolic acid (OA) and Betulinic acid methyl ester (BA-ME) 
as shown in Table 1 [57]. Meanwhile, the other substances present in the dry triterpene 
extract have now been characterised but are still undisclosed. The birch bark 
triterpenes are pentacyclic triterpenes and can be divided into the two basic Lupan and 
Oleanol backbones (Figure 2).  
Table 1. Triterpene composition of birch bark extract. 
 Triterpene Triterpene extract [% (W/W)]  
Betulin (BE) 81.60  
Lupeol (LU) 2.08  
Betulinic acid (BA) 3.84  
Erythrodiol (ER) 1.05  
Oleanolic acid (OA) 0.97  
Betulinic acid methyl ester (BA-ME) 0.52  
Other (undisclosed) substances 9.94  
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Figure 2. (a) Lupan and (b) Oleanol backbones of pentacyclic triterpenes from birch bark 
extract. 
1.3.4 Galenical properties of birch bark extract 
The triterpene extract consists of small particles and agglomerates with a d50 value of 
about 2-3 µm and a large rough hydrophobic surface resembling to that of cauliflower. 
The extract is in water practically insoluble (0.1 µg/mL) whereas in oils it is slightly 
soluble (0.15-0.3% (m/m)) [58]. Hence, the low solubility of these triterpenes in polar 
and non-polar solvents may hinder development of suitable pharmaceutical 
formulations or lead to a poor bioavailability which might limit their therapeutic 
application [29, 30]. TE forms semi-solid gels when suspended in oils through 
hydrogen bonds [32, 59]. Further, TE act as Pickering stabilizer to form water in oil 
emulsions [32, 60]. It has also been used to produce water-in-oil foams [31, 61].  
 
 
9 
 
1.3.5 Birch bark extract in wound healing 
Ex-vivo and in vivo studies have been successfully undertaken to evaluate the wound 
healing properties of the birch bark extract. Ex-vivo studies have demonstrated the 
positive effects of TE on wound healing for example on diabetic wounds [62]. 
Additionally, the effects of TE-based formulations have been already investigated in 
vivo on different types of wounds such as superficial partial thickness burn wounds, 
surgical skin lesions including dystrophic epidermolysis bullosa where TE treatments 
promote or accelerate wound healing [63-65]. Beyond that, TE has been used to treat 
actinic keratoses and in the treatment of necrotizing herpes zoster after unsuccessful 
conventional therapy [66, 67]. A study conducted by Ebeling et al. showed the 
molecular mechanism of the effects of birch bark extract on wound healing properties 
in human primary keratinocytes and porcine ex-vivo wound healing models. They 
showed that TE and Betulin mainly accelerated re-epithelialization by enhancing 
migration of keratinocytes and their differentiation. Beyond that, they found that TE led 
to upregulation of proinflammatory mediators such as COX-2 and IL-6 which play a 
key role in wound healing und epidermal barrier repair [28, 68]. TE positive effects 
have been observed in all three phases of wound healing [33]. Porcine ex-vivo wound 
healing assays were performed with TE-oleogel (10% TE, 90% sunflower oil). It is 
worthwhile to note that TE together with sunflower oil support more wound healing than 
in combination with other oils as examined by Steinbrenner et al. [29]. An oleogel 
(Episalvan) consisting of TE and sunflower oil received the European marketing 
authorization in January 2016 for the treatment of superficial skin wounds [33]. 
1.3.6 Colloidal dispersions 
A colloidal dispersion is defined by the IUPAC gold book as a system in which particles 
of colloidal size of any nature (e.g. solid, liquid or gas) are dispersed in a continuous 
phase of a different composition (or state) [69]. Colloidal dispersions have been widely 
used to create good colloidal drug carriers for various potential therapeutic applications 
i.e. oral, ocular, dermal and parenteral [70-74]. They have been used to incorporate 
poorly water soluble drugs, increase their bioavailability and can be used to minimise 
the side effects of potent drugs [75-78]. Several methods have been utilized to 
manufacture colloidal dispersions. Mostly they can be formed by first forming a primary 
coarse dispersion with large particle sizes in the micron range (1-5 µm) and 
subsequently subjecting them to e.g. high-pressure homogenization they can be 
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reduced to colloidal range (<1 µm) down to several hundred nanometers (100 – 500 
nm). The pre-dispersion formed in the first step using a rotor-stator high shear mixer 
have high variable particle sizes whereas the subsequent high-pressure 
homogenization produces dispersions with more uniform particle sizes (Figure 3). 
Surface active substances such as proteins, polysaccharides and phospholipids play 
a key role in production and stabilization of colloidal dispersions [71, 79-81]. 
 
Figure 3. Schematic diagram of a typical two-step procedure used to produce colloidal 
dispersion. 
1.3.7 Properties of phospholipids 
Phospholipids (PL) are commonly found in all cell membranes and therefore exist in 
all living organisms where they serve both structural and functional purposes. Lecithin 
is the most common form of phospholipids where phosphatidylcholine (PC) is the major 
component [82, 83]. United States Pharmacopeia (USP) explains “lecithin as a 
complex mixture of acetone-insoluble phosphatides, which consist chiefly of 
phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and 
phosphatidylinositol, combined with various amounts of other substances such as 
triglycerides, fatty acids, and carbohydrates, as separated from the crude vegetable oil 
source. It contains not less than 50.0 percent of acetone-insoluble matter”. This 
definition is lost where lecithin grades contain > 80% PC (arbitrarily PC) and those with 
< 80% PC are arbitrarily known as lecithin. Nowadays, food and cosmetic industry uses 
“lecithin” as a trade name for the mixture of phosphatides [82, 84]. Phospholipids are 
amphiphilic in nature having a polar head group and two lipophilic tails (Figure 4). The 
polar head unit containing a phosphate group can be esterified with an alcohol to an 
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organic molecule such as phosphatidylcholine (PC) with choline, in 
phosphatidylethanolamine (PE) with ethanolamine, phosphatidylglycerol (PG) with 
glycerol etc. Ionization status of phospholipids is controlled by their structure of the 
polar region and pH of the medium, where PE and PC are zwitterionic with a neutral 
charge at pH of about 7 whereas PG is negatively charged. PL can be derived from 
various sources such as eggs, meats, fish, shellfish, cereal grains and oilseeds hence 
differences in PLs content. The properties and composition of various PL classes with 
their origin are well described in the literature [82, 85, 86]. 
 
Figure 4. Chemical structure of a typical phospholipid, phosphatidylcholine. 
Due to their amphiphilic character, PL shows various lyotropic and thermotropic phase 
structures. Depending on the solvent, the lipid composition and the temperature used, 
phospholipids can form self-assembled structures such as micelles, liposomes, 
hexagonal, lamellar, cylindrical structures and aggregates when they become 
hydrated. Hence, transitions between the phases can be induced for example, through 
temperature or lipid concentration variation. For instance, a lipid bilayer can take a 
solid gel phase state at lower temperature but undergo phase transition to a liquid 
crystalline state at higher temperature. This highly depends on the PL type and 
physicochemical properties, as PL chain length increases, phase transitions occur at 
higher temperatures. In liquid phase, PL is likely to form bilayer structures when 
swollen in water but tend to separate into two monolayers when swollen in oil. It has 
been reported that phase transition temperature of unsaturated PL is below 0 °C 
whereas that of saturated PL is between 40-55 °C after being hydrated [83, 87]. Fully 
hydrated phospholipids and glycolipids have been reported to undergo the following 
generalized sequence of thermotropic phase transitions:  
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Lc ⇾ Lβ ⇾ Pβ ⇾ Lα ⇾ QII ⇾ HII ⇾ MII 
Upon heating from low to high temperatures, a sub-transition begins where crystalline 
(Lc) phase transforms into a hydrated lamellar gel phase (Lβ) with ordered lipid chains 
which may either be tilted or not tilted. Thereafter, a pretransition from the low 
temperature gel phase to an intermediate (rippled) gel phase (Pβ) occurs. After that, 
main or chain melting from the gel phase with ordered chains to the fluid lamellar phase 
(Lα) phase with disordered lipid chains. In the fluid phase, further transitions may take 
place with increasing temperature form the lamellar phase to non-lamellar phases of 
the inverted (water-in-oil) type. The sequence of non-lamellar phases would be first 
inverted cubic (QII) and then inverted hexagonal (HII). Finally, an isotropic melt would 
take place close to capillary melting point, presumably to an inverted micellar phase 
(MII) which would be present as an immiscible oil in excess water. Some lipids can 
form two or more modifications of a given phase [88, 89]. 
1.3.8 Phospholipids interactions with triterpenes 
Bioactive triterpenes such as Betulin, Betulinic acid and Lupeol can cause alterations 
of erythrocyte membrane through their hydrogen bonding properties [90]. Additionally, 
triterpenes like Betulin affect the lipidome of keratinocytes where it contributes to 
upregulation of glycerolphospholipids, sphingolipids and diacylglycerides, whereas 
those of cholesteryl esters and triacylglycerides were downregulated. It was concluded 
that Betulin is incorporated in the membrane and metabolized in keratinocytes [91]. It 
has been reported that phospholipid molecules can interact with triterpenes forming 
monolayers [92]. Further, triterpenes interact with phospholipids, being amphiphilic, 
through the choline head group and alkyl chains of PL. This depends on the structural 
properties of triterpenes. Specifically, triterpenes interact with PL and fluidize lipid 
membranes controlled by their free polar groups where tetracyclic triterpenes (e.g. 
cortisol) tend to be located at the head group, whereas pentacyclic ones (e.g. 
erythrodiol) being more hydrophobic are incorporated deeply in the lipid bilayers [93]. 
Cyclic triterpenes share similar structural properties with cholesterol, and it has been 
reported that such a monolayer containing cholesterol and PL is highly ordered. On 
the other hand, binary films of triterpenes and PLs are amorphous [92].  
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1.3.9 Phospholipids as a stabilizer 
Natural phospholipid mixtures have high amounts of unsaturated fatty acids. The acyl 
chains being unsaturated, phase transition temperature from liquid crystalline to gel 
phase is below 0 °C. However, where stable formulations with increased stability are 
the target, PL with higher phase transition temperatures are favorable. The solution is 
to hydrogenate the unsaturated fatty acids natural PL. As a result, saturated PL are 
produced which are chemically more susceptible to oxidation and can be used to form 
stable formulations. Under certain conditions, PL when dispersed in water forms 
vesicles or liposomal structures which include multilamellar vesicles (> 500 nm), small 
unilamellar vesicles (< 100 nm) and large unilamellar vesicles (> 100 nm). These 
vesicles can be designed and loaded with bioactive compounds to create drug delivery 
systems [94, 95]. Stabilizing properties of PL have been well investigated making them 
suitable as perfect excipients to be used in pharmaceutical, cosmetic and food industry 
[82, 96-98]. On the other hand, since phospholipids contain both hydrophilic and 
hydrophobic groups they can form a monolayer at the oil/water interface which possess 
a thickness in the range of 1–3 nm [99-101]. Due to diffusion-controlled monolayer 
adsorption, the interfaces become viscoelastic [102]. Stabilizers adsorbed at oil–water 
interfaces play a key role in determining the stability and other physicochemical 
characteristics of dispersions [103]. Beyond that, this mechanism can also affect their 
production process which may include high shear mixing and homogenization [104]. 
Stabilizers have proved their efficiency in particle size reduction enhanced by their 
complex behaviour in the interface. The adsorption of PL at the oil-water interface 
results to a decrease of the interfacial tension between the two phases and reduces 
the pressure gradients required to disrupt the particles during emulsification process. 
The dispersion particle size depends on the stabilizer concentration whereby the 
particles significantly decrease in size as the stabilizer content was increased [103, 
105-107]. These unique features make phospholipids most suitable to be used as 
excipients for poorly water-soluble drugs [108]. More exclusively, they can be used to 
increase their solubility and thereby leading to a better bioavailability [82]. 
1.3.10 Profile drop analysis 
The measurement of dynamic interfacial tension can be performed using the Profile 
Analysis Tensiometer (PAT) through methods such as pendant drop and buoyant drop 
method (Figure 5). These methods involve the determination of the profile of a drop of 
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one liquid immersed in another immiscible liquid. By analysing the drop shape, 
conclusions can be drawn on the interfacial tension. Additionally, dynamic surface 
tension can also be analysed through these methods, if measurements are made in 
air as the bulk phase [109]. As mentioned in sub-section 1.3.9, the disruption of the 
particles depends on the oil-water interfacial tension; particle break-up is facilitated 
when the interfacial tension is low. The presence of stabilizer in the system may help 
to decrease the interfacial tension and then to minimise the effects of interfacial forces. 
The time taken by the stabilizer to adsorb at the interface is also important; for example, 
during emulsification process, a stabilizer must adsorb quickly at the particles which 
facilitates the particle disruption. The underlying concept to the measurement with PAT 
is the Young-Laplace equation (Equation 1). It represents the relationship between the 
curvature and the drop shape of a liquid in another immiscible liquid as follows: 
 
Figure 5. Buoyant drop method. 
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Where 𝑅𝑅1 and 𝑅𝑅2 are main radii of interface curvature, 𝛾𝛾 is the interfacial tension, ∆𝑃𝑃0 
is the pressure difference at a reference plane, ∆𝜌𝜌 is the density difference, g is the 
gravitational constant and z is the vertical height measured from the reference plane 
[110, 111]. 
1.3.11 Interfacial rheology  
Interface refers to the contact surface between two phases (liquid/liquid, gas/liquid or 
solid/liquid) and the forces acting in the interfaces are known as interfacial tension. If 
forces are acting where one of the two phases is gaseous, it is known as surface 
tension [112]. Interfacial rheology serves as a powerful tool to investigate events 
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happening when molecules are adsorbed at fluid/fluid interfaces and both interfacial 
shear and dilatational deformation can be used. For instance, interfacial tension 
between the immiscible liquid phases, which usually consist of oil and water can be 
lowered by adding amphiphilic surface-active substances such as surfactants, 
polymers and phospholipids to enhance better stabilization [110]. These surface-active 
molecules lower the free energy at the phase boundary. Therefore, interfacial activity 
of these amphiphilic compounds plays an important role in the characteristics and 
stability of various formulations such as foams and dispersions. For example, they can 
hinder instabilities occurring in dispersions such as coalescence, flocculation, 
sedimentation and creaming [102, 113]. For instance, in this work, oscillating drop 
method using the buoyant drop technique (Figure 5) was employed to study dynamic 
dilatational rheology of interfacial layers. The principle of oscillating drop method 
involves changes of the size of the interface, where surface-active molecules are 
located, by continuously altering the drop volume. In a sinusoidal change (expansions 
and compressions) of drop volume and thus the interface, several observations can be 
made: as the interface narrows, stabilizer molecules desorb from the interface 
(interfacial tension increases temporarily) and during the subsequent enlargement 
adsorb the molecules again (interfacial tension decreases temporarily) [110, 114]. 
Hence, the rheological properties of adsorption layers are expressed by the 
relationship between the variation of the interfacial tension, from its initial value, and 
the expansion of the surface area. The interfacial elastic (E) and viscosity modulus can 
be expressed as [115]:  
𝐸𝐸 =
d𝛾𝛾
d ln(𝐴𝐴)
 (Equation 2) 
ƞ𝑑𝑑 =
d𝛾𝛾
(d𝐴𝐴/𝑑𝑑𝑑𝑑)/𝐴𝐴
 (Equation 3) 
Where E: interfacial elasticity, 𝛾𝛾 is the interfacial tension and A is the area of the 
interface and ƞ𝑑𝑑 is interfacial dilational viscosity. 
1.3.12 Polyvinyl alcohol (PVA) 
PVA is a hydrophilic polymer which is water soluble with excellent chemical resistance, 
physical characteristics, non-toxic, biodegradable and biocompatible. This makes it 
one of the most frequently used synthetic polymer in the textile and paper industry, and 
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due to its good biodegradability and biocompatibility has found its use in biomedical 
applications such as drug delivery systems, tissue engineering and wound dressings 
[116, 117]. A Commercially available PVA polymer is usually made by the 
polymerization of vinyl acetate to first produce polyvinyl acetate, followed by the 
hydrolysis of polyvinyl acetate through saponification whereby the ester group is 
replaced by a hydroxyl group. Impurities from the production process such as sodium 
acetate, methanol and methyl acetate could be present in the final product. The 
percentage of acetate groups converted to hydroxyl groups determines the hydrolysis 
degree of PVA, thus affecting the degree of polymer crystallinity and solubility. Hence, 
PVA can be partially (84.2%-89%), moderately (92.2%-96.5%) or fully hydrolyzed 
(98%-99%) where fully hydrolyzed PVA exhibit high crystallinity and low solubility. The 
presence of acetyl groups in partially hydrolyzed PVA as spacers makes it semi-
crystalline (18-60%). It has also been reported that the melting point for partially 
hydrolyzed PVA is between 180°C-190°C and 230°C for fully hydrolyzed whereas the 
boiling point of pure PVA is at 228°C. The glass transition temperature of pure PVA is 
in the range of 75°C-85°C. In addition, PVA has a wide range of molecular weights, 
varying between 20,000-400,000 g/mol. The degree of hydrolysis together with 
molecular weight highly affects the overall polymer behavior in aqueous solutions [38, 
39, 118-120].  
 
Figure 6. Structure of PVA. 
An increase in molecular weight of PVA results to an increase in tensile strength, 
crystallinity, adhesion, resistance to solvents, film-formation and viscosity [121]. 
Moreover, adding PVA to water reduces the surface tension of water [122]. Notably, 
all these physicochemical properties are expected to have a significant impact in 
electrospinning. Studies have been carried out by use of different PVA molecular 
weights to investigate their behavior and the structures that may be formed through 
electrospinning [123, 124]. Researchers have also utilized PVA polymer where it has 
either been used alone or blended with other polymers and incorporated active 
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ingredients to produce electropsun nanofibrous meshes for wound healing 
applications. Some of these incorporated substances have antibacterial effects which 
would prevent the wound from infection during healing [5, 125, 126].  
Table 2. PVA-based electrospun scaffolds as wound dressings. 
Electrospun Scaffold References 
Chitosan/silver nanoparticles/PVA [126] 
PVA/Chitosan/Tetracycline hydrochloride [127] 
PVA/Soursop Leaves Extract (SLE) [128] 
PCL/PVA/curcumin (CU) [129] 
PVA/zein nanoparticles (NPs)/diclofenac (DLF) [130] 
PVA/PVP/PEG/Aloe vera [131] 
PVA/Gum tragacanth [132] 
PVA/chitosan/starch [133] 
PVA/silver nanoparticles [134] 
PVA/Tranexamic acid [135] 
PVA/hyaluronic acid/L-arginine [136] 
PVA/propolis [137] 
1.3.13 Phospholipids in electrospinning  
As highlighted above, PL can form self-assembled structures such as lamellar phases 
or liposomes into various types of colloidal particles which can be further used to 
develop drug delivery systems [138]. The use of phospholipids in electrospinning has 
not been commonly practised but recently electrospun fibers with phospholipids have 
been prepared as drug delivery systems for bioactive substances as shown in Table 
3. The use of PL alone in electrospinning has been performed to form electrospun 
fibers. However high concentrations of PL are needed >35% in order to form 
electrospun solutions. Further, electrospinning was possible at concentrations above 
the onset of entanglements of the micelles [139]. Asolectin, a mixture comprising 
roughly equal proportions of lecithin, cephalin and phosphatidylinositol, has also 
proved to provide antioxidant effect in electrospun fibers with increased encapsulation 
of drugs [140]. Surprisingly, there are very few studies on electrospinning with 
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hydrogenated phospholipids. De Freitas Zômpero et al. loaded β-carotene liposomes 
in PVA/PEO fibers and proposed that, strong interactions existed between the hydroxyl 
groups along the PVA polymer chain and the phospholipid head groups [141]. Beyond 
that, PL have been successfully used to develop core-sheath structured fibers through 
emulsion electrospinning. The principle here is to first load the compounds into 
dispersion systems such as O/W or W/O dispersions using PL as a stabilizer to 
produce colloidal dispersions to allow good encapsulation as well as miscibility with a 
polymer prior to electrospinning. As a result, the release of the incorporated 
substances can be modulated in the process. Furthermore, sensitive compounds can 
be protected against adverse conditions such as acidity and temperature [35, 142].  
Table 3. Applications of phospholipids in electrospinning. 
Application Electrospun material References 
Nonwoven fibrous membranes Lecithin [139] 
Fibrous scaffolds 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE) 
[143] 
Novel biomedical materials and 
drug delivery systems 
Polyvinylpyrrolidone (PVP) / 
soybean lecithin 
[144] 
Encapsulation and antioxidant 
systems 
Asolectin / curcumin/vanillin [140] 
Transdermal drug delivery 
system 
Chitosan / Phospholipids 
(asolectin) / curcumin, diclofenac 
and vitamin B12 
[145] 
UV photostability β-carotene/PVA / polyethylene 
oxide (PEO) 
[141] 
Protection  Conjugated linoleic acids (CLA) / 
PVA / gelatin / cellulose acetate 
(CA) 
[146] 
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1.5 Research objectives 
The overall aim of this project was to design, fabricate and examine PVA-based 
electrospun wound dressings containing birch bark extract with an additional potential 
to improve the wound healing process. The aims and objectives set at the beginning 
of this work can be summarised as:  
• To study the interaction of the birch bark extract with hydrogenated 
phospholipids 
• To develop a suitable workflow to produce o/w-colloidal dispersions containing 
the active substance birch bark dry extract stabilized using hydrogenated 
phospholipids.  
• To develop a suitable processing methodology to produce TE-loaded/PVA 
structures by electrospinning 
• To study the influence of the addition of colloidal dispersions into polymeric PVA 
matrix 
• To study the combined effects of polymer and electrospinning associated 
variables on the structure of the electrospun fibers. Parameters such as- 
solution concentration, molecular weight, applied voltage, tip-to-collector 
distance and flow rate will be investigated.  
• To evaluate betulin release from TE-loaded dressings through ex-vivo 
permeation and in vitro drug release studies. Investigation on the effect of 
adjusting constituents of colloidal dispersions and polymer molecular weight on 
drug release will also be included. 
• To examine the efficacy of TE-loaded PVA electrospun wound dressings 
through ex-vivo wound healing assay 
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1.6 Thesis layout 
This thesis is composed of 5 chapters: 
1. Chapter 1 is an introduction underlining the motivation, significance, general basics 
and objectives of this work 
 
2. Chapter 2 of this thesis represents a comprehensive literature review on 
electrospinning technology in biomedical applications. It introduces electrospinning 
technology and parameters affecting the electrospinning process. It also gives an 
overview of the recent advances in electrospinning design for areas like tissue 
engineering and drug delivery applications. Further, such a review will allow 
identification of potential polymeric biomaterials with properties such as 
biocompatibility, biodegradability and non-toxicity which are suitable for 
development of wound dressing materials. The review concludes with an illustration 
of possible challenges and future directions of electrospinning. 
 
3. Chapter 3 of this thesis describes production of colloidal dispersions. Initially, a 
study on interfacial interaction of phospholipids together with the lipophilic 
components; triterpene extract and sunflower oil, was investigated through dynamic 
interfacial tension measurements using Profile Analysis Tensiometer. These 
interfacial rheological experiments might reveal the possible key role played by 
phospholipids at the interface. This chapter concludes with production of TE-loaded 
colloidal dispersions through a step-wise homogenization procedure using 
hydrogenated phospholipids as a stabilizer. Here, a full factorial design of 
experiment (DOE) was used to generate combinations of formulations. In particular, 
the influence of phospholipid composition and phospholipid-to-oil ratio towards the 
reduction of particle size was evaluated and optimized. 
 
4. Chapter 4 of this thesis focuses on ex-vivo wound healing efficacy of electrospun 
wound dressings. It also provides a comparative analysis between low and high 
loaded TE-dressings, TE-oleogel, control and placebo. Further, a detailed analysis 
towards ex-vivo permeation and in vitro drug release was also undertaken. 
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5. Chapter 5 is where a novel methodology was established to produce nanofibrous 
mats containing TE-loaded colloidal dispersions optimized in chapter 3. Further 
work in this chapter involved influence of the three different PVA molecular weights 
(Mw 67,000, Mw 130,000 and Mw 146-186,000) in fabrication and characterization 
of TE-loaded electrospun fibers. The influence of PVA molecular weight towards 
the resulting rheological properties of polymer solutions and fiber morphologies was 
explored. In addition, physicochemical properties as well as in vitro drug release 
and ex-vivo permeation experiments were also assessed. 
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2.1 Abstract  
Electrospinning has been revolutionized as an efficient process to prepare nanofibers 
from polymer solutions. It is a highly scalable process with a range of parameters which 
can be tuned to affect the outcome of the fiber properties. Therefore, proper control of 
these parameters is necessary to achieve desired fiber morphologies and diameters. 
The resulting nanofibers have special features, such as high surface area to volume 
ratio and can form mats/fleeces with high porosity which makes them attractive for 
many applications, such as in air filtration, textile industry, drug delivery, tissue 
engineering, and wound healing. In this chapter, we will present a concise introduction 
of the electrospinning technique and its application in drug delivery, tissue engineering 
and wound healing. Other issues such as technology challenges, limitations, regulatory 
aspect and possible future trends are also discussed. 
Keywords:  
Electrospinning, Nanofibers, Drug delivery, Extracellular Matrix (ECM), Tissue 
engineering 
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2.2 Introduction 
Electrospinning, as the name suggests, is a process by which nanofibers are 
generated from a polymer solution or melt in the presence of an electric field. It was 
known back in 1934 when A. Formhals patented this process describing the production 
of cellulose acetate based fibers using an acetone / alcohol solution as the solvent [1]. 
Thereafter, many researchers like Reneker and others especially in the 1990s stepped 
up further in using electrospinning technology to produce nanofibers and now we know 
that a wide range of polymers can be electrospun into nanofibers [2-8]. Since then, the 
technology has gained a lot of momentum and interest in the recent years and 
nowadays it is widely used to generate nanofibers for various applications from drug 
delivery to tissue engineering [9]. The electrospinning technique is a simple and 
versatile process for preparing fibers having a diameter from few micrometers down to 
several nanometers [10, 11]. Even preparing nanofibers below 1 nm seems to be 
possible [12]. Beyond that, the obtained nanofibers possess not only good mechanical 
properties but also exhibit unique properties, such as high surface area to volume ratio 
and are able to form mats with small pore sizes and high porosity [8]. Porous fibers 
can allow large drug loading, free drug diffusion, outstanding cell attachment, sufficient 
nutrients transport, and quick waste removal [13, 14]. These outstanding 
characteristics together with the structural similarity of electrospun fibers to native 
extracellular matrix (ECM) makes electrospun scaffolds perfect biomaterials to be used 
in tissue engineering, wound healing and other biomedical applications [15, 16]. The 
composition of ECM varies with the nature of tissues. The two most common 
constituents involve structural proteins e.g., collagens, elastins, fibronectins, and 
proteoglycans [17]. 
Polymers required to fabricate nanofibers intended for various biomedical applications 
including controlled drug release and tissue engineering should be biocompatible and 
biodegradable [18]. Such polymers are highly desired as biomaterials, since they are 
broken down, excreted, or are absorbed from the body after serving their intended 
purpose; therefore, a second surgery intervention for implant removal can be avoided. 
Generally, they should not be only biocompatible and biodegradable but also non-
immunogenic, non-toxic, and non-mutagenic. In addition, these polymers undergo 
biodegradation by hydrolytic or enzymatic route [19, 20]. These polymers may be 
synthetic, (esters, amides, ethers, urethanes) or of natural kind (polysaccharides and 
proteins) [21]. The most popular natural polymers are such as collagen, gelatin, silk 
fibroin, chitosan and alginate whereas synthetic polymers include polyvinyl alcohol 
(PVA), poly(ε-caprolactone) (PCL). Polyglycolide (PGA), and polylactide (PLA) 
together with their copolymers, namely poly (lactic-co-glycolic acid) (PLGA) and Poly(l-
lactide-co-ε-caprolactone) (P(LLA-CL)), have been already approved for clinical use 
by the FDA. These polymers allow to tailor the degradation kinetic by using either the 
homopolymers or copolymers with a distinct molar ratio of the monomers [19].  
A wide variety of these polymers can also be used for 3D printing. Unlike in 
electrospinning, the polymers are not dissolved in a suitable solvent but are processed 
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by hot-melt extrusion technique, e.g., in fused in fused deposition modelling (FDM). 
This enables 3D printing to precisely produce scaffolds according to user-defined 
specifications of the overall geometric structures. In electrospinning, this is still a 
challenge to produce scaffolds with an exact shape and complex geometries [22]. 
However, through 3D printing it is only possible to produce fibers of micrometer range 
which does not mimic the ECM with low cell adhesion properties as compared to 
electrospun nanofibers. Three-dimensional-printed scaffolds exhibit good mechanical 
properties and hence can be combined with electrospun nanofibers to produce 
structures with an improved biological and mechanical function [23]. 
Different strategies have been used for incorporation of therapeutic agents into the 
electrospun scaffolds namely; blending, coaxial, emulsion, surface modification and 
electrospraying can be performed. These techniques enable successful integration of 
any drug, DNA, growth factors, cells and other bioactive molecules [24]. 
The selection of solvent used to dissolve a polymer in electrospinning is important 
since solvents interact differently with polymers. Here, the Hansen parameters can be 
utilized while searching for an appropriate solvent in electrospinning that could produce 
good quality fibers. These parameters which are related to the Hildebrand solubility, 
essentially divide the solubility into three components including polar interactions (δP), 
hydrogen bonding (δH), and dispersive or van der Waals interactions (δD) in a three-
dimensional sphere system [25]. Furthermore, Hansen solubility parameters are widely 
used to predict material properties such as their affinity, encapsulation efficiency of 
drugs and in selection of good or poor solvents for polymers [26-28]. The dissolution 
of a polymer depends not only on the type of the solvent used but also the temperature 
and degree of polymerization [29]. It is good to note that, the issue of molecular weight 
is a major concern when it comes to polymer and active ingredient selection. Many 
physicochemical properties of polymers are influenced by the length of the polymer 
chain like viscosity, glass transition temperature, and mechanical strength. Higher 
molecular weight is generally preferred as there will be greater chain entanglement to 
facilitate the formation of fibers during spinning. However, at higher polymer 
concentrations, an excessive viscosity increase may cause difficulty in the 
electrospinning process. In contrast, lower molecular weight polymer solutions tend to 
break up into droplets or form beads. In this case, increasing the concentration may 
facilitate the formation of fibers without running into problems due to a too high 
viscosity. However, the spinnability of a polymer with the resulting fiber morphology 
should always be tested [30-32].  
Machotova et al. investigated through electrospinning of styrene-ethyl acrylate 
copolymers the influence of polymer polarity and glass transition temperature (TG) on 
fiber formation and hydrophobicity. They concluded that, by performing the 
electrospinning process at the temperatures above the polymer glass transition 
temperature, sticking of fibers may occur resulting to non-uniform fibers with increased 
diameters. The hydrophobic / hydrophilic character of the electrospun mats was also 
influenced by changing the polarity of the polymer and TG [33]. On the other hand, the 
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molecular weight of the active ingredient and its acidity/basicity should also be taken 
into consideration in controlling release [34]. Hence, depending on the intended 
purpose of use and the active agent to be loaded, a careful polymer selection is needed 
as the final product will also be affected [16]. 
The objective of this chapter is to give a reader a quick overview of the recent advances 
in electrospinning design for tissue engineering, drug delivery, and other biomedical 
applications (Fig. 3.1). An overview of the processing variables and setups used to 
modulate scaffold architecture in the electrospinning process is provided. A summary 
of available electrospun products together with scaling up opportunities and regulatory 
aspects is also covered. 
 
FIGURE 3.1. Diverse applications of electrospun nanofibers. 
2.3 Electrospinning process and set up 
Electrospinning occurs when high electric potential is applied to a pendant droplet of a 
starting polymer solution or melt to form a thin fiber. Precisely, the liquid is forced 
through a nozzle by a constant flow pump or pressurized gas, which initially forms a 
pendant drop at the nozzle tip. The drop is held there by its surface tension. An 
electrode from the high voltage supply is then directly attached to the nozzle of which 
blunt needles are most commonly used. The voltage supply is then turned on charging 
the polymer solution. The resulting electrical repulsion forces acting on the polymer 
solution causes the pendant droplet to deform into a conical shape which is also known 
as Taylor cone [35, 36]. When the voltage is increased, and a certain threshold is 
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reached, surface tension of the polymer solution is overcome, and a charged jet 
emerges from the Taylor cone migrating towards the collector. During its migration 
from the needle tip to the collector, the solvent from the jet evaporates quickly and the 
fibers are deposited over the grounded collector. As the jet travels towards the 
collector, it experiences stretching, bending and whipping favoured by repulsive 
charges existing along the jet [37, 38]. The resulting nanofiber mats are either in a 
nonwoven or aligned form depending on the type of the collector used.  
The process of electrospinning is closely related to electrospraying although there is a 
marked difference in the morphology of the final product. The difference between the 
two processes is based on the concentration of the polymer solution. In electrospinning 
process, when the concentration of polymer concentration is high, provided that the 
resulting viscosity is optimal, there is elongation of a jet from the Taylor cone leading 
to fiber formation. On the other hand, if the polymer concentration is low, the jet is 
destabilized without elongation, and only fine droplets are formed [39]. 
In order to obtain nanofibers from a polymer solution, the electrospinning process as 
shown in Fig. 3.2 requires three major components: a high-voltage source, a pump 
providing a constant flow rate, e.g., a syringe pump on lab scale, and a collector which 
is normally grounded [5]. The voltage supply provides high electrical voltage to start 
the spinning process, a syringe pump holds a plastic or glass syringe with a needle 
attached to it and delivers the polymer solution at a constant flow rate throughout the 
electrospinning process. Deposition of formed fibers takes place at a collector. Fig. 3.3 
shows formation of electrospun mat and its microscopic structure. 
It is important to note that, the nozzle can be configured in either single or coaxial 
design and both are regarded as conventional approaches to process fibers in 
electrospinning. Single nozzle is the simplest used at laboratory level for ejecting single 
polymer solution out of the nozzle to form fibers. Coaxial design is an extension of 
single nozzle, where it has been modified to deliver two different liquids independently 
resulting in core-shell or hollow structured fibres [40] (Figs. 3.4 and 3.5). However, 
recent developments in electrospinning have led to needleless-electrospinning 
techniques e.g. use of rollers, discs, balls, bubbles, bearing the potential to produce 
nanofibers in large quantities including overcoming clogging issues faced with single 
nozzle electrospinning [41]. The major parameters affecting the outcome of fiber 
morphology are further explained below. 
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FIGURE 3.2. Single needle electrospinning set up. 
 
 
FIGURE 3.3. (A) Image of an electrospun fiber mat. (B) Scanning electron micrograph 
of electrospun Polyvinyl alcohol (PVA) fibers. 
2.3.1 Process parameters 
2.3.1.1 Voltage 
A critical voltage value is the driving force needed for jet initiation and formation of 
nanofibers. An increase in the applied voltage leads to the formation of nanofibers with 
a smaller diameter due to the stretching of the electrospinning jet caused by increased 
charge repulsion. Further increase of voltage value causes high jet instability, resulting 
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in the formation of beaded nanofibers and poor fiber morphology [42, 43]. A typical 
voltage in electro-spinning ranges from 5 to 50 kV [44]. 
2.3.1.2 Flow rate 
The feed rate of the polymer solution significantly effects fiber morphology and optimal 
flow rate is needed to obtain uniform nanofibers. High feed rates result in poor fiber 
morphology formation with beads. For instance, uniform nanofibers of polystyrene 
could be formed at 0.5 mL/hr, while increasing the flow rate to 1.5 mL/hr led to the 
formation of beaded nanofibers with flattened web-like structures. This is due to 
incomplete drying of the nanofibers in the space between the needle and the collector 
at high flow rates [45]. Also, increasing feed rate increases the mean fiber diameter 
[42]. 
 
FIGURE 3.4. Morphology of electrospun fibers as drug-delivery systems from different 
approaches. (A) blend electrospinning; (B) hollow and (C) core-shell fibers through 
coaxial electrospinning; (D) emulsion electrospinning.  
2.3.1.3 Collector 
Electrospun fibers can be collected using a wide variety of collectors, mainly consisting 
of stationary or rotating platforms. These collectors will affect the final design of the 
electrospun fibers. Random or nonwoven fibers can be collected while using a plate 
collector whereas more aligned fibers are obtained with a rotating drum collector 
(mandrel). When using a rotating collector, the fiber diameter can be influenced by the 
circumferential speed of the collector. With increasing speed higher stretching forces 
are evolved which elongate the fibers and make them thinner. Motamedi et al. were 
able to collect polyvinylidine fluoride (PVDF) aligned fibers with decreasing mean fiber 
diameter by increasing the rotating collector speed from 1000 to 2500 rpm [42]. 
2.3.1.4 Nozzle tip-to-collector distance 
The separating distance between nozzle tip and collector dictates the evaporation rate 
and deposition time of the electrospinning jet. When the spinning distance decreases 
to a critical length, poor fiber morphology with beads can be observed due to 
insufficient fiber stretching and solvent evaporation. Increasing the spinning distance 
provides a larger space for jet stretching and longer time for solvent evaporation from 
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the fibers and uniform fibers with thinner diameters can be formed [42, 43]. Shen et al. 
using melt-electrospinning of polypropylene fibers found out that if the distance 
between nozzle tip and collector is too long (> 8 cm) the strength of electric field 
weakens, resulting in the increase of fiber diameter [46]. Also, when the collector is 
kept too far away from the nozzle tip, a decrease or fail in fiber collection can occur 
[47]. 
2.3.1.5 Polymeric solution 
It is reported that polymer solutions depending upon the molecular weights and 
concentration used, exhibit different electrospinnability, a good electrospinnability is 
directly related to optimum viscosity of polymeric solution. Usually at very low polymer 
concentration, the viscosity of the solution is low and not enough for polymer 
entanglements and fiber formation which results in electrospraying instead of 
electrospinning. Therefore, polymer viscosity plays a crucial role on the morphology of 
electrospun nanofibers where low viscosity results in the formation of beaded 
structures and increased viscosity leads to the formation of smooth bead free 
nanofibers. However, too high viscosity of polymer solution clogs the nozzle tip without 
fiber formation. Also, the conductivity of the polymer solution seems to affect the 
diameter of the electrospun nanofibers. Increased conductivity (> 0.55 mS/cm) induces 
higher stretching of the jet; which lead to a smaller diameter nanofiber [43]. 
The above-described parameters signify that the whole electrospinning process is a 
highly adjustable process. Thus, electrospinning process provides an opportunity for 
easy or free control over fiber diameter, morphology, surface characteristics, porosity 
and ease of getting fiber diameter in nanometer range. It is noteworthy that each 
polymer has an optimal working space taking into account both solution and process 
parameters in which it can be electrospun. Therefore, it is not possible to make a 
general recommendation for example for particular molecular weights / concentrations, 
flow rate, voltage, distance, and the resulting fiber morphology and diameter, because 
the optimal values of these parameters vary considerably with the polymer and solvent 
used. Hence, a critical optimization of both solution and process parameters is vital in 
order to achieve desirable fiber specifications beside a proper polymer selection [48] 
(Table 3.1). 
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TABLE 3.1 Some of the electrospun polymers and their parameters. 
Polymer and 
Solvent type 
Molecular weight Electrospinning 
parameters 
References 
Collagen/PLGA, 
1,1,1,3,3-hexafluoro-
2-propanol (HFP) 
90,000–126,000 Da Collector distance: 
17 cm, flow rate: 1 
mL/h, voltage:29 kV 
[49] 
PVA, Water 89,000-98,000, 
~125,000, 146,000-
186,000 g/mol 
Collector distance: 
15 cm, flow rate: 0.5 
mL/h, voltage:12, 
15, 18 kV 
[50] 
PCL, HFP ~120,000–300,000 
g/mol 
Collector distance: 
15 cm, flow rate: 0.8 
mL/h, voltage:20 kV 
[51] 
PLA, chloroform:N, N-
dimethylacetamide 
(DMAc): (80:20) 
200,000 g/mol Collector distance: 
12 cm, flow rate: 1 
mL/h, voltage:11 kV 
[52] 
2.4 Drug delivery applications 
2.4.1 Electrospun fibers as drug-delivery systems 
Electrospun fibers in drug delivery applications are administered mainly via oral, and 
topical routes or as implantable devices [53, 54]. Both natural and synthetic polymers 
have been widely used in the development of drug nanofibers as drug carriers to 
enable the release of drug in a controlled manner over a desired period (Table 3.2). 
Due to their characteristics like degradability, high porosity, high surface area-to-
volume ratio of the fibers can be efficient in some processes, such as cell binding and 
proliferation, high drug loading, and mass transfer processes. Many drugs ranging from 
antimicrobials and anticancer drugs to bioactive molecules like DNA and RNA, proteins 
and other active agents have been incorporated into nanofibers producing drug 
delivery systems for various therapeutic applications [55].  
  
 
 
39 
 
TABLE 3.2 Electrospun drug-loaded nanofibers in drug-delivery applications. 
Route Drug incorporated Polymer References 
 
 
 
 
Oral 
Ofloxacin/gellan PVA [56] 
Ondansetron hydrochloride PVA [57] 
Ibuprofen/carvedilol PCL [58] 
Ibuprofen Polyvinylpyrrolidone 
(PVP) 
[59] 
Caffeine/riboflavin PVA [60] 
Donepezil HCl PVA [61] 
Clobetasol-17-propionate Eudragit RS100 / PVP 
/ PEO 
[62] 
Salmon calcitonin (SCT) Sodium alginate / PVA [63] 
 
 
 
Dermal 
Ciprofloxacin.HCl PVA / Chitosan / PCL [64] 
Ketoprofen (KP) PVA / Poly(acrylic 
acid) / Multi-walled 
carbon nanotubes 
(MWCNTs) 
[65] 
Asiaticoside (AC) Cellulose acetate [66] 
Vitamin A acid/ Vitamin E Cellulose acetate [67] 
Meloxicam PVA [68] 
Curcumin/diclofenac/vitamin 
B12 
Chitosan/phospholipids [69] 
Tetracycline 
hydrochloride/phenytoin 
sodium 
Cellulose acetate /PVA [70] 
 
 
Other 
implants 
Collagen/salicylic acid (SA) PVA [71] 
Amoxicillin Polyethylene glycol 
(PEG)/PLGA 
[72] 
Cefradine/5-fluorouracil PLGA/Gelatin [73] 
Doxorubicin PLA [74] 
Paclitaxel Polyurethane(PU) 
/Eudragit® L100-55 
[75] 
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Several techniques are illustrated in the literature for drug incorporation using 
electrospinning devices, include blending, coaxial, emulsion, and surface modification. 
With these methods, drugs can either be attached to the fiber surface or encapsulated 
into the fiber core. And every technique has its own merits and demerits since not all 
drugs can be loaded with any method, the approach used heavily relies on the drug’s 
physicochemical properties, intended application, polymeric characteristics, and the 
expected drug release rate [76, 77].  
During blending technique, the active agent is mixed with polymer solution prior to 
electrospinning. Here, hydrophobic-hydrophilic properties of drug and polymer should 
always be thought-about. Mostly, issues of initial burst release of drugs from 
electrospun fibers is observed. This can be reduced through different combinations of 
hydrophilic and hydrophobic polymers or by use of emulsion and coaxial 
electrospinning method [76, 77]. Surface modification ensures that therapeutic agents 
are bound to the fiber surfaces. This can be for example used for gene or growth factor 
delivery. Electrospraying has been for example applied to load bioactive nanoparticles 
into electrospun scaffolds [77, 78].  
Electrospinning using a coaxial nozzle design allows the production of core–shell 
structured nanofibers. The Coaxial process involves creating a drug loaded core which 
is sheathed by a drug-free (or drug-containing) polymer shell. In most cases, drugs 
sandwiched inside will be initially protected from environmental factors, such as the 
solvents used for electrospinning. Also, since the drug is encapsulated within the core 
portion of a nanofiber, a long-lasting biological stability can be achieved. Therefore, it 
gives a possibility to encapsulate and protect environmental or stress sensitive 
compounds like proteins [79, 80]. The release mode and kinetics of compounds from 
the inner core can be adjusted by controlling shell properties such as thickness and 
biodegradability [81].  
Lastly, emulsion electrospinning is an efficient method to encapsulate drugs into the 
nanofibers (Table 3.3). With the help of two types of emulsions; oil-in-water (O/W) and 
water-in-oil (W/O), it is possible to manufacture nanofibers containing small drug 
enriched compartments and to modulate drug release rate by regulating the oil and 
water phase of the emulsions. Surfactants e.g., phospholipids play a key role for 
production of emulsions aiming to produce stable sub-micron sized droplet which are 
vital for encapsulation including proper stabilization in the polymeric system. Use of 
W/O emulsion electrospinning could improve the release of hydrophilic drugs, 
whereas, with O/W emulsions, encapsulation of lipophilic components to electrospun 
fiber can be useful [82]. 
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TABLE 3.3 Applications of the emulsion electrospinning technique. 
Application Electrospun material References 
 
Wound dressing 
PCL/hyaluronan/epidermal 
growth factor 
[83] 
Ketoprofen/PCL/gelatin [84] 
Human Epidermal Growth 
Factor (rhEGF) and Aloe 
vera/PLGA 
[85] 
Gentamicin 
sulfate/metronidazole/PLA 
[86] 
PLGA/Chitosan/PVA [87] 
 
Tissue engineering 
Cefradine/5-
fluorouracil/PLGA/Gelatin 
[73] 
Hydroxyapatite/laminin/PLCL [88] 
Alginate/PLA [89] 
Silk Fibroin/PCL [90] 
 
 
Drug delivery 
Metformin-
hydrochloride/metoprolol 
tartrate/PCL/Poly(3-
hydroxybutyric acid-co-3-
hydroxyvaleric acid (PHBV) 
[91] 
Phytoncide/PVA [92] 
Doxorubicin hydrochloride 
/PEG-PLLA 
[93] 
Recent advances have seen smart nanofibers being developed as stimuli-responsive 
electrospun nanofibers for controlled release. Such stimuli can include pH, enzymes, 
oxidative stress, temperature, light and electric or magnetic fields. The idea here is to 
trigger the release of therapeutic agents at the targeted site by means of these stimuli 
[54, 94]. General mechanisms of drug release are found to be diffusion, desorption, 
matrix degradation / erosion, and swelling which is dependent on the nature of the 
polymer system used for delivery including the geometry of nanofibers. For example, 
fibers of smaller diameter exhibit faster drug release compared to fibers with larger 
diameters [95-97]. In most cases, based on the drug release profile, initial burst release 
process followed by a drug diffusion manner can be observed. 
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2.4.2 Needleless foam electrospinning 
Several foam electrospinning techniques have been used to manufacture foam-based 
electrospun nanofibers apart from the commonly used nozzle-based electrospinning 
method. A new approach of needleless electrospinning involves utilizing foams to 
produce nanofibers was performed by Higham et al. [51]. They were using PVA and 
polyethylene oxide (PEO) solutions. They fed compressed carbon dioxide gas into 
polymer solutions through a fritted funnel. Upon immersion of a copper electrode 
coupled with a high voltage supply into the polymer solution, foam formation on the 
surface occurs and once the electric force is applied, jets are formed migrating towards 
the collector to form the nanofibers. This technique not only overcome the clogging 
problems encountered on the needle tip during electrospinning as the solvent 
evaporates, but also improves the production rate of fibers [98]. Furthermore, an 
addition of non-ionic surfactants e.g. Triton X‐100 in small concentrations (0.01-0.1 
wt.%) to electrospinnable solutions can improve foam formation, without negatively 
affecting the desired fiber morphology. In fact, syringe electrospinning and foam 
electrospinning have shown a relationship when it comes to electrospinnability of 
polymer solutions and the resulting fiber morphology. This suggests that optimal 
process and solution parameters found to electrospun fibers through syringe 
electrospinning can also be employed to deliver the same results via foam 
electrospinning [98]. 
Also, Sidaravicius et al. used this foam electrospinning principle to test 
electrospinnability of aqueous polymer solutions [99]. Ahirwal et al. developed PCL 
based 3D-cm thick foams with high porosity through the honeycomb self-organization 
of nanofibers and these foams could be ideal materials for tissue engineering 
applications [100]. 
Other nanofiber-based foams can be developed via freezing method by first producing 
a membrane through electrospinning. For instance, Si et al. 2014 constructed a foam 
by first cutting small pieces of polyacrylonitrile/benzoxazine (PAN/BA-a) and SiO2 
electrospun membranes in water/tert-butanol mixture to form a dispersion and further 
freeze dried to a foam which can be used for various applications [101]. In general, 
nanofibers-based foams have been rarely used in drug delivery applications. However, 
Svagan et al. in 2016, successfully developed cellulose nanofiber (CNF)-based foam 
materials with a model drug riboflavin and a prolonged drug release was observed. 
Such materials could be useful in gastroretentive drug delivery [102]. 
2.4.3 Nanofibers impregnated with nanoparticles 
Nanoparticles have particle sizes ranging from 100 to 500 nm [103]. Several methods 
like emulsification-solvent evaporation have been extensively applied to prepare such 
nanoparticles [104]. Nanoparticles in drug delivery come with advantages, such as 
they enhance the solubility of hydrophobic drugs, increase the physiochemical stability 
of therapeutic agents, can be used to modulate drug release rate, and improve the 
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bioavailability of therapeutic agents [105]. Recently, incorporation of nanoparticles 
(NPs) within electrospun fibres has emerged as one of most interesting research topics 
in the field of electrospinning. When these nanoparticles are combined with nanofibers, 
we can potentially maximise the effective functional output from nanoparticles as we 
widen the scope use of nanofibers in the field of pharmacy and medical devices. Silver 
nanoparticles have been widely incorporated into electrospun nanofibers by many 
researchers for antimicrobial applications and wound healing [106-108]. Nie and Wang 
in 2007 successfully prepared DNA/chitosan nanoparticles and PLGA/HAp composite 
scaffold for bone tissue engineering. This scaffold showed higher cell attachment, 
greater cell viability and improved DNA transfection efficiency in human marrow stem 
cells (hMSCs) [109]. Furthermore, it is also possible to load anticancer drugs e.g. Kim, 
Ebara and Aoyagi in 2013 electrospun the fibers from a solution of the polymer poly 
(NIPAAm-co-HMAAm, a copolymer of N‐Isopropylacrylamide and N‐
hydroxymethylacrylamide) mixed with a solution of magnetic nanoparticles and 
doxorubicin. Using this scaffold, they effectively demonstrated of killing cancer cells, 
the human melanoma [110]. 
2.4.4 Wound dressings 
Based on the nature of the healing process, wounds can be classified as acute or 
chronic wounds. Acute wounds include, mechanical injuries caused by knives, gun 
shots and surgical wounds including burns and chemical injuries. Acute wounds 
usually take short period (8-12 weeks) to heal completely, whereas chronic wounds 
such as those from diabetes ulcers, decubitis ulcers heal slowly and take beyond 12 
weeks to recover [111]. Electrospun nanofibers have unique properties, such as high 
porosity, high encapsulation efficiency, and high surface-area-to-volume ratio, and 
thus high drug loading. These features make electrospun mats perfect materials for 
wound dressing. Besides mimicking the native extracellular matrix of human tissues, 
their high surface area and high porosity allow efficient gaseous exchange including 
removal of exudate, and they also act as a physical barrier against entry of 
microorganisms while preventing dehydration during wound healing [19, 112-114]. 
Many wound dressings based on electrospun fibrous mats have been developed and 
loaded with diverse active ingredients (Table 3.4) [85, 111, 115]. In particular, the 
incorporation of active ingredients with antibacterial properties in the electrospun 
wound dressing would prevent infection of the wound and accelerates the healing 
process. However, some of them have been reported to show adverse effects like 
allergic contact dermatitis [69] and use of dressings loaded with antibiotics has risk of 
developing antimicrobial resistance [70].  
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Table 3.4 Electrospun nanofibers used in wound dressing applications. 
Application Electrospun Scaffold References 
Wound dressing Sodium alginate /PVA/moxifloxacin 
hydrochloride (MH) 
[116] 
Gelatin/keratin/PVA [117] 
PCL/PVA/curcumin (CU) [118] 
Chitosan (CS)/PVA/ Ampicillin [119] 
PVA/ zein nanoparticles (NPs)/diclofenac 
(DLF) 
[120] 
Chitosan/silver-NPs/PVA [121] 
 PVA/Chitosan/Tetracycline hydrochloride [122] 
 PVA/Soursop Leaves Extract (SLE) [123] 
 Silk fibroin/gelatin [124] 
 Hyaluronic Acid/PLGA [125] 
 PLA/Ag NPs/ Momordica charantia fruit 
extract 
[126] 
 PLA-Hyperbranched polyglycerol/ curcumin [126] 
 Spirulina extract-alginate PCL [127] 
 Collagen/ Silver nanoparticles (AgNPs) [128] 
 PLGA/metformin [129] 
Moreover, frequent dressing changes have to be avoided as this causes a lot of pain 
and trauma to patients, damage to new sensitive epithelial cells and even affecting the 
wound healing pattern. These problems can be solved by careful selection of the 
ingredients especially with respect to the irritation and sensitization potential. 
Moreover, polymers with good biocompatibility and which are biodegradable should be 
preferred as they do not require an invasive and / or traumatic intervention for dressing 
removal. In wound treatment, an initial burst release frequently observed from release 
profiles of drug loaded nanofibers could be of great importance; if for example the drug 
has antimicrobial and/or anti-inflammatory properties, it can provide immediate relief, 
while a subsequent slow release of drug prevents reinfection [111, 130]. Furthermore, 
sustained drug release also supports less frequent dressing changes and could thus 
improve patient compliance. Therefore, the main goal should be to develop an 
electrospun wound dressing with less or free of adverse effects suitable for human use 
with effective wound therapy even after long term usage. To this end, in our 
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laboratories we have developed a bioactive PVA based electrospun wound dressing 
through emulsion electrospinning containing birch bark extract, an active ingredient 
clinically proven to improve wound healing [131, 132]. 
2.5 Tissue engineering 
2.5.1 Biomimetic scaffolds 
The goal of tissue engineering (TE) in regenerative medicine is to use cells, 
biomaterials, and bioactive molecules such as growth factors to restore or replace 
damaged human tissues or organs. Hence, suitable scaffolds for tissue engineering 
applications should be biodegradable, biocompatible, nontoxic, non-mutagenic, and 
nonimmunogenic [20]. Biodegradability is very important and ideally the scaffold 
should degrade within the same period of time as it is replaced with newly regenerated 
tissues. Natural tissue consists of a structural component, the ECM, and other tissue-
specific cells that occupy it. Electrospun scaffolds aims to resemble the natural tissue 
as closely as possible so that they can serve as a perfect material for cell regeneration. 
For this purpose, electrospun based polymeric scaffolds play a vital role in tissue 
engineering through cell seeding, proliferation followed by new tissue formation. 
Another advantage of electrospun nanofiber scaffolds is that their morphology can be 
modified by controlling the electrospinning parameters to obtain the architecture that 
best fits the intended application. Studies have shown that electrospun fibrous 
scaffolds with aligned fibers both in vitro and in vivo to enhance better cell migration 
and differentiation as they tend to mimic ECM well compared to other forms of scaffolds 
[14, 133]. In addition, nanofiber sheets can be formed into almost any shape e.g. tubes 
based on the site of desired implantation [134]. Through electrospinning, many 
researchers have utilized a variety of biocompatible synthetic and natural polymers to 
produce electrospun products, such as vascular grafts including bone grafts for tissue 
engineering. 
2.5.2 Bone scaffolds 
Bone matrix mainly consists of aligned collagen and hydroxyapatite materials which 
gives bone its balance of stiffness, strength and toughness [135]. The versatility of 
electrospinning has enabled many researchers to investigate various ways of 
manufacturing scaffolds for bone healing and repair. An ideal material must be 
biocompatible and bioactive to be able to initiate osteogenesis, and eventually lead to 
bone repair [136]. Several research groups have utilized electrospun scaffolds to 
develop bone grafts by incorporating bioactive substances to assist proliferation and 
mineralization of osteoblasts, enhancing bone regeneration. For example, Abdal-hay 
et al. used scaffolds of polyamide 6 nanofibers and coated them with hydroxyapatite 
(HA). An in vitro culture test revealed that HA-Polyamide nanofibers showed good 
biocompatibility and faster cell growth and proliferation compared to pristine scaffolds 
[137].  
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In addition, both natural and synthetic polymers have been used to design scaffolds in 
bone tissue engineering (Table 3.5). Studies have also shown that natural polymers 
like chitosan that exhibit weak mechanical properties but with excellent bioactivity can 
be combined with other synthetic polymers, e.g., PCL, to produce bone grafts with both 
improved physical and biological characteristics. Numerous studies combined 
biodegradable synthetic polymers like PGA, PLA, PLGA and PCL, PVA with stem cells, 
e.g., bone marrow-derived mesenchymal stem cells (BM-MSCs) and osteoblasts and 
obtained excellent bone scaffolds [136, 138-141]. Lim et al. demonstrated that 
alignment of fibers influences bone cell growth behaviour as they favoured more 
mesenchymal stem cells (MSCs) proliferation than random-oriented fibers [142]. 
Moreover, physicochemical properties including porosity, pore geometry, surface 
chemistry as well as biological and mechanical properties have been found to be 
important parameters when designing a bone scaffold [138]. 
TABLE 3.5 Electrospun nanofibers used in various biomedical applications. 
Application Electrospun Scaffold References 
Tissue 
engineering: 
 
 
vascular grafts 
PCL/collagen (type I) [143] 
Gelatin/PCL and collagen/PLCL [144] 
Chitosan/PCL [145] 
Tecophilic/gelatin [146] 
PLA/PCL [147] 
PLGA/smooth muscle cells (SMCs) and 
endothelial cells (ECs) 
[148] 
  
 Cellulose/nano-hydroxyapatite [149] 
 PCL/octacalcium phosphate [141] 
 Silk fibroin/bone morphogenetic protein 2 (BMP-
2)/ hydroxyapatite 
[150] 
Bone grafts PLGA/nHA/insulin [151] 
 PCL/carboxymethyl chitosan (PCL/CMC) [152] 
 Nanohydroxyapatite/ cellulose nanofibers/PVA 
(nHAp/CNF/ PVA) 
[140] 
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2.6  Scaling-up and electrospun-based commercial products 
The use of biocompatible polymers in the biomedical sector has promoted the 
production of electrospinning-based artificial tissue and the development of drug-
delivery systems. However, the single nozzle electrospinning approach is a simple way 
to produce nanofibers on lab scale but with low production rates. Usually, it is only 
possible to process up to several liters of polymer solution under constant runs. 
Therefore it is only useful in academic research and product development where 
majority of the experiments are performed under few millilitres [153]. In order to 
economically and efficiently manufacture fibers in large scale needed in commercial 
applications, strategies for scaling up the process of electrospinning are required. This 
has led to development of new equipment and technological solutions with many 
electrospun materials paving their way to commercialization.  
 
 
FIGURE 3.5. Multiple-hole electrospinning technique using a hollow tube [154]. 
New emerging companies are dedicated to supply electrospinning equipment from 
laboratory level to industrial scale or even offering services such as supplying 
nanofibrous products. Even contract manufacturing companies are already in the 
market offering electrospinning services. To increase the production rate of fibers, 
multi-spinneret components have been employed where the polymer injection system 
has been modified. Other techniques for manufacturing of nanofibers in large scale 
include, use of needleless electrospinning systems, e.g., rotating disks, rollers, balls 
and bubbles and centrifugal spinning [155, 156].  
For example, the Nanospider developed by the Czech company Elmarco and 
Nanospinner416 from Inovenso Ltd., INFL8100 by FNM company and Yflow from 
Spain have been developed as industrial-scale instruments.  
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Nanospider technology, for example, is a needle-free high voltage electrospinning 
process. The principle behind this technology is, that Taylor cones, and the subsequent 
jet formation, occur from a thin film of a polymer solution (Fig. 3.6). 
 
 
FIGURE 3.6. Schematic diagram of rotating cylinder electrospinning method 
(Nanospider) [157]. 
By utilizing such production lines, nanofibers can be produced at large scale level while 
cutting off high production costs. Table 3.6 summarizes a few electrospinning-based 
companies and their developed biomedical products. 
TABLE 3.6 List of electrospun-applied commercial products in biomedical applications. 
Product Company Country Application 
RIVELIN patch Bioinicia Spain Drug delivery 
PK Papyrus Biotronik Germany Covered stent 
ReDura dura patch Medprin Germany Duraplasty 
Nanofiber scaffolds Stellenbosch (SNC) South Africa biomedical 
Scaffolds for tissue 
regeneration 
The electrospinning 
company  
United Kingdom  biomedical 
Antimicrobial 
Dressings 
PolyRemedy United States Wound care 
AVflo™ vascular 
graft 
Nicast Israel biomedical 
ReBOSSIS Ortho Rebirth Japan Biomedical, 
synthetic bone 
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2.7 Regulatory aspects 
The primarily goal of the International Organization for Standardization (ISO) is to 
ensure that products and services for the consumer are safe, reliable and of good 
quality. Electrospun-based products meant for biomedical applications, and depending 
on their intended use, are highly regulated or controlled using different international 
standards. Therefore, electrospinning companies across the globe should acquire and 
harmonize with these regulatory requirements to help them design, develop, 
manufacture and supply scaffolds meant for biomedical applications. ISO 9001 and 
ISO 13485 are two important guidelines for medical device manufacturers. Both are 
revised every five years and have been recently updated to ISO 9001:2015 and ISO 
13485:2016 [158]. 
ISO 13485 is the most commonly adhered to standard for the efficient production of 
the intended medical device. ISO 13485 certification adapts ISO 9001 model except 
that this is specifically for medical device. ISO 13485:2016 as the latest standard 
contains requirements for a quality management system whereby a company can 
produce medical devices and services that are consistent with consumer safety and 
ensuring that applicable regulations are adhered to. It deals with all aspects of the 
device such as product development, risk management, complains, labelling and 
manufacturing [159, 160].  
In addition, there are specific standards and guidelines dealing with compatibility and 
safety requirements for the medical device that comes into direct contact with the body. 
For this matter, ISO 10993 is used which covers biological evaluation of medical 
devices. Several testing such as cytotoxicity, implantation, genotoxicity, irritation and 
skin sensitization, carcinogenicity, biodegradation, etc. are carried out under the 
regulations of Good Laboratory Practice upon registration through regulatory 
authorities like FDA and the European union (EU) [161]. If the medical device is an 
electrical system, it should satisfy International Electrotechnical Commission (IEC) 
60601 requirements [162]. 
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2.8 Possible challenges and future directions 
Electrospinning has been fully recognized as a simple way to produce (drug eluting) 
wound dressings and scaffolds for biomedical applications because of their special 
characteristics and that it has an enormous potential for innovative drug delivery 
systems. Despite the tremendous advances seen in this field in the last decade, there 
are still some challenges encountered while developing electrospun products. It 
remains a challenge to overcome clogging of spinneret during fiber preparation with 
needle-based systems. Low production rates are limiting when scaffolds for biomedical 
applications have to be produced in larger amounts. Nevertheless, single-needle 
electrospinning will remain beneficial to many researchers especially in the academic 
area, for example, to preinvestigate the behaviour and electrospinnability of a polymer. 
Thanks to the current advances in the industry, for example by use of needleless 
electrospinning devices, it renders possible to produce scaffolds at large scale level. 
However, more work is necessary to evaluate the morphology and performance of the 
nanofibers produced using the large-scale equipment and for ensuring consistent fiber 
quality is guaranteed throughout. 
Another challenge is the frequent use of organic solvents, of which most of them are 
toxic and harmful to humans limiting the use of electrospun products. Current 
advances in electrospinning technology has also brought the emergence of green 
electrospinning. Use of degradable materials, green solution electrospinning, and 
solvent‐free electrospinning are concepts revolving around green electrospinning. The 
idea here is to use raw materials which are not only biodegradable but also friendly to 
our environment, e.g., a solvent which is nontoxic and pollution‐free [163]. 
Furthermore, the residual solvent in the fibers may not only restrict many promising 
potential applications, especially in biomedical field, but also removal of solvent 
residues from nanofibers and the corresponding analytic are very costly. Within this 
context, green electrospinning for example by use of water as the solvent, enables 
electrospun products to be further used in the biomedical field, such as tissue 
engineering, wound healing, and drug delivery, without any obstacles, since there is 
no organic solvent residue in the nanofibers. This could enhance a low-cost production 
and easier commercialization of electrospun-based biomedical products that are not 
only eco-friendly but also widely acceptable. 
One of the challenges that needs to be further investigated is the ability of electrospun 
scaffolds to recreate the complexity of the human tissues. The development of 
scaffolds going forward for wound-healing therapies will need to address these issues 
of creating an environment that closely resembles that of native skin, where materials 
in the future should mimic the dermis in terms of their structure as well as it’s biological 
function. Moreover, drug-eluting wound dressings should be able to deliver several 
drugs in a time dependant manner to set the stage for an enhancement of the 
subsequent phases of wound healing. Nevertheless, use of scaffolds, for example, in 
tissue engineering will remain helpful when it comes to biomedical research, especially 
when testing new drug formulations. Although most of the biodegradable polymers 
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have been already approved by the FDA for clinical use, in vivo stability, degradation 
rate and more extensive toxicity studies should be undertaken, especially on humans, 
in the future for the electrospun products to be clinically approved. 
When it comes to large-scale production, it seems to be still challenging to repeatedly 
produce complex electrospun scaffolds with precise dimensions and morphology as 
each polymer will likely respond differently to the control system. Hence, careful 
selection of correct polymer / solvent combination including proper manipulation of 
process parameters, such as flow rate and the electrical field between Taylor cone and 
collector, is needed. 
Studies involving smart electrospun nanofibers, their advantages, and shortcomings, 
should be further investigated, especially in drug delivery, to come up with more 
interesting electrospun products. 
Overall, with the ongoing significant developments and with what have already 
occurred so far, the future of electrospinning technology in both biomedical and 
pharmaceutical field is bright, and more innovations will continue to evolve. 
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3.1 Abstract 
This study investigated the formulation and processing of aqueous colloidal 
dispersions containing a birch bark dry extract (TE) as the active substance and 
hydrogenated phospholipids (Phospholipon 90H) as stabilizer, which can be used in 
the preparation of electrospun wound dressings. Colloidal dispersions manufactured 
using a two-stage homogenization process had a bimodal particle size distribution, 
which was most significantly (p < 0.0001) affected by the phospholipid content. The 
size of the single particles decreased from an average particle size of about 4 µm to 
a particle size of approximately 400 nm. Dynamic interfacial tension studies 
performed using a profile analysis tensiometer (PAT) showed that the phospholipids 
strongly declined the interfacial tension, whereas a further decrease was observed 
when phospholipids were combined with birch bark extract. Interfacial viscoelasticity 
properties analyzed using the oscillating drop technique resulted in an increase of 
both interfacial elasticity and viscosity values. These results indicated that the 
phospholipids are preferentially located at the lipophilic/water interface and a stable 
film is formed. Furthermore, the results point to a synergistic interaction between 
phospholipids and TE. Confocal Raman microscopy (CRM) suggested that the TE 
is predominantly located in the oil phase and the phospholipids at the interface. 
Keywords: colloidal dispersions; birch bark extract; phospholipids; sunflower oil; 
high-pressure homogenization; interfacial rheology 
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3.2 Introduction 
Dry extracts from the outer bark of birch consist mainly of pentacyclic triterpenes, 
which are known for various pharmacological properties such as anti-inflammatory, 
anti-viral, anti-cancer activity, and wound-healing effects [1–8]. A well-characterized 
commercially used triterpene dry extract from the outer bark of birch contains about 
80% (w/w) betulin and is obtained by accelerated solvent extraction with n-heptane 
[9]. Other disclosed triterpenes of the dry extract include lupeol (LU), erythrodiol 
(ER), betulinic acid (BA), and oleanolic acid (OA), as shown in Table 1 [10]. However, 
the low solubility of these triterpenes in polar and non-polar solvents makes 
formulation a challenging task, which might limit their therapeutic application 
[7,11,12]. For topical application, only a few formulation concepts are known. These 
include cosmetic water-in-oil creams, water-in-oil foams [8], and an oleogel 
consisting of TE and sunflower oil, which received the European marketing 
authorization in January 2016 [12]. To the best of our knowledge, an aqueous 
colloidal dispersion of TE has not been described so far. 
However, such a colloidal dispersion would be a prerequisite as we intend to develop 
a bioactive wound dressing containing colloidal dispersions of birch bark extract 
through a blend electrospinning technique [13]. In this case, the colloidal TE 
dispersions will be blended with a suitable water-soluble polymer, e.g., polyvinyl 
alcohol (PVA) or polyvinyl pyrrolidone (PVP), to create sub-micron-sized electrospun 
fibers even without further modification of the spinneret. 
Table 1. Physical–chemical characteristics of the birch bark dry extract (TE) used [8]. 
TE Composition Specific Surface Area 
Particle Size 
D50% 
Betulin 81.60%, lupeol 2.08%, betulinic acid 3.84%, 
erythrodiol 1.05%, oleanolic acid 0.97%, betulinic 
acid methyl ester 0.52%, unidentified substances 
9.94% 
42 ± 0.4 m2/g 5.8 µm 
Phospholipids (PL) are commonly found in all cell membranes and therefore exist in 
all living organisms where they serve both structural and functional purposes. 
Lecithin is the most common form of phospholipids, where phosphatidylcholine (PC) 
is the major component [14,15]. Phospholipids are amphiphilic in nature, having a 
polar head group and two lipophilic tails. The polar head unit containing a phosphate 
group can be esterified with an alcohol to an organic molecule such as PC with 
choline, in phosphatidylethanolamine (PE) with ethanolamine, phosphatidylglycerol 
(PG) with glycerol, etc. Examples of these phospholipid derivatives can be found 
here [14]. Due to their amphiphilic characteristics, they have been shown to form 
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bilayers and liposomes or micelles under certain conditions [15]. As a result, PLs are 
frequently used as emulsifiers in the pharmaceutical, cosmetic, and food industry 
[14,16–18]. Being amphiphilic in nature, they can form a viscoelastic interfacial film 
that provides excellent colloidal stability [19–22]. Studies have shown that the 
dispersion particle size depends on the surfactant concentration whereby the 
particles significantly decrease in size as the surfactant concentration was increased 
[23–26]. Beyond that, many studies suggest that there is a direct interaction between 
PL and pentacyclic triterpenes [27,28]. This is also supported by preliminary studies 
in our group indicating that colloidal aqueous dispersions of TE are feasible in the 
presence of hydrogenated PL. These unique features make phospholipids most 
suitable to be used in this study in the preparation of colloidal dispersions containing 
birch bark extract. 
Colloidal dispersions, e.g., nanoemulsions or solid-lipid nanoparticles, are widely 
known as drug carriers for various potential therapeutic applications i.e., oral, ocular, 
dermal, and parenteral [29–33]. More exclusively, they have been used to 
incorporate poorly water-soluble drugs, increase their bioavailability, or minimize the 
side effects of potent drugs [34–37]. Several methods have been utilized to 
manufacture such colloidal dispersions. Mostly, they can be formed by first forming 
a primary coarse dispersion with larger particle sizes in the micron range (1–5 µm) 
and then after subjecting them to high-energy dispersion methods, e.g., high-
pressure homogenization, they can be reduced to the colloidal range (<500 nm). 
Usually, pre-dispersions formed in the first step by high shear mixing have high 
variable particle sizes, whereas the subsequent high-pressure homogenization 
produces dispersions with smaller and also more uniform particle sizes [30,38,39]. 
However, a simple preparation of TE-based aqueous or oily colloidal suspensions 
have been reported to be challenging due to the unique structure of the extract 
particle, which has been described as a “cauliflower-like” structure. These highly 
porous triterpene particles cannot be crushed by common techniques to reach 
particles in the colloidal size range, even when high-energy dispersion techniques, 
e.g., sonication or high-pressure homogenization, were utilized [40]. 
The aim of this study was (1) to study the role played by PL with respect to the 
distribution of TE in particular at the oil–water interface, (2) to develop a suitable 
workflow for the production of aqueous colloidal dispersions containing TE with 
particle sizes in colloidal range through a homogenization process, and (3) to 
investigate the influence of PL and sunflower content on particle size reduction.  
 
64 
 
3.3 Materials and Methods 
3.3.1 Materials 
Hydrogenated phospholipids from soybean lecithin (Phospholipon 90H) were 
supplied by Lipoid GmbH (Ludwigshafen, Germany). Sunflower oil was purchased 
from Caesar & Loretz GmbH (Hilden, Germany). Birch bark extract was obtained 
from Amryt AG, (Niefern-Öschelbronn, Germany). Reverse osmosis water (ELGA 
Labwater, Celle, Germany) was used for the preparation of all aqueous solutions. 
3.3.2 Experimental Design and Statistical Analysis 
All statistical calculations, experimental design generation, and optimization 
procedures were performed with JMP version 14.2 software (SAS Institute, Cary, 
NC, USA). A full factorial design of experiment (DoE) was used to generate 
combinations of formulations with a 3 × 4 design as shown in Table 2. Phospholipon 
90H (PL90H) and sunflower oil (SO) content were taken as independent variables, 
whereas the amount of TE was kept constant at 0.5%. Thereafter, the respective 
formulations were prepared and assessed for particle size and polydispersity index 
(PDI). The observed response (particle size (nm)) was analyzed and compared with 
the predicted values. Beyond that, 3-D surface representations and leverage plots 
were constructed. The significance of each factor was evaluated by analysis of 
variance (ANOVA), and P values less than 0.05 were considered significant. 
Table 2. Design of experiment (DoE) employed for the preparation of aqueous 
colloidal dispersions. 
Batch 
Code Pattern TE (wt %) PL90H (wt %) SO (wt %) 
F1 111 0.5 0.5 0 
F2 112 0.5 0.5 0.3 
F3 113 0.5 0.5 0.5 
F4 114 0.5 0.5 1 
F5 121 0.5 1 0 
F6 122 0.5 1 0.3 
F7 123 0.5 1 0.5 
F8 124 0.5 1 1 
F9 131 0.5 2.5 0 
F10 132 0.5 2.5 0.3 
F11 133 0.5 2.5 0.5 
F12 134 0.5 2.5 1 
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3.3.3 Preparation of Aqueous Colloidal Dispersions 
The colloidal dispersions prepared in this work consisted of PL90H, sunflower oil, 
and TE as the dispersed phase (1–4%) and water as the continuous phase (96–
99%). A set of formulations as suggested by the corresponding DoE (Table 2) were 
prepared with varying concentrations of PL90H (0.5%, 1% and 2.5%) and sunflower 
oil (0%, 0.3%, 0.5%, and 1%), whereas birch bark extract (TE) concentration was 
kept constant at 0.5% in all runs. Briefly, during the preparation of each formulation, 
a pre-dispersion (PD) was prepared by first dispersing PL90H and TE in water at 70 
°C for 30 min under magnetic stirring at 400 rpm using a MR 3001 K magnetic 
hotplate stirrer (Heidolph, Schwabach, Germany). Then, this mixture was 
homogenized for 5 min using a rotor-stator system (Ultra Turrax T25, IKA, Staufen, 
Germany) at 9500 rpm. Thereafter, the formed dispersion was added into the SO 
and homogenized for 3 min. Finally, the pre-dispersion was homogenized using a 
high-pressure homogenizer (Emulsiflex C-3, Avestin, Mannheim, Germany) for 8 
cycles at a pressure of 100 MPa. 
3.3.4 Particle Size Analysis 
Dispersion particle size distribution and polydispersity were determined using 
dynamic light scattering (DLS) (Zetasizer Nano-ZS, Malvern Instruments, 
Herrenberg, Germany). In general, samples were diluted (1:10,000) with reversed 
osmosis water in 1.5 mL polystyrene disposable cuvettes prior to analysis to avoid 
multiple scattering effects. The results are reported as mean particle diameter (Z-
average), size distribution by volume, and uniformity of the distribution 
(polydispersity index (PDI)). All formulations were analyzed on the day of 
manufacture, and DLS measurements were carried out at 25 °C in triplicate. 
3.3.5 Density Measurements 
Density was measured at 25 °C by means of a DMA 4500 density meter with an 
oscillating U-tube (Anton Paar, Filderstadt, Germany). 
3.3.6 Interfacial Tension and Elasticity 
Dynamic interfacial tension and elasticity was measured using a profile analysis 
tensiometer PAT-1D (Sinterface Technologies, Berlin, Germany) by applying the 
buoyant drop method. This method involves imaging the drop and fitting the shape 
to the Young–Laplace equation. To prepare the test solutions, TE and/or PL90H 
were dissolved completely in SO by sonication at 65 °C and cooled down to room 
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temperature before performing further experiments. A buoyant drop was formed in a 
cuvette made of optical glass 35 × 35 × 32 (mm) containing the aqueous phase, and 
its shape was imaged via a charge coupled device (CCD) camera and fitted to the 
Young–Laplace equation using the profile drop analysis software provided 
(Sinterface Technologies, Berlin, Germany). The interfacial tension, given as a 
function of time, was calculated from the drop shape using the Young–Laplace 
Equation: 
𝛾𝛾 �
1
𝑅𝑅1
 +  
1
𝑅𝑅2
� = ∆𝑃𝑃0 + (∆𝜌𝜌)𝑔𝑔𝑔𝑔 (1) 
where 𝑅𝑅1 and 𝑅𝑅2 are main radii of interface curvature, γ is the interfacial tension, ∆𝑃𝑃0 
is the pressure difference at a reference plane, ∆𝜌𝜌 is the density difference, g is the 
gravitational constant, and z is the vertical height measured from the reference plane 
[41]. Hence, the interfacial tension values in equilibrium were manually extracted 
from the extrapolation of the measured data by a γ (1/√t) plot to infinite time [19]. The 
diffusion rates of all the samples were also determined from the slope of the plot. 
Interfacial rheology was measured by applying the oscillating drop method using the 
buoyant drop technique with the profile analysis tensiometer PAT-1D (Sinterface 
Technologies, Berlin, Germany). The principle of the oscillating drop method 
involves changes of the size of the interface, where PL molecules are located, by 
continuously altering the drop volume. In a sinusoidal change of drop volume, and 
thus also the interface, the following can be observed: as the interface narrows, 
stabilizer molecules desorb from the interface (interfacial tension increases) and 
during the subsequent enlargement adsorb the molecules again (interfacial tension 
decreases) [41,42]. Hence, the rheological properties of adsorption layers are 
expressed by the relationship between the variation of the interfacial tension, from 
its initial value, and the expansion of the surface area. The interfacial elastic (E) and 
viscosity modulus can be expressed as [43]. 
𝐸𝐸 =
d𝛾𝛾
d ln(𝐴𝐴) (2) 
ƞ𝑑𝑑 =
d𝛾𝛾
(d𝐴𝐴/𝑑𝑑𝑑𝑑)/𝐴𝐴 (3) 
where E is the interfacial elasticity, γ is the interfacial tension, A is the area of the 
interface, and ƞ𝑑𝑑 is the interfacial dilational viscosity. 
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The experiments were started after 10 min to allow equilibration of the interface. A 
single frequency of 0.1 Hz was used to study interfacial elasticity and viscosity. A 
drop volume of 10 µL ± 2 µL was formed at the capillary tip. Subsequently, the data 
were fitted, and the interfacial elasticity and viscosity values were calculated through 
a Fourier Transformation (FT) with the associated software. All measurements were 
performed at 25 °C. 
To calculate the interfacial characteristics, the densities of the involved phases are 
required. The following values have been used: SO (0.91761 g/cm3), SO + 0.1% TE 
(0.91782 g/cm3): SO + 0.1% PL90H (0.91782 g/cm3), and SO + 0.1% TE + 0.1% 
PL90H (0.91798 g/cm3)). 
3.3.7 Confocal Raman Spectral Imaging 
A pre-dispersion containing sunflower oil, water, TE, and phospholipids was imaged 
using an alpha 500R Raman microscope (WiTec GmbH, Ulm, Germany) equipped 
with a DV401-BV CCD detector, connected via an optical fiber to a UHTS 300 
spectrometer and a 532 nm laser excitation source. A 100× air objective (EC 
Epiplan-Neofluor, Carl Zeiss, Oberkochen, Germany) with a numerical aperture of 
0.9 was used to view the sample, while the laser intensity was adjusted to 35 mW. 
The spectral range covered the fingerprint region between 710 and 1820 cm−1 and 
the region between 2700 and 3580 cm−1. The spectra of all single components 
(PL90H, SO, and TE) were first collected and used as a reference to monitor the 
presence of each component in the dispersion. Subsequently, the test samples were 
presented to the microscope on glass slides (VWR-International, Darmstadt, 
Germany) and covered with a coverslip. Image scans of dispersion using 25 µm × 
25 µm area of the surface were taken at an integration time of 0.01 s. Henceforth, 
color-coded images were obtained by initial cosmic ray removal and spectral 
background subtraction using the WiTec Project data analysis software 4.1 (WiTec 
GmbH, Ulm, Germany). By assigning the spectrum of each component to a color, 
the distribution of all components within the sample can be indicated, resulting in the 
color-coded image of the scanned area [44]. 
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3.4 Results and Discussion 
3.4.1 Confocal Raman Spectral Imaging 
This study focused on colloidal systems consisting of PL, SO, and water, which to 
the best of our knowledge enabled for the first time the preparation of a colloidal TE 
dispersion. To get a first insight into the spatial distribution of the components, 
Raman microspectral imaging was applied to a coarse pre-dispersion consisting of 
2.5% PL90H, 1% SO, and 0.5% TE. As can be seen in Figure 1, TE (red) enriches 
predominantly in the oil phase (yellow), meaning that the extract has high affinity to 
sunflower oil. On the other hand, no isolated TE particles dispersed in the aqueous 
phase have ever been detected on Raman images. As expected, the images clearly 
reveal that the PL90H (green) forms an interfacial layer between the lipophilic droplet 
(TE and SO) and water (blue). Consequently, this will lead to a reduction of the 
interfacial tension and stabilizes the dispersion of the two lipophilic components in 
the aqueous phase. Due to the limited spatial resolution, the Raman microscopic 
images could neither give hints on a direct interaction of TE and PL90H in these 
coarse dispersions nor could it seriously be applied to colloidal dispersions. 
 
Figure 1. Confocal Raman microscopic color-coded images of aqueous pre-dispersion (a) 
Red: TE, Green: PL90H, Blue: Water, (b) shows TE removed in the image to facilitate the 
better identification of the yellow sunflower oil (SO). 
3.4.2 Interfacial Tension and Viscoelasticity 
To gain further insights into the potential role of PL90H in the dispersions process 
and its interaction with TE, we have conducted dynamic interfacial tension 
experiments at the oil–water interface in the absence and presence of PL90H. Figure 
2 illustrates the results of the interfacial tension measurements of SO, reference 
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(21.58 ± 0.27 mN/m), SO + 0.1% TE (19.96 ± 0.39 mN/m): SO + 0.1% PL90H (8.4 
± 0.58 mN/m), and SO + 0.1% TE + 0.1% PL90H (4.75 ± 0.54 mN/m). 
It is evident that where PL90H is present, a significant reduction of interfacial tension 
occurs, whereas TE displays only marginal interfacial activity. From the slope of the 
plot (interfacial tension versus 1/√t), diffusion rates toward the interface can be 
calculated. This seems to be of particular interest when comparing the ternary 
system water, SO, and PL90H with the quaternary system consisting of water, SO, 
PL90H, and TE. 17.22 mN/m s−1/2 or SO + 0.1% PL and SO + 0.1% TE + 0.1% 
PL90H exhibited the highest diffusion rate of 55.91 mN/m s−1/2. This reveals that 
PL90H and TE strongly interact with each other, probably synergistically forming a 
film/membrane at the interface, which leads to a faster and more effective reduction 
of the interfacial tension. 
 
Figure 2. Dynamic interfacial tension curves of PL90H, TE, and PL90H + TE mixture 
dispersed in SO with water (n = 10). 
The interfacial elasticity and viscosity of the test samples obtained from the 
oscillatory perturbation at a frequency of 0.1 Hz. Pure SO presented low interfacial 
elastic and viscosity values whereas for samples containing TE and PL90H, both 
values strongly increased. With an addition of PL90H to triterpene extract, both 
interfacial elastic and viscosity values significantly shifted toward higher values as 
compared to reference oil. It seems with the observed higher interfacial elastic 
values (Figure 3), that PL90H adsorbs at the interface and over the time, a plateau 
is formed; consequently, the interface becomes more elastic and more structured. 
Studies have shown that phospholipid molecules can adsorb at the interface, forming 
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a strong elastic film [15,45,46]. Therefore, the obtained high interfacial elasticity 
values indicate a stable rigid film formation at the interface. Moreover, low elasticity 
in the interface would require less energy to break the dispersion particles during the 
emulsification process. High interfacial elasticity is necessary in the stability of 
dispersions, as a stable film can hinder various instabilities such as the coalescence 
of dispersion particles from taking place [22,25,47]. Hence, the interfacial elasticity 
and viscosity can play a key role in the assessment of the deformability of dispersion 
particles and thus their stability [48]. In this study, the results indicate that a mixture 
of phospholipid + triterpene extract forms together a combined film with the highest 
elasticity at the interface, and such a complex again reveals that these two 
substances interact and do have a synergetic action. Further studies have shown 
that triterpenes interact with phospholipids (PL) and fluidize lipid membranes 
controlled by their free polar groups where tetracyclic triterpenes (e.g., cortisol) tend 
to be located at the head group, whereas pentacyclic ones (e.g., erythrodiol) being 
more hydrophobic are incorporated deeply in the lipid bilayers [28,49]. Cyclic 
triterpenes share similar structural properties with cholesterol, and it has been 
reported that such a monolayer containing cholesterol and PL is highly ordered. On 
the other hand, binary films of triterpenes and PLs are amorphous [27]. 
 
Figure 3. Interfacial elasticity (a) and viscosity (b) of 0.1% PL90H, 0.1% TE and PL90H + 
TE dispersed in sunflower oil (Mean ± SD, n = 6). statistically significant, * p < 0.05; ** p < 
0.01 vs. sunflower oil (reference). 
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3.4.3 Particle Size Reduction 
The suitability of high-pressure homogenization to produce colloidal dispersions of 
TE, PL90H, and SO in water was first tested with a formulation consisting of 2.5% 
PL90H, 0.5% TE, and 1% SO. After mixing and homogenizing with an Ultra Turrax, 
a mean particle size of 3400 ± 390 nm (pre-dispersion (PD), PDI: 0.9) was achieved. 
This could be reduced to 400 ± 49 nm (PDI: 0.5) by high-pressure homogenization, 
yielding a bimodal distribution function. The intensity weighed particle size 
distribution revealed a major peak at 364 nm comprising 81% and a smaller one at 
76 nm representing 19% (Figure 4). 
 
Figure 4. Bimodal particle size distribution by intensity of colloidal dispersion (2.5% 
PL90H:1% SO:0.5% TE). 
To gain further insight, a DoE has been applied in order to identify the composition 
variables that influence the particle size distribution of the colloidal dispersions 
consisting of PL90H, SO, water, and a constant amount of 0.5% TE. The design 
space has to be restricted with respect to maximal PL90H (<2.5%) and SO 
concentration (<1%) in order to obtain sufficiently fluid systems necessary for high-
pressure homogenization. Table 3 summarizes the respective results. 
As expected, and shown in Table 3, pre-dispersions (PD) in all prepared formulations 
exhibited large particle sizes that were significantly reduced after high-pressure 
homogenization. Increasing either or both the content of SO and PL90H affected the 
size and distribution width (expressed as PDI) positively, whereby PL90H had a 
more pronounced effect. By increasing the concentration of PL90H from 0.5% (1033 
nm) to 1% (730 nm) in the system while concentrations of SO and TE are kept 
constant (0.5%), the particle size could be reduced by a percentage of approximately 
30%. A further increase of PL90H to 2.5% revealed a mean particle size of 400 nm 
which equals to a reduction by ca. 90%. 
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Table 3. Observed and predicted particle size and polydispersity index values of aqueous TE dispersions measured using Zetasizer, (Mean 
± SD, n = 3). PD: pre-dispersion, PDI: polydispersity index. 
Batch Code Pattern TE (wt %) PL90H (wt %) SO (wt %) PD (nm) Particle Size [nm] Dv (d.nm) Span PDI 
Predicted  
Particle Size (nm) 
Predicted 
PDI 
F1 111 0.5 0.5 0 2486 ± 379 1049 ± 176 
D10: 93 
D50: 510 
D90: 769 
1.3 0.7 1063 0.8 
F2 112 0.5 0.5 0.3 1838 ± 405 1174 ± 365 
D10: 33 
D50: 407 
D90: 642 
1.5 0.8 1013 0.8 
F3 113 0.5 0.5 0.5 1738 ± 220 1033 ± 160 
D10: 54 
D50: 392 
D90: 547 
1.3 0.8 981 0.8 
F4 114 0.5 0.5 1 1988 ± 343 878 ± 292 
D10: 82 
D50: 690  
D90: 930 
1.2 0.7 898 0.7 
F5 121 0.5 1 0 1147 ± 167 866 ± 215 
D10: 61  
D50: 451 
D90: 748 
1.5 0.7 930 0.7 
F6 122 0.5 1 0.3 1968 ± 59 935 ± 39 
D10: 85  
D50: 554 
D90: 788 
1.3 0.7 881 0.7 
F7 123 0.5 1 0.5 2982 ± 25 730 ± 114 
D10: 36 
D50: 72 
D90: 403  
5.1 0.7 848 0.7 
F8 124 0.5 1 1 1127 ± 108 655 ± 48 
D10: 76  
D50: 429  
D90: 596  
1.2 0.7 766 0.7 
F9 131 0.5 2.5 0 1799 ± 165 382 ± 35 
D10: 58 
D50: 299  
D90: 554  
1.7 0.5 533 0.5 
F10 132 0.5 2.5 0.3 2420 ± 556 589 ± 36 
D10: 415  
D50: 678 
D90: 1070  
0.9 0.4 484 0.5 
F11 133 0.5 2.5 0.5 1892 ± 253 525 ± 48 
D10: 59  
D50: 524  
D90: 866 
1.5 0.5 451 0.5 
F12 134 0.5 2.5 1 3400 ± 390 400 ± 49 
D10: 57  
D50: 152 
D90: 400 
2.3 0.5 370 0.5 
Dv: Size distribution by Volume; Span = (𝐷𝐷90 − 𝐷𝐷10)
𝐷𝐷50
. 
 
 
73 
 
The whole model actual versus predicted plot with the details of ANOVA (p-value < 
0.0001, R2 of 0.86) in Figure 6 shows that all data points are close to the straight line, 
indicating that the plot is suitable, and the model fits well. The regression line and the 
95% confidence curves crossed the horizontal line at the mean of the response 
(particle size (nm)). This implies that the whole factorial model with all combined effects 
(Figure 5) explains a significant proportion of the variation in particle size [50]. 
Furthermore, the constructed leverage plots in Figures 6–8 revealed that the factor that 
caused the most significant effect on reducing particle size was the PL90H 
concentration (p-value < 0.0001), followed by the SO (p-value < 0.085). In addition, the 
leverage plot for PL90H showed that both the regression line and the 95% confidence 
curves crossed the horizontal line; thus, the independent variable significantly 
influenced and contributed to variations of particle size. 
Full model prediction equations for particle size and PDI including independent 
variables were found to be: 
Particle size (nm) = 715.66 − 264.81 × (PL90H − 1.5) − 82.01 × ((SO − 0.5) / 0.5) 
PDI = 0.63 − 0.13 × (PL90H − 1.5) − 0.025 × ((SO − 0.5) / 0.5). 
Using the optimization and desirability function of the JMP software, it was predicted 
that a formulation consisting of 2.5% PL90H, 1% SO, and 0.5%TE allowed to achieve 
particle sizes as low as 370 nm and with a PDI of 0.5. This is in perfect accordance to 
our experimental results, where we measured for such an optimal formulation a particle 
size of 400 nm and a PDI of 0.5. 
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Figure 5. Effect of independent variables on particle size presented in 3D response surface. 
 
Figure 6. Leverage plot for the whole model of actual vs. predicted particle size. 
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Figure 7. Leverage plot for Phospholipon 90H (PL90H). 
 
Figure 8. Leverage plot for sunflower oil (SO). 
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3.5 Conclusions 
A suitable two-stage homogenization process was successfully developed to produce 
aqueous colloidal dispersions containing TE. The interfacial properties of the PL90H 
with its SO–TE dispersions were evaluated, and the results showed differences in 
terms of equilibrium interfacial tension and viscoelastic characteristics, clearly 
indicating an interaction of PL90H and TE. Confocal Raman spectral imaging allowed 
visualizing that the two lipophilic components namely, triterpene extract and sunflower 
oil, were predominantly co-located whereas hydrogenated PL was preferably detected 
at the oil/water interface. The characteristics of aqueous colloidal dispersions with 
varied phospholipid-to-sunflower oil ratio were evaluated through particle size 
measurement. The particle size produced was highly depending on the PL-to-oil ratio. 
Increasing the PL-to-oil ratio decreased significantly the mean particle sizes. The 
production of colloidal dispersions with particle sizes of below 1 µm was feasible, as it 
was our main goal. The optimal composition in the tested design space could be 
predicted by means of a statistic software. 
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4.1 Abstract 
Novel birch bark dry extract (TE)-loaded polyvinyl alcohol (PVA) fiber mats intended 
for wound therapy were developed through an electrospinning process. Colloidal 
dispersions containing TE as the active substance were prepared by the high-pressure 
homogenization (HPH) technique using hydrogenated phospholipids as stabilizer. 
Subsequently, the colloidal dispersions were blended with aqueous PVA solutions in 
the ratio of 60:40 (wt.%) and electrospun to form the nanofiber mats. Fiber morphology 
examined using scanning electron microscopy (SEM) indicated that fibers were 
uniform and achieved diameters in the size range of 300–1586 nm. Confocal Raman 
spectral imaging gave good evidence that triterpenes were encapsulated within the 
electrospun mats. In vitro drug release and ex vivo permeation studies indicated that 
the electrospun nanofibers showed a sustained release of betulin, the main component 
of birch bark dry extract, making the examined dressings highly applicable for several 
wound care applications. Ex vivo wound healing studies proved that electrospun fiber 
mats containing TE accelerated wound healing significantly more than TE oleogel, 
which was comparable to an authorized product that consists of TE and sunflower oil 
and has proved to enhance wound healing. Therefore, our results conclude that the 
developed TE-PVA-based dressings show promising potential for wound therapy, an 
area where effective remedy is needed. 
Keywords: electrospinning; PVA; birch bark extract, wound dressing; phospholipids 
 
4.2 Introduction 
The human skin serves as a barrier between the body and the environment. Therefore, 
it is prone to microbial, thermal, mechanical, and chemical threats, which can cause 
acute or chronic wounds. Triterpenes have been shown to improve wound healing 
recovery by inducing cell migration, cell proliferation, and collagen deposition [1]. Outer 
birch bark extracts have a high content of triterpenes, which are known for various 
pharmacological properties such as anti-inflammatory, antimicrobial, antiviral, 
anticancer activity, and wound healing effects [2–10]. A well characterized 
commercially used triterpene dry extract from the outer bark of birch (TE) contains 
about 80% (w/w) betulin as the main component and is obtained by accelerated solvent 
extraction with n-heptane [11]. Other disclosed triterpenes of the dry extract include 
lupeol (LU), erythrodiol (ER), betulinic acid (BA), and oleanolic acid (OA) as shown in 
Table 1 [12]. However, the low solubility of these triterpenes in polar and nonpolar 
solvents may lead to a poor bioavailability, which might limit their therapeutic 
application [8,13]. 
A study conducted by Ebeling et al. showed the molecular mechanism of the effects of 
birch bark extract on wound healing properties in human primary keratinocytes and 
porcine ex vivo wound healing models. They showed that TE and betulin mainly 
accelerated reepithelialization in a porcine ex vivo wound healing model after wound 
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treatment with TE-oleogel (10% TE, 90% sunflower oil). Beyond that, they found out 
that TE led to upregulation of proinflammatory mediators such as COX-2 and IL-6, 
which play a key role in wound healing und epidermal barrier repair [6,14]. Additionally, 
the effects of TE-based formulations have been already investigated in vivo on different 
types of wounds including dystrophic epidermolysis bullosa where treatments promote 
wound healing and was found out to be safe and well tolerated [15–17]. It is good to 
note that TE together with sunflower oil (SFO) supports wound healing better than in 
combination with other oils as examined by Steinbrenner et al. [8]. At the moment, 
there are a few available topical formulations containing these triterpenes, including 
water-in-oil foams [9], cosmetic water-in-oil creams, and an oleogel consisting of TE 
and sunflower oil that received European marketing authorization in January 2016 [18]. 
Table 1. Physicochemical characteristics of the dry birch bark extract used [9]. 
TE Composition Specific surface area 
Particle size 
D50% 
Betulin 81.60%, lupeol 2.08%, betulinic acid 3.84%, 
erythrodiol 1.05%, oleanolic acid 0.97%, Betulinic acid 
methyl ester 0.52%, unidentified substances 9.94% 
42 ± 0.4 m2/g 5.8 µm 
The electrospinning technique is a simple and versatile process for preparing fibers 
having a diameter from few micrometers down to several nanometers [19,20]. The 
resulting nanofibers have special features, such as high surface area to volume ratio, 
and can form mats/fleeces with high porosity which makes them attractive materials 
for wound dressing [21,22]. Beyond that, electrospun fibrous scaffolds mimic the 
structure of the native extracellular matrix (ECM) and hence facilitate cell proliferation, 
improve gaseous exchange, removal of exudate, and act as a physical barrier against 
entry of microorganisms during wound healing and regeneration of damaged tissues 
[21, 23–26]. 
Polymeric nanofibers made from biodegradable and biocompatible synthetic or natural 
polymers have been utilized to develop drug delivery systems to treat various ailments. 
One of the potential areas to use them is medicated wound dressing [21,23]. PVA is a 
biocompatible and biodegradable hydrophilic polymer with good chemical and 
mechanical properties, and has been approved by the U. S. Food and Drug 
Administration (FDA) for different biomedical and pharmaceutical applications [27,28]. 
For instance, PVA has been used to create hydrogels for wound dressing [29] or 
electrospun together with active substances, such as silver nanoparticles [30], and 
curcumin [31], to produce wound dressings. Several wound dressings in the market 
containing active agents such as hydrocolloids or silver dressings often used on wound 
healing have shown negative effects such as allergic contact dermatitis [32], and use 
of dressings loaded with antibiotics has risk of developing antimicrobial resistance [33]. 
Our interest in this study is to develop a dressing loaded with birch bark extract with a 
sustained drug release that is suitable for human use on wound healing with effective 
therapy even after long-term usage. To satisfy this requirement, we ensured that all 
the components used in this study are biocompatible and biodegradable when applied 
to the human body, such that an invasive and/or traumatic intervention for dressing 
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removal, like in the case of deep wounds, is unnecessary. Furthermore, sustained drug 
release could lead to less frequent dressing changes, which are painful, especially in 
treatment of chronic wounds, and thereby resulting in better patient compliance. In 
addition to that, our concept allows one to avoid organic solvents and uses water as 
the only solvent throughout the whole processing of the wound dressing. This 
guarantees not only that the solvent is nontoxic and affordable, but also that it is eco-
friendly and can thus be regarded as green electrospinning. However, encapsulation 
of birch bark dry extract into nanofibers may present a challenge. For instance, earlier 
studies showed that due to their unique structure, the particle sizes of the dry extract 
cannot be grinded by common techniques to reach sufficiently small particles even 
when high energy dispersion techniques, e.g., sonication or high-pressure 
homogenization, were used with aqueous and organic suspensions of the material 
[34]. This was solved through processing of oil in water (O/W) colloidal dispersions 
with birch bark dry extract as the active substance, phospholipids as stabilizer, 
sunflower oil, and the water phase through a step-wise homogenization process. 
Hydrogenated soybean phosphatidylcholine (HSPC) types of phospholipids containing 
mainly esterified stearic and palmitic acid enhanced the producibility of colloidal 
dispersions with particle sizes < 1 µm and enabled miscibility and stabilization of the 
lipophilic components in the hydrophilic PVA matrix prior to electrospinning. 
The purpose of this study was to (1) develop wound dressing materials with 
incorporated colloidal dispersions of TE and to (2) study their efficiency related to 
wound healing performance and (3) drug release. The surface properties of 
electrospun fiber mats were characterized by using SEM, thermal analysis with 
differential scanning calorimetry (DSC) and confocal Raman spectral imaging for 
visualization of all components within the fiber mats. We also conducted ex vivo 
permeation and in vitro release studies using Franz diffusion cell. The efficacy of the 
developed wound dressings was evaluated through an ex vivo wound healing assay. 
Here, low and highly TE-loaded dressings were tested and compared to an oleogel 
similar to the authorized product. To the best of our knowledge, there are no reports 
focusing on the development of this kind of wound dressing; therefore, this will be the 
first polymer-based wound dressing containing birch bark dry extract aimed for future 
potential use in wound therapy. 
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4.3 Materials and methods 
4.3.1 Materials 
PVA with a molecular weight of 146–186 kDa was purchased from Sigma Aldrich 
(Steinheim, Germany), hydrogenated phospholipids from soybean lecithin 
(Phospholipon 90 H) were supplied by Lipoid GmbH (Ludwigshafen, Germany). SO 
was purchased from Caesar & Loretz GmbH (Hilden, Germany). Birch bark extract was 
obtained from Amryt AG (Niefern-Öschelbronn, Germany). Reverse osmosis water 
(ELGA Labwater, Celle, Germany) was used for the preparation of all solutions. 
Parafilm® was from Bemis Company Inc., (Oshkosh, WI, USA). Whatman Nuclepore 
polycarbonate membrane filters were purchased from Sigma-Aldrich (Steinheim, 
Germany). Pig ears for permeation studies were obtained from the Department of 
Experimental Medicine at the University of Tuebingen [35] and for wound healing 
studies from a slaughterhouse in Schleswig-Holstein after slaughtering the pigs for 
human consumption. 
4.3.2 Preparing the Colloidal Dispersions 
Three different dispersions were prepared with varying concentrations of TE as shown 
in Table 2. Dispersions 1 and 2 (D1 and D2) were necessary to investigate the impact 
of high or low TE concentration on wound healing, whereas dispersion 3 (D3) was used 
as a placebo. It is important to mention that it was only practically possible to produce 
dispersions consisting of high TE (5%) loading by use of high concentrations of PL90H 
(8%). That is why 8% PL90H was used in preparation of dispersion consisting 5% TE. 
Dispersion containing 2.5% PL90H was the optimized colloidal dispersion from our 
previous study. Briefly, during preparation of each formulation, a predispersion was 
prepared by first dispersing Phospholipon 90H (PL90H) and TE in water at 70 °C for 
30 min under magnetic stirring at 400 rpm using Heidolph MR 3001 K magnetic 
hotplate stirrer (Schwabach, Germany). Then, this mixture was homogenized for 5 min 
using a rotor-stator system (Ultra Turrax T25, IKA, Staufen, Germany), at 9500 rpm. 
Thereafter, the formed dispersion was added into the SO and homogenized for 3 min. 
Finally, the predispersion was homogenized using a high-pressure homogenizer 
(Emulsiflex C-3, Avestin, Mannheim, Germany) for eight cycles at a pressure of 100 
MPa and their particle sizes measured with a Zetasizer Nano-ZS (Malvern Instruments, 
Herrenberg, Germany). 
Table 2. Composition (wt.%) of the prepared aqueous dispersions with their particle sizes. 
Dispersion Composition Particle Size (nm) 
D1 2.5% PL90H, 1% SO and 0.5% TE 400 ± 49 
D2 8% PL90H, 10% SO and 5% TE 840 ± 17 
D3 8% PL90H, 10% SO and 0% TE 477 ± 58 
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4.3.3 Preparation of Electrospinning Solutions 
The 12 wt.% PVA solution was prepared by dissolving PVA in water at 90 °C under 
magnetic stirring for 5 h. The solution was allowed to cool to room temperature and 
used the following day. Subsequently, for colloidal dispersion-PVA electrospinning 
experiments, the above aqueous dispersions (D1–D3) were blended with a PVA 
polymer solution in the ratio of 60:40 using a magnetic stirrer for 2 h at 40 °C to form a 
homogeneous solution. Samples were then cooled down to room temperature prior to 
electrospinning. 
4.3.4 Electrospinning of nanofibers 
The electrospinning setup purchased from Nanolab Instruments Sdn. Bhd., Subang 
Jaya, Malaysia consisted of a syringe pump holding a 5 mL plastic syringe with a blunt-
end needle (18-gauge), a grounded rotating collector, and a high-voltage power 
supply. Electrospun fibers were prepared from solutions and dispersions as listed in 
Table 3. Pure polymer solution serves as a reference mainly for the physicochemical 
characterization. F1 represents the placebo formulation. F2 and F3 were chosen to 
investigate the effect of high and low TE concentration. The syringe was filled with the 
solution and electrospun at a target collector distance of 10 cm and an applied voltage 
of 15 kV. Solutions were pumped through the syringe at a flow rate of 0.5 mL/h and 
the rotating speed of the collector was fixed at 1000 rpm. All electrospinning studies 
were carried out at ambient temperature (24 °C) and a relative humidity of 45%. 
Table 3. Final composition (wt.%) of formulation blends for electrospinning. 
Component Formula 1 (F1) [%] Formula 2 (F2) [%] Formula 3 (F3) [%] 
PVA 7.2 7.2 7.2 
PL90H 3.2 1 3.2 
Sunflower oil 4 0.4 4 
TE - 0.2 2 
Purified water ad 100 ad 100 ad 100 
4.3.5 Characterization of Nanofiber Morphology 
Fiber morphology was analyzed through SEM, Zeiss DSM 940 A, (Carl Zeiss GmbH, 
Oberkochen, Germany). Fiber mats of 0.5 cm × 0.5 cm sizes were placed of a 
conductive double-sided tape and sputter coated with gold using Biorad E 5100 Sputter 
Coater (Bio-Rad GmbH, Munich, Germany) at 2.1 kV and 20 mA for 240 s and imaged 
using the microscope. Thereafter, the average fiber diameters were determined from 
the SEM images by randomly selecting a minimum of 30 segments and their diameters 
calculated using ImageJ software (National Institute of Health, Bethesda, MD USA). 
For fiber diameter distribution, numbers of fiber diameters were converted into their 
percentage total values and plotted against grouped fiber diameter. The thicknesses 
of the fiber mats were measured with a digital micrometer using both magnetic 
induction and eddy current methods (Dualscope FMP20, Helmut Fischer GmbH, 
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Sindelfingen Germany) taking the average of 15 measurements at randomly selected 
places. 
4.3.6 Confocal Raman Spectral Imaging 
Raman images of wound dressings were acquired using an alpha 500R Raman 
microscope (WiTec GmbH, Ulm, Germany) equipped with a DV401-BV charge coupled 
device (CCD) detector, connected via an optical fiber to a UHTS 300 spectrometer and 
a 532 nm laser excitation source. A 100× air objective (EC Epiplan-Neofluor, Carl 
Zeiss, Oberkochen, Germany) with a numerical aperture of 0.9 was used to view the 
sample while the laser intensity was adjusted to 35 mW. The spectral range covered 
the fingerprint region between 710 and 1820 cm−1 and region between 2700 and 3580 
cm−1. Spectra of all single components (PL90H, SO, PVA and TE) were first collected 
and used to monitor the presence of each component in the wound dressing. 
Subsequently, nanofiber mats were presented to the microscope on glass slides 
(VWR-International, Darmstadt, Germany) without the use of a coverslip. Image scans 
of wound dressings using 25 µm × 25 µm area of the surface were taken at an 
integration time of 0.01 s. Henceforth, color-coded images were obtained by initial 
cosmic ray removal and spectral background subtraction using the WiTec Project data 
analysis software 4.1 (WITec GmbH, Ulm, Germany, 2016). By assigning the spectrum 
of each component to a color, the distribution of all components within the formulation 
can be indicated, resulting in a color-coded image of the scanned area [36]. 
4.3.7 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) studies of the produced nanofiber mats were 
carried out using a DSC 820 differential scanning calorimeter (Mettler-Toledo GmbH, 
Gießen, Germany). The DSC was calibrated for temperature and enthalpy using 
indium as a standard. Samples of 4–7 mg were sealed in an aluminium pan with one 
pinhole in the lid. The furnace was purged with nitrogen at a flow rate of 80 mL/min. 
The DSC scans were obtained by heating in the range of 25-250 °C at a rate of 10 
°C/min. 
4.3.8 Skin Permeation and In Vitro Drug Release Studies 
Both permeation and release studies were performed using modified vertical Franz 
diffusion cells (Gauer Glas, Püttlingen, Germany) with a receptor volume of 12 mL. For 
in vitro release studies, synthetic polycarbonate membranes with a pore size diameter 
of 0.4 µm were used to separate donor and receptor compartments. For permeation 
studies, pig ears were obtained from the Department of Experimental Medicine of the 
University Hospital Tuebingen. The live animals were kept at the Department of 
Experimental Medicine and sacrificed during their experiments, with the approval of 
the ethics committee of the University Hospital Tuebingen.  The ears were delivered 
directly after the death of the animals. The Department of Pharmaceutical Technology 
is registered for the use of animal products at the District Office of Tuebingen 
(registration number: DE 08 416 1052 21). Fresh pig ears were first cleaned with 
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isotonic saline using cotton balls and after postauricular skin excision, they were 
wrapped in aluminium foil and stored at −30 °C until use. During the day of experiment, 
the skin samples were thawed at room temperature, skin strips of 3 cm width were 
made and pinned to a block of Styrofoam precovered with aluminium foil. Thereafter, 
wounded skin samples were prepared according to [9] by a skin grafting method using 
a Dermatom (Dermatom GA 630, Aesculap AG & Co. KG, Tüttlingen, Germany). The 
skin was first “wounded” through removal of the outermost layers of the skin with a 
thickness of 0.2 mm using Dermatom. Subsequently, the remaining skin was then 
dermatomed to a thickness of 0.4 mm. From the prepared porcine skin, a specimen 
was punched to obtain discs of 25 mm in diameter using a circular hole punch (Eduard 
Gottfried Ferne, Remscheid, Germany) [37]. 
The synthetic membrane/dermal porcine skin was mounted between the 
compartments of diffusion cells, and the effective diffusion area was 1.77 cm2. For both 
in vitro release and ex vivo permeation experiments studies, samples of 20 mg fiber 
mats (F2 and F3), exactly weighed, were used. Consequently, all samples were loaded 
in the donor compartments and covered with parafilm to prevent solvent evaporation. 
A mixture of ethanol and water, 50:50 (v/v), was used as the receptor medium and the 
diffusion cells were maintained at 32 °C under constant magnetic stirring at 500 rpm. 
At predetermined time intervals, samples of 1 mL were taken from the receptor 
compartment and replaced with the same volume of fresh prewarmed receptor medium 
to maintain sink condition. The samples removed were analyzed directly using the 
HPLC-UV method as described below. The experiments were conducted in triplicate. 
4.3.9 Entrapment Efficiency 
The amount of betulin entrapped within fiber mats was estimated by dissolving 
approximately 20 mg of electrospun fiber mat, exactly weighed, in 30 mL ethanol:water 
(50:50 v/v) solution by means of sonication at 65 °C (Sonorex RK 31H, Bandelin, 
Berlin). Samples were then filtered using hydrophilic polyethersulfone (PES) syringe 
filters (Macherey-Nagel, Düren, Germany), and the total amount of drug extracted was 
quantified by High Performance Liquid Chromatography with Ultraviolet detection 
(HPLC-UV). The percentage entrapment efficiency (%EE) was calculated by the 
following equation: 
% EE = Total mass of drug extracted from nanofiber
Mass of total drug added 
 × 100% (4) 
4.3.10 Betulin Permeation/Release Kinetics Studies 
The release/permeation kinetics were estimated by linear regression analysis of the in 
vitro release and ex vivo permeation data using various mathematical models [38]. The 
four models included zero order (Equation 2), first order (Equation 3), Korsmeyer–
Peppas (Equation 4), and Higuchi (Equation 5) and the mathematical model that best 
fitted the kinetic release profile was selected based on the highest coefficient of 
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determination, R2. In all equations, Mt represents the amount of betulin released at time 
t. 
Zero-order model, where k0 is the zero-order release constant: 
Mt = k0t (5) 
First order model where K1 is the first order release rate constant: 
In (1 − Mt) =−K1t (6) 
Korsmeyer–Peppas model: Mt = ktn; where K is the Korsmeyer–Peppas constant, 
which is connected to the characteristics of the delivery system and the encapsulated 
drug. The n is the diffusional exponent that shows the drug release mechanism; where 
n equal to 0.45 represents a Fickian diffusion mechanism and 0.45 < n < 1 is referred 
to as a non-Fickian diffusion mechanism (anomalous transport) in which both Fickian 
diffusion and Case-II transport occurs [39]. (4) 
Higuchi model, where k is Higuchi constant:  
Mt= kt0.5 (5) 
4.3.11 HPLC Analysis 
Betulin quantification was performed using an LC-20A prominence HPLC system 
(Shimadzu, Kyoto, Germany). The mobile phase, a mixture of acetonitrile and water 
with the addition of 0.1% (v/v) phosphoric acid, was used as a gradient system for 
chromatographic separation. For efficient separation, gradient conditions were used 
according to the isocratic/gradient modes developed by Armbruster et al. [40]. A 
Nucleosil 100-5 C18 EC 125/4 column with a precolumn Universal RP EC 4/3 
(Macherey-Nagel, Düren, Germany) was kept at 40 °C and a flow rate of 1.2 mL/min 
was used. A sample volume of 100 µL was injected and the peaks were detected at 
210 nm. The retention time of betulin was approximately 7.5 min. 
4.3.12 Ex Vivo Wound Healing Assay 
In order to characterize the wound healing efficiency, a porcine ex-vivo wound healing 
assay was performed as described elsewhere [8]. Briefly, pig ears were immediately 
delivered after slaughtering for human consumption to the laboratory, cleaned, and 
disinfected. Thereafter, 6 mm punch biopsies were taken from the plicae of the ears 
and fat and subcutis were removed. Consequently, wounds were generated by the 
removal of the epidermis and upper dermis in a central area of 7.1 mm2. Then, the so 
formed ex vivo wound healing model was placed dermis-down on gauze in culture 
dishes and incubated at the air–liquid interface with Dulbecco’s modified Eagle´s 
medium supplemented with hydrocortisone, 2% fetal calf serum, penicillin, and 
streptomycin. The tested sample groups were divided into six groups (n = 10): (i) 
untreated control, (ii) TE-oleogel, (iii) pure PVA mat (iv) F1, (v) F2, and (vi) F3 fiber 
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mats. Subsequently, sections of the electrospun fiber mats (4 mm in diameter)/5 µL of 
the oleogel were immediately applied after wounding, and the models were incubated 
for 48 h at 37 °C and 5% CO2. Further steps involved shock freezing, preparations of 
cryostat sections of the central parts of the wound healing models, and staining with 
hematoxylin and eosin. Wound healing progress (reepithelialization) was assessed by 
measuring the distance between the wound margin and the tip of the regenerated 
epidermis using a Leica DMLS microscope (10 ×), a Leica MC 170 HD CCD camera, 
and the Leica LAS V4.9 software (Leica, Wetzlar, Germany, 2017). Means of left and 
right wound margins were calculated. 
4.3.13 Statistical Analysis 
All the experiments unless mentioned otherwise were carried out in triplicate and the 
results were expressed as mean ± standard deviation (mean ± SD). Statistical analysis 
of the acquired data was performed by Student’s t-test and analysis of variance 
(ANOVA). p-value less than 0.05 was considered statistically significant, and where 
significance has been proven, it is indicated by *p < 0.05, **p < 0.01, and ***p < 0.001. 
4.4 Results and Discussion 
4.4.1 Fiber Preparation and Morphological Characterization Using SEM 
Preparation of the electrospun fibers building the wound dressing mats followed the 
optimized protocol as given in section 2.4. In our previous preliminary studies, we 
varied all typical parameters that might have an impact on the fiber’s properties. 
Parameters investigated included (1) flow rate, which was varied between 0.1, 0.5, and 
2 mL/h, (2) needle tip-to-collector distances were in range of 5, 10, and 20 cm, (3) 
speed of the collector was fixed at 1000 rpm, and (4) voltage was varied at 7, 15, and 
20 kV. The electrospinning parameters used to manufacture fiber mats as highlighted 
in Section 2.4 were optimized to a flow rate of 0.5 mL/h, needle tip-to-collector distance 
of 10 cm, and an applied voltage of 15 kV. 
Figure 1 shows SEM images of the electrospun wound dressings and the 
correspondingly measured fiber diameters. Pure PVA fiber mats had a thickness of 
about 51.67 ± 4.9 µm, F1 of 100 ± 9.09 µm, F2 of 39.59 ± 3.4 µm, and F3 exhibited 
the highest thickness of 110 ± 5.4 µm. Pure PVA electrospun fibers were randomly 
oriented with smooth surface and a few interconnected web-like structures in several 
points, while their fiber diameter ranged from approximately 750 to 1600 nm. The fiber 
diameter of F1 was between 390 and 600 nm without formation of beads. F2 fibers 
were observed as smooth and uniform with fiber diameters of 340 to 500 nm without 
beads. On the other hand, F3 fibers were observed as uniform but rough surfaces with 
presence of interconnected beads and their fiber diameter ranged from 350 to 900 nm. 
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Figure 1. SEM micrographs and fiber diameter distribution of (a) pure PVA, (b) F1 (c) F2, 
and (d) F3 electrospun fiber mats. 
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The results clearly show that not only the morphology of electrospun fibers, but also 
the resulting fiber diameter was changed after PVA was blended with the aqueous 
dispersions. In general, the addition of colloidal dispersions resulted in a decrease of 
the average fiber diameter due to the reduced viscosity of polymeric solutions shown 
in Figure 2. However, the increase of TE concentration in the mixture influenced the 
structure of the fibers, and the average diameter of the nanofibers also increased 
(Table 4). The observed web-like interconnected structures/beads were due to high 
viscosity, which caused resistance to jet stretching during the electrospinning process. 
In addition, it was very difficult to process F3 with a high amount of TE (2%) because 
unstable Taylor cone and discontinuous jet during electrospinning with intermediate 
clogging of the needle occurred. The discontinuous jet formation led to loss of the 
electrospinning solution, meaning that much drug was also lost in the process. 
Therefore, lower amounts of constituents in the colloidal dispersions led to reduction 
of viscosity, which resulted in better and stable stretching of the jet with an overall good 
performance during the electrospinning process even over a long production run (4 h). 
As a result, improved fiber morphology with smooth, thinner fibers was observed 
[41,42]. The two formulations showed good drug entrapment efficiencies of about 76% 
for F2 and 69% for F3. 
Table 4. Fiber diameters of the obtained electrospun fibers. 
Formulation Average Diameter (nm) 
Minimum Diameter 
(nm) 
Maximum Diameter 
(nm) 
Pure PVA 1105 ± 236 768 1586 
F1 481 ± 49 399 577 
F2 392 ± 42 341 499 
F3 626 ± 94 390 853 
 
 
Figure 2. Viscosity of non-loaded and TE-loaded PVA solutions. * statistically significant, 
** p < 0.01; *** p < 0.001 vs. pure PVA. 
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4.4.2 Differential Scanning Calorimetry Analysis 
DSC measurements of the pure constituents of the electrospun fiber mats as well as 
of the final fiber mats were performed to observe the effect of the addition of colloidal 
dispersions in PVA matrix; their thermograms are presented in Figure 3. The DSC 
thermogram of the TE extract showed the melting process of a metastable modification 
at the beginning, accompanied by subsequent exothermic recrystallization in a more 
stable form, which melts at about 248 °C [43]. PL90H showed a major endothermic 
peak at around 119 °C where a partial melting of side chains as well as 
phosphatidylcholine transition to a thermotropic liquid crystalline state occurs. The 
peaks at around 141 °C, 153 °C, and 178 °C were thought to show further phase 
transitions, and lastly, the peak at 231 °C is where melting of phosphatidylcholine takes 
place [44]. The DSC thermograms of the electrospun products are characterized by 
two major endothermic peaks, one broader band between 70–100°C associated with 
evaporation of water, and a melting peak at 177 °C. This melting peak is in good 
accordance with the melting of pure PVA fibers (Table 5). Interestingly, the electrospun 
fibers show neither the melting peaks and phase transitions of the phospholipid, nor 
the melting peak of the TE. This indicates that the colloidal dispersions embedded in 
nanofibers were present mostly in the amorphous state. However, a final decision on 
the crystallinity requires further analytical methods, e.g., X-ray diffraction [45,46]. 
 
Figure 3. DSC thermograms for (a) Phospholipon 90H, (b) birch bark extract (TE), (c) 
Pure PVA mat, (d) F1, (e) F2, and (f) F3 fiber mats. 
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Table 5. Thermal properties of nonloaded and TE-loaded electrospun PVA-
based fiber mats. 
Sample Tm (°C) 
Birch bark extract  248 ± 2.92 
Phospholipon 90H 231 ± 1.11 
Pure PVA mat 177 ± 0.42 
F1 177 ± 0.27 
F2 178 ± 1.53 
F3 177 ± 0.14 
 
4.4.3 Confocal Raman Spectral Imaging 
The obtained Raman images of the nanofiber mats of F2 and F3 are shown in Figure 
4. By observing the red spots, these color-coded images clearly show that F3 
contained higher amount of the incorporated TE. TE (red spots) is found predominantly 
colocated with the oil phase (yellow spots), demonstrating that the extract has high 
affinity to sunflower oil. Although spatial resolution of Raman microscopy is in the 
submicron range and not on the molecular level, the images give, as expected, clear 
hints that the phospholipon 90H (blue spots) forms an interfacial layer between the 
lipophilic components (TE and sunflower oil) and PVA (green). Consequently, this will 
ensure better encapsulation as well as stabilization of the two lipophilic substances 
within the hydrophilic PVA matrix. Indeed, the color-coded images not only show 
homogeneous TE distribution throughout the fiber mats, but also strengthens a good 
encapsulation of TE within the nanofiber mats. Accordingly, confocal Raman 
microscopy allowed the investigation of the spatial distribution of all components within 
the fiber mats. 
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Figure 4. Confocal Raman microscopic color-coded images of TE-loaded fiber mats 
from (a) to (d) F3 (e), and (f) F2, Color code: Red: TE, Blue: PL90H, Green: PVA, 
Yellow: Sunflower oil; stack order of color code left column: green, yellow, blue, red; 
stack order of color code right column: green, red, blue, yellow. 
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4.4.4 In Vitro Release Studies 
Figure 5 shows the cumulative betulin release from PVA-based wound dressings for a 
period of 72 h at 32 °C represented in percent and µg/cm2 for the two TE-containing 
wound dressings. The release in µg/cm2 units could be vital for a possible clinical 
therapy, which makes it easier to calculate the dose needed based on the size of the 
wound dressing. Besides, the release in percentage would thereby be helpful to 
estimate the encapsulation efficiency. By observing the percentage amount released 
after 3 days, 44% of betulin was released from the F2 nanofibers whereas only 22% 
was released from F3 fiber mats. Although the amount of TE incorporated in F3 blend 
was high, this formulation shows a slower percentage drug release than F2 (p < 0.05) 
where a faster release is observed. The reason behind this was F3 blend contained 
components at very high concentrations (3.2% PL90H, 4% SO), which slowed the 
release of the drug, whereas the F2 blend had only 1% PL90H and 0.4% SO, hence 
quicker release of the drug from the hydrophilic matrix. Obviously, the amount released 
in µg/cm2 from F3 formulation was higher than F2 blend due to large differences in the 
amount initially incorporated. From these results, we can conclude that, initially, the 
drug is being released faster from the wound dressings, followed by a sustained 
release manner. 
Table 6 shows the modelling results obtained from the four kinetic models. On 
comparing the R2 values of the two formulations, it was found that betulin release from 
the electrospun PVA wound dressings closely fitted Korsmeyer–Peppas model as this 
model showed higher R2 values followed by Higuchi square root model than other 
models. From the Korsmeyer–Peppas model, n values were found to be between 0.42 
and 0.62 for both dressings, indicating that betulin release from PVA/TE fiber mats can 
be largely described as matrix diffusion [47,48]. 
In addition, the obtained results show that, by regulating the sunflower oil and PL90H 
concentrations in both formulations, betulin release can be controlled. Several 
mechanisms could be responsible for betulin’s controlled release. In our previous 
study, we observed through interfacial tension measurements that PL90H and TE 
strongly interact with each to form a stable film. Moreover, studies have shown that 
triterpenes interact with PL and fluidize lipid membranes controlled by their free polar 
groups where tetracyclic triterpenes (e.g., cortisol) tend to be located at the head 
group, whereas pentacyclic ones (e.g., erythrodiol), being more hydrophobic, are 
incorporated deeply in the lipid bilayers [49]. The ratios between PL90H:TE were 2:0.4 
for F2 and 6.4:4 for F3 which demonstrates that increasing the concentration of PL90H 
reduces rate of drug release. On the other hand, the F2 contained lower concentrations 
of sunflower oil and PL90H which allows release medium to easily penetrate through 
the hydrophilic matrix, hence allowing faster betulin release. Another possible reason 
is that the F2 dressing had thinner fibers, with an average fiber diameter of 392 nm, 
than the thicker fibers of F3 (626 nm) where betulin has to travel a longer distance 
through the polymeric matrix, leading to a slower release [50]. It is also known that 
through emulsion electrospinning, core–shell nanofibers can be produced while 
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designing controlled release drug delivery systems such that the drug release rate can 
be modulated, for example, by just adjusting the oil phase and the water phase of the 
emulsions [51]. 
 
Figure 5. In vitro drug release studies. (a) Percentage of released betulin and (b) 
amount of betulin released (µg/cm2) from TE-loaded wound dressings. 
Table 6. In vitro release kinetics data of the two TE-loaded electrospun fiber mats 
fitted to mathematical models. 
Sample Zero-Order First-Order Higuchi Korsmeyer–Peppas Model R2 R2 R2 R2 n 
F2 0.9105 0.9405 0.9847 0.9943 0.42 
F3 0.9834 0.9877 0.9975 1 0.62 
4.4.5 Ex vivo Permeation Through Wounded Skin 
The developed wound dressings are intended to be applied on wounded skin. Figure 
6 shows the cumulative amount of betulin permeated from the two wound dressings 
through stimulated “injured skin”. Again, the data is represented in both percent and 
µg/cm2. The cumulative amount of drug permeated from the F3 formulation was 124.24 
± 11.5 µg/cm2, and 74.58 ± 4.7 µg/cm2 for the F2 dressing at 168 h. The large 
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differences in permeation profiles are due to the high amount of TE incorporated in the 
F3 formulation. However, the drug permeated much faster from the F2 dressing 
(permeation coefficient: 6.2 × 10−3 mg/cm2.h), reaching about 22.81%, than the F3 
formulation (permeation coefficient: 3.6 × 10−3 mg/cm2.h) where only 7.21% was 
achieved at 168 h. Beyond that, as shown in Figure 6, the ex vivo drug permeation 
profiles were similar to in vitro drug-release profiles. On comparing the R2 values of 
the two formulations, again, betulin permeation profiles closely fitted to Korsmeyer–
Peppas model (R2: 0.9914 for F2, 0.9934 for F3) and Higuchi square root model (R2: 
0.9844 for F2, 0.9968 for F3) than other models. From the Korsmeyer–Peppas model, 
n values were found to be between 0.42 and 0.75 for both dressings, showing that 
betulin permeation from PVA/TE fiber mats can be mainly attributed to diffusion of the 
drug from the polymer matrix. Mostly, the release of the drug from drug-loaded 
electrospun nanofibers is mainly governed by diffusion through the polymer matrix, 
including release by polymer matrix degradation and drug desorption from the surface 
of the nanofibers [52,53]. 
As expected, in vitro drug release and skin permeation studies are markedly different 
(p < 0.05) in that the drug release with the use of synthetic membrane is much faster 
in comparison to the dermatomed skin. For instance, only 19% (62.78 ± 12.5 µg/cm2) 
of betulin from F2 permeated through the skin, whereas about 44% (145 ± 15.5 µg/cm2) 
was released through the synthetic membrane after 3 days. These data suggest that 
the diffusion of betulin across the synthetic membrane demonstrates how the skin due 
to its complexity, presents as a barrier leading to a slower permeation even when 
injured skin was tested. 
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Figure 6. Ex vivo drug permeation studies. (a) percentage of permeated betulin and 
(b) amount of betulin permeated (µg/cm2) from TE-loaded wound dressings. 
4.4.6 Ex Vivo Wound Healing Model 
The healing performance of the wound dressings was microscopically evaluated in an 
ex vivo experiments. As shown in Figure 7, all the tested formulations favored wound 
closure in comparison to control, but the greatest wound area reduction was observed 
in the group treated with the F2 fiber mats. This is clearly reflected by the 
corresponding histological micrographs (Figure 8) where the F2 fiber mat (Figure 8 (e)) 
showed a complete reepithelialization and proved to enhance wound healing more 
efficiently than all other tested samples. Statistical evaluation revealed that the 
differences with the rest of the groups were statistically significant (***p < 0.001). 
Among the rest of the groups, the electrospun wound dressings performed much better 
than the TE-oleogel. Moreover, given that F2 fiber mats presented a significantly higher 
wound closure, it can be observed that low concentrations of TE are more favorable to 
wound healing than higher amounts of TE (F3 fiber mats, *p < 0.05). Perhaps higher 
concentrations of TE inside the fiber mats had some impairing effects on the cells, 
which slowed wound closure. In addition, the two placebos, F1 fiber mats (**p < 0.01) 
and pure PVA fiber mats (***p < 0.001), also showed a significant improvement of 
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reepithelialization in comparison to the control, but the formulation containing PL90H 
without TE was slightly better than pure PVA scaffolds. However, it would be interesting 
to assess the effects of PL90H on the wound healing process in a further study. Other 
researchers have shown that electrospun scaffolds in wound healing promote cell 
proliferation, cell support, and enhanced tissue regeneration [21,24]. 
 
 
Figure 7. Wound healing recovery. * statistically significant, * p < 0.05; ** p < 0.01; *** 
p < 0.001 vs untreated control and ## compared to TE-oleogel. 
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Figure 8. Microscopic observation: histological evaluations of wounds treated with TE-oleogel 
(b), pure PVA fiber mat (c), F1 (d), F2 (e), and F3 (f). (a) is the untreated control. 
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4.5 Conclusions 
In conclusion, for the first time, we have successfully developed a bioactive PVA-based 
wound dressing containing colloidal dispersions of birch bark extract through emulsion-
electrospinning. The betulin was released from the electrospun fiber mats in a 
diffusion-controlled manner. Scanning electron microscopy showed that fiber 
characteristics and morphology can be influenced by just adjusting compositions in the 
colloidal dispersions. The electrospun fiber mats varied from smooth to rough surfaces 
with average fiber diameters between 300 and 1586 nm. Confocal Raman spectral 
imaging confirmed that TE and other substances were indeed part of the electrospun 
fiber structures. The ex vivo wound healing assay carried out in porcine ears showed 
an improvement in wound healing in terms of wound closure and reepithelialization 
when PVA-TE fiber mats were applied on the wound. Accordingly, these results 
demonstrated that the developed wound dressings ideally suited for the treatment of 
wounds. The proven sustained release enables less frequent changing of the wound 
dressing. Due to the extended TE release, application to chronic wounds seems also 
to be conceivable. Such a TE-PVA hybrid system comes with tremendous effects not 
only for covering wounds, but also essential in accelerating the wound healing process 
due to the positive effects of TE. In addition, the wound healing study showed that 
wound healing is a complex process and that the performance of a wound dressing 
can be not estimated neither from the physicochemical characterization nor from ex 
vivo permeation studies. Selection must be done on a case-by-case approach. 
However, it can be concluded that such a composite scaffold fabricated through 
emulsion electrospinning would be an appropriate candidate for wound healing 
applications. 
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5.1 Abstract 
Triterpenes from the outer bark of birch (TE) are known for various pharmacological 
effects including enhanced wound healing. Apart from an already authorized oleogel, 
electrospun nanofiber mats containing these triterpenes in a polyvinyl alcohol (PVA) 
matrix appear to be an advantageous application form. The effects of PVA molecular 
weight and concentration on the fiber morphology have been investigated. Three 
different molecular weights of PVA ranging from 67 to 186 kDa were used. The 
concentration of PVA was varied from 5 to 20 wt%. Polymer solutions were blended 
with colloidal dispersions of birch bark extract at a weight ratio of 60:40 (wt.%). The 
estimated viscosity of polymer solutions was directly linked to their concentration and 
molecular weight. In addition, both pure and blended solutions showed viscoelastic 
properties with a dominant viscous response in the bulk. Fiber morphology was 
confirmed using scanning electron microscopy (SEM). Both polymer concentration and 
molecular weight were found to be significant factors affecting the diameter of the 
fibers. Fiber diameter increased with a higher molecular weight and polymer 
concentration as more uniform fibers were obtained using PVA of higher molecular 
weight (146–186 kDa). In vitro drug release and ex vivo permeation studies indicated 
a faster drug release of betulin from electrospun scaffolds with lower PVA molecular 
weight. Our research suggests that the fabricated TE-loaded PVA electrospun 
dressings represent potential delivery systems of TE for wound care applications. 
 
Keywords: Electrospinning, PVA, Molecular weight, Birch bark extract, Wound 
dressing 
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5.2 Introduction 
Once the skin is damaged, very important skin functions such as physical protection 
and thermoregulation are lost which can result in either acute or chronic wounds. Most 
of the wound dressings in the market have their basic functions to provide a protective 
barrier against bacterial contamination and absorb exudate [1]. Thus, developing 
wound dressings for not only covering wounds but with loaded active ingredients to 
improve the wound healing process would be greatly beneficial. The pentacyclic 
triterpenes from outer birch bark extract are known for their pharmacological effects 
such as anti-inflammatory, antimicrobial, anti-viral, anti-cancer activity and wound 
healing effects [2–9]. A suitable triterpene dry extract (TE) from the outer bark of birch 
contains > 80% (w/w) betulin as the main component and is obtained by accelerated 
solvent extraction with n-heptane [10]. Other disclosed triterpenes of this dry extract 
include lupeol (LU), erythrodiol (ER), betulinic acid (BA) and oleanolic acid (OA) (Table 
1) [11]. However, TE exhibits low solubility in polar and non-polar solvents that may 
lead to a poor bioavailability which might limit its therapeutic application [8,12]. 
Currently, topical formulations containing TE include water-in-oil foams [9], cosmetic 
water-in-oil creams (Imlan Creme pur, Birken AG) and a TE oleogel based on 
sunflower oil received from the European marketing authorization in January 2016 [13]. 
Notably, TE together with sunflower oil supports more wound healing than in 
combination with other oils as examined by Steinbrenner et al [8]. The efficacy of TE-
based formulations has been well investigated in vivo on different types of wounds 
including dystrophic epidermolysis bullosa, where treatments promoted wound healing 
[14–16]. A study conducted by Ebeling et al. showed the molecular mechanism of the 
effects of birch bark extract on wound healing properties in human primary 
keratinocytes and porcine ex vivo wound healing models. They showed that TE and 
betulin mainly accelerated re-epithelialization by enhancing migration of keratinocytes 
and their differentiation. Beyond that, they found that TE led to upregulation of 
proinflammatory mediators such as COX-2 and IL-6 which play a key role in wound 
healing and epidermal barrier repair [6]. In addition, TE positive effects have been 
observed in all three phases of wound healing [13]. 
Table 1 Physical-chemical characteristics of the dry birch bark extract used [9]. 
TE Composition Specific surface area 
Particle size 
D50% 
Betulin 81.60%, lupeol 2.08%, betulinic acid 
3.84%, erythrodiol 1.05%, oleanolic acid 0.97%, 
Betulinic acid methyl ester 0.52%, undisclosed 
substances 9.94% 
42 ± 0.4 m2/g 5.8 µm 
By use of the electrospinning technique, it is possible to prepare fibers with a diameter 
from a few micrometers down to several nanometers [17,18]. These nanofibers have 
interesting characteristics, e.g., high surface area to volume ratio, and can form 
mats/fleeces with high porosity which makes them attractive materials for wound 
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dressing [19]. Additionally, electrospun nanofibrous scaffolds tend to mimic the 
structure of the native extracellular matrix (ECM), hence they facilitate cell proliferation, 
improve gaseous exchange, assist in the removal of exudate and act as a physical 
barrier against entry of microorganisms during wound healing with eventual tissue 
repair of damaged tissues [19–23]. 
PVA is a water-soluble, non-toxic, biocompatible and biodegradable hydrophilic 
polymer with good chemical and mechanical properties, and has been approved by 
the U.S. Food and Drug Administration (FDA) for both biomedical and pharmaceutical 
applications [24,25]. Many researchers have investigated the influence of various 
parameters on fiber morphology and diameters of electrospun PVA fibers. Some of 
these parameters include polymer molecular weight and solution concentration [26,27]. 
PVA polymer has either been used alone or combined with other biodegradable 
polymers and electrospun to form scaffolds for various applications. Furthermore, PVA 
has also been blended and electrospun with active ingredients such as hyaluronic 
acid/L-arginine, soursop leaves extract, silver nanoparticles and curcumin for wound 
healing [28–31]. Recently, we have developed, for the first time, a PVA bioactive 
wound dressing containing TE which showed accelerated wound healing [32]. In this 
present work, we investigated the influence of PVA molecular weight on TE-loaded 
electrospun nanofibers.  
The purpose of this work was to (1) assess the effect of PVA molecular weight, blend 
composition and solution concentrations on rheological properties and the resulting 
fiber morphology, and (2) investigate the relationship of rheological properties and 
electrospinnability of polymer solutions. Rotational and amplitude sweep tests of the 
prepared solutions were performed. The surface properties of electrospun fiber mats 
were characterized by SEM. We also conducted ex vivo permeation and in vitro release 
studies using Franz diffusion cells to test the biopharmaceutical characteristics of 
betulin containing electrospun nanofiber mats.  
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5.3 Results and Discussion 
The electrospinnability of polymer solutions is known to depend strongly on their 
viscosity, surface tension and electrical conductivity. This might be affected further by 
the properties of an active compound which is added to the matrix forming polymer. In 
this study, the active compound is added as a colloidal dispersion consisting of TE, 
Phospholipon 90H (PL90H) and sunflower oil (SO) dispersed in water [33]. Therefore, 
the properties of PVA solutions and blended dispersions were assessed and related 
to their ability to form electrospun fibers. 
5.3.1 Rheological Characterization of the Electrospinning Solutions 
Rotational and amplitude sweep tests were performed on all PVA/TE blended solutions 
as well as on plain polymer solutions. Figure 1 (a) shows the results obtained from 
rotational tests, where changes in viscosity as a function of concentrations for pure 
polymer solutions with different molecular weights are presented. As expected, 
solution viscosity clearly increases significantly (p < 0.05) with increasing polymer 
concentration and molecular weight. For example, the viscosity of the pure PVA 
solutions (5–20 wt.%) varied from 0.012 to 2.43 Pa × s (low molecular weight (LMW)), 
0.035 to 17.9 Pa × s (medium molecular weight (MMW)) and 0.09 to 40.2 Pa × s (high 
molecular weight (HMW)). The results presented in Figure 2 show the viscoelastic 
properties of the pure polymer solutions (5–20 wt.%) with their molecular weights. It 
can be observed that the loss modulus (G″) and storage modulus (G′) increase 
consistently with an increase in PVA concentration and molecular weight. Additionally, 
solutions with low PVA concentrations (< 10 wt.%) showed a steep decline in their 
storage modulus (G′) already at weak deformation. Notably, G″ dominates always over 
G′, indicating that PVA forms predominantly viscous liquids. Similar observations were 
also made elsewhere [26,34,35].  
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Figure 1. (a) Influence of molecular weight and PVA concentration on viscosity. (b) 
Viscosity of blended PVA/TE dispersions solutions in the ratio of 60:40 (error bars are 
smaller than the symbol size). 
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Figure 2. Storage (G′) and loss (G″) moduli as a function of PVA concentration (wt.%). 
(a) Low molecular weight (LMW), (b) medium molecular weight (MMW) and (c) high 
molecular weight (HMW) (error bars are smaller than the symbol size). 
As expected, blending of pure polymer solutions with colloidal dispersions (60:40) 
resulted in a reduction in the viscosity (Figure 1 (b)). The viscosity is almost the same 
as for plain PVA solutions with the respective lower concentration indicating that there 
is no specific interaction of PVA and the colloidal dispersion. A similar reduction in 
viscosity has been reported after blending PVA with other agents [36–38]. Figure 3 
shows the results from rotational tests when 12 wt.% of all molecular weights was 
blended with the colloidal dispersion in different compositions (20:80, 40:60, 50:50, 
60:40, 70:30, 80:20). It can be clearly seen that the viscosity increased significantly (p 
< 0.05) as the amount of PVA increased in the blend. Again, there are no hints that the 
colloidal TE dispersions interact specifically with PVA. PVA/TE dispersion blended 
solutions maintained their viscoelastic characteristic, with the loss modulus (G″) always 
being greater than the storage modulus (G′). Further, both G″ and G′ values increase 
as the molecular weight increases in the blend composition. 
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Figure 3. Viscosity as a function of PVA/colloidal dispersion aqueous blends (error 
bars are smaller than the symbol size). 
Not surprisingly, polymer concentration, molecular weight and viscosity are correlated 
with each other. An increase in polymer solution concentration will result in greater 
polymer chain entanglement since polymer chain length or molecular weight is directly 
proportional to the number of entanglements [26,27,39]. 
5.3.2 Surface Tension and Conductivity of Polymer Solutions 
Electrospinning only occurs when the charges applied on the polymer solution are high 
enough to overcome the surface tension. Therefore, a low surface tension is favorable 
in electrospinning as this minimizes the amount of critical voltage needed for the jet 
formation from the Taylor cone. The results in Figure 4 (a) clearly show that the used 
PVA solutions are surface-active being related to H-bonding between hydroxyl groups 
on PVA chains and water [40]. The surface tension of the polymer solutions remained 
nearly unchanged regardless of the polymer concentration and molecular weight used, 
indicating that the surface is completely saturated with the polymer in the whole 
relevant concentration range. The conductivity values in Figure 4 (c) increased 
gradually as the amount of PVA concentration and molecular weight increased. This 
can be attributed to the fact that sodium acetate is a major impurity during production 
of PVA, dissociating into sodium and acetate ions in water, and therefore conductivity 
increases as a higher amount of PVA is added [41,42]. As expected, the addition of 
the colloidal TE dispersion which comprised only substances which are practically 
insoluble in water did neither affect the surface tension nor the electrical conductivity 
(Figure 4 (b) and (d)), the latter being only reduced according to the reduced fraction 
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of PVA in the blend. With respect to electrospinnability, it is known that both a too low 
or a conductivity beyond a critical value, for example, through addition of salts, e.g., 
NaCI, will hinder Taylor cone formation and the electrospinning process [43,44]. The 
measured values (0.34–0.96 mS/cm) are within a range that are reported to be suitable 
for electrospinning [45,46]. 
 
Figure 4. (a) Surface tension and (c) conductivity as a function of PVA concentration 
and molecular weight. (b) Surface tension and (d) conductivity of blended PVA/TE 
solution (60:40) at different molecular weights (error bars are smaller than the symbol 
size). 
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5.3.3 Qualitative Analysis of Electrospinning Process and Nanofiber 
Formation 
Pure polymer solutions at lower concentrations < 10 wt.% of LMW showed unstable 
Taylor cone and discontinuous jet during electrospinning. Only at 12 wt.%, a stable jet 
was observed. Beyond this concentration, Taylor cone and jet instability occurs. The 
same phenomena were observed with MMW, where below 7 wt.% PVA polymer 
solution, an unstable jet and Taylor cone were formed. Between 10 and 12 wt.%, the 
jet stability improved. Beyond 15 wt.%, unstable jet formation can be observed. Pure 
polymer solutions of HMW between 5 and 7 wt.% exhibited stable continuous jet, 
whereas they destabilized between 10 and 15 wt.% and became discontinuous. After 
a prolonged electrospinning process with polymer solutions of high concentrations, the 
Taylor cone dries out and clogging of the needle tip was observed. With the polymer 
solution at 20 wt.% of HMW, the solution did not flow through the needle tip, while jet 
formation only occurred for a few seconds and the electrospinning process stopped. 
No jet formation with PVA/TE blends of LMW at low concentrations (< 12 wt.%), < 10 
wt.% of MMW and < 7 wt.% of HMW was observed. Blends of 20 wt.% in LMW, 12–15 
wt.% in MMW and 10–12 wt.% in HMW had good performance in the formation of a 
continuous jet during the electrospinning process even after a long duration (4 h).  
The success of the electrospinning process is strongly correlated with the 
characteristics of the polymer solutions from which the fibers were produced. Hence, 
with the change in molecular weight and concentration, a difference in the 
electrospinnability and morphology of the obtained fibers was expected. For instance, 
in the case of pure PVA solutions (Figure 5), bead-free fibers were obtained with 
solutions at lower concentrations (5–7 wt.%) of HMW and 7–15 wt.% for MMW, while 
for LMW in the range of 12–20 wt.%. While electrospinning pure polymer solutions at 
high concentrations of 10–20 wt.%, particularly of HMW, the high viscosity prohibits 
the continuous flow of the polymer solution jet towards the collector. Even practical 
handling of such a kind of solution was difficult. At 5–7 wt.% of HMW blended solutions 
(Figure 6), due to low viscoelasticity, only beaded fibers were formed. Once the PVA 
solution concentration was increased to 10–15 wt.%, the bead defect was completely 
removed and smooth fibers were formed. The solutions with low viscosity (< 0.09 Pa 
× s), mainly those of LMW or low amounts of PVA in blend composition, produced a 
mixture of fibers and beads. Only droplets were produced instead of jet formation, due 
to the jet breaking up into droplets similar to electrospraying. This indicated that by 
increasing the polymer concentration of the solution, chain entanglement increases 
among polymer chains which overcome the surface tension and bead-free fibers can 
be produced [26,43,47]. We hereby conclude that polymer solutions or blends should 
show greater viscous properties over elastic behavior in the bulk, but only a proper 
relation between these two characteristics enables jet and fiber formation during the 
electrospinning process. 
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5.3.4 Effect of Concentration and Molecular Weight on Fiber Morphology 
Figure 5 shows electrospun fibers produced from pure PVA polymer solutions. SEM 
analysis showed drastic changes in terms of fiber morphology when the molecular 
weight and concentration of polymer solutions were changed. In LMW, no fibers were 
formed over the collector with the polymer solution of 5 wt.% due to the low viscosity. 
With higher concentrations of 7 wt.% and 10 wt.%, a mixture of fibers with beads was 
formed. From 12 wt.% PVA, uniformity of fibers increased, where at 20 wt.% PVA, 
smooth uniform thicker fibers were observed instead of beaded fibers. For MMW, the 
formation of beaded fibers was only observed at 5 wt.% PVA. With 7 to 15 wt.% 
polymer solutions, smooth, uniform and bead-free fibers were produced. Flat and 
thicker fibers were observed with the polymer solution of 20 wt.% due to its high 
concentration. 
In the case of HMW, a different pattern was observed, where only between 5 and 7 
wt.% PVA, smooth, uniform fibers were produced. Besides that, between 10 and 20 
wt.% PVA, fiber uniformity decreased and resulted in flat non-uniform thicker fibers 
with a few interconnected web-like structures in several points. Further, the observed 
poor fiber morphology of unloaded electrospun fibers (Figure 5) especially with HMW 
at high concentrations (10 to 20 wt.%) was due to the high viscosity which caused 
resistance to jet stretching during the electrospinning process.  
The measured fiber diameter indicated that the fiber diameter not only increased 
across polymer concentrations but also with the increase to the higher molecular 
weight. Pure electrospun fibers produced with LMW had average diameters between 
147 (10 wt.%) and 390 nm (20 wt.%), MMW ranged between 183 (5 wt.%) and 1357 
(20 wt.%) nm and HMW ranged between 269 (5 wt.%) and 2204 nm (20 wt.%) (Table 
2). In accordance with Koski et al. [26], this finding shows that polymer concentration 
and molecular weight are influential in determining whether fibers or beads are 
produced. 
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Figure 5. SEM images at 10,000× showing the obtained electrospun fibers from pure 
PVA polymer solutions. All scale bars represent 1 µm. 
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Table 2. Fiber diameters of the obtained electrospun fibers from pure PVA 
solutions 
Molecular 
weight 
PVA 
(wt.%) 
Average diameter 
(nm) ± SD 
Minimum 
diameter 
(nm) 
Maximum 
diameter 
(nm) 
LMW 
5% - - - 
7% - - - 
10% 147 ± 24 91 202 
12% 174 ± 25 113 228 
15% 224 ± 22 178 271 
20% 390 ± 36 304 466 
     
MMW 
5% 183 ± 46 108 307 
7% 224 ± 35 162 276 
10% 372 ± 26 288 418 
12% 543 ± 70 437 670 
15% 655 ± 46 589 759 
20% 1357± 450 742 2333 
     
HMW 
5% 269 ± 24 226 311 
7% 358 ± 38 305 443 
10% 688 ± 94 482 863 
12% 975 ± 170 768 1364 
15% 1135 ± 405 762 2337 
20% 2204 ± 151 1500 2397 
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5.3.5 Incorporation of TE Colloidal Dispersions into Nanofibers  
Figure 6 shows the examined SEM morphologies after blending of differently 
concentrated pure PVA solutions with colloidal dispersions (60:40), where different 
structures with varied molecular weight and concentration were observed. The results 
clearly show that not only the morphology of electrospun fibers but also the resulting 
fiber diameter was changed after PVA was blended with the aqueous colloidal 
dispersions. As can be seen, with blends of LMW at 5 and 7 wt.%, no fibers were 
formed due to the low viscosity. By increasing the concentration from 10 to 20 wt.%, 
fiber uniformity increased gradually as the blend at 20 wt.% produced more uniform 
fibers. In the case of MMW, blends at 5 and 7 wt.% produced a mixture of fibers and 
beads, whereas at 10 to 12 wt.%, uniformity increased with the presence of a few 
beads. Blends at 15 and 20 wt.% produced smooth, uniform fibers without beads.  
Similar observations were made with blends of HMW at 5 to 7 wt.%, where a mixture 
of beads and fibers was formed. In contrary, smooth, uniform homogenous fibers were 
already achieved at 10 to 15 wt.%. Blends of electrospun fibers produced with LMW 
had average diameters between 143 (12 wt.%) and 241 nm (20 wt.%), MMW ranged 
between 174 (10 wt.%) and 424 nm (20 wt.%) and HMW ranged between 319 (10 
wt.%) and 605 nm (15 wt.%) (Table 3). Overall, the addition of colloidal dispersions 
resulted in a decrease in the average fiber diameter to submicron range < 1 µm due to 
the viscosity reduction of polymeric solutions. Moreover, and as also reputed by other 
groups, the reduced viscosity contributed to better stretching of the jet and improved 
fiber morphology with smooth, thinner fibers [36,48,49]. Furthermore, formation of 
smooth, uniform fibers without beads indicated that colloidal dispersions were 
entrapped in the fibers and were within the range of the carrying capacity of the fibers 
[32]. 
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Table 3. Diameters of the obtained electrospun fibers from PVA/colloidal 
dispersions blends (60:40). 
Molecular 
weight 
PVA 
(wt.%) 
Average diameter 
(nm) ± SD 
Minimum 
diameter 
(nm) 
Maximum 
diameter 
(nm) 
LMW 
12% 143 ± 29 88 225 
15% 187 ± 31 152 272 
20% 241 ± 28 191 298 
     
MMW 
10% 174 ± 22 129 225 
12% 241 ± 32 178 317 
15% 308 ± 29 263 373 
20% 424 ± 33 355 497 
     
HMW 
10% 319 ± 56 267 503 
12% 392 ± 41 341 499 
15% 605 ± 55 509 689 
 
 
 
 
123 
 
 
Figure 6. SEM morphologies at 10,000× of loaded electrospun PVA/TE blend (60:40) 
fibers at different concentrations and molecular weights. All scale bars represent 1 µm. 
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5.3.6 Fiber Morphology in Different Compositions 
The polymer solutions with 12 wt.% PVA of all molecular weights blended with the 
colloidal dispersion in different compositions (20:80, 40:60, 50:50, 60:40, 70:30, 80:20) 
were electrospun and the obtained fiber morphologies are shown in Figure 7. It is 
evident that the composition of the spinning solutions had a significant impact on the 
morphology of the nanofibers. In all cases, improved morphological changes are 
observed with increasing amounts of PVA in the blend, resulting in an increase in the 
values of their rheological properties. However, at very high amounts of PVA (70:30 
and 80:20) in the blends of HMW, the uniformity decreases. Therefore, we conclude 
that if the PVA fraction is less than 40% in the blend, beaded fibers are formed, while 
fiber uniformity improves from the ratio of 50:50 with the best uniformity being achieved 
at 60:40 of HMW. 
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Figure 7. SEM morphologies at 10,000× of electrospun 12 wt.% PVA/colloidal 
dispersion fibers at different compositions and molecular weights. All scale bars 
represent 1 µm. 
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5.3.7 In Vitro Release Studies 
Electrospun fiber mats prepared from blends with 12 wt.% PVA solutions of different 
molecular weights and colloidal TE dispersions (60:40) were subjected to release 
studies using modified Franz diffusion cells. Figure 8 depicts the cumulative amount of 
betulin released within 72 h. As can be seen, nanofibers from LMW showed higher and 
quicker release of betulin (194.46 ± 35.1 µg/cm2), followed by MMW (182.67 ± 5.2 
µg/cm2) and HMW (165.13 ± 11.2 µg/cm2) electrospun fibers. This effect was attributed 
to the fiber morphologies and diameters. Blends from both molecular weights, LMW 
and MMW, exhibited a mat of thinner fibers making it easier for the drug to diffuse 
through. Between LMW and MMW, no significant differences were observed. On the 
other hand, the blend of HMW showed thicker fibers and drug molecules have to travel 
a longer distance through the polymeric matrix leading to a slower release [50]. 
Release profiles between LMW and HMW differed significantly (p < 0.05) on the 
release of betulin from electrospun fibers. 
 
Figure 8. In vitro drug release studies. (a) Percentage of released betulin and (b) 
amount of betulin released from TE-loaded wound dressings. 
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Table 4 shows the modeling results obtained from the four kinetic models. On 
comparing the R2 values of the formulations, it was found that betulin release from the 
electrospun PVA could be best fitted by the Korsmeyer–Peppas model as this model 
showed higher R2 values than all the other models. From the Korsmeyer–Peppas 
model, n values were found to be between 0.41 and 0.48 for all dressings, indicating 
that betulin release from PVA/TE fiber mats can be largely described as matrix diffusion 
[51,52]. This is in perfect agreement with the spatial distribution of the colloidal TE 
dispersion within PVA found by confocal Raman micro-spectroscopy, indicating that a 
hydrocolloid matrix is formed [32]. A fiber mat can be assumed to be a multiparticulate 
matrix system where the overall TE release is largely affected by the size of the 
individual fibers which form a diffusion barrier [50,53]. 
Table 4. In vitro release kinetics data of the TE-loaded electrospun fiber mats fitted to 
mathematical models. 
Sample Zero-order First-order Higuchi Korsmeyer-Peppas model 
R2 R2 R2 R2 n 
LMW 0.8674 0.8955 0.9518 0.9727 0.41 
MMW 0.9062 0.9233 0.9705 0.9875 0.46 
HMW 0.9504 0.9670 0.9947 0.9967 0.48 
5.3.8 Ex vivo Permeation Through Wounded Skin 
The developed wound dressings are intended to be applied on wounded skin. Figure 
9 shows the cumulative permeated amount of betulin from PVA/TE blend electrospun 
fiber mats in different molecular weights after 120 h. The cumulative amount of drug 
permeated from LMW was 146.81 ± 35.6, 95 ± 8.8 for MMW and 92 ± 1.8 µg/cm2 from 
the HMW/TE blend at 120 h. Again here, a higher and faster cumulative amount of 
drug permeated from the LMW formulation (permeation coefficient: 8.3 × 10−2 
mg/cm2.h, p < 0.05), whereas no substantial differences were observed between MMW 
(permeation coefficient: 4.8 × 10−2 mg/cm2.h) and HMW (permeation coefficient: 5.4 × 
10−2 mg/cm2.h) nanofibers. Electrospun fibers from MMW (241 nm) and HMW (392 
nm), being thicker in diameter, demonstrated lower drug permeation in comparison to 
LMW (143 nm) where the fibers are thinner.  
Analysis of the permeation data showed that the kinetic can be fitted best to the 
Korsmeyer–Peppas model (R2: 0.9938 for LMW, 0.9997 for MMW and 0.9912 for 
HMW). From the Korsmeyer–Peppas model, n values were found to be between 0.74 
and 0.77 for all the dressings, showing that betulin permeation from PVA/TE fiber mats 
is largely influenced by the diffusion through the skin even though the barrier had been 
removed.  
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Drug release from the electrospun fibers and transport through the synthetic 
membrane is markedly faster (p < 0.05) in comparison to diffusion through the 
dermatomed skin. For instance, only 22% (108 ± 19.5 µg/cm2) of betulin from LMW/TE 
fibers permeated through the skin, whereas about 40% (194.46 ± 35 µg/cm2) was 
released through the synthetic membrane after 72 h. However, an influence of the kind 
of electrospun fibers is still visible. To put this in the context of wound healing, a 
controlled release from the PVA matrix is achievable in the very early phase of the 
treatment, whereas with increasing closure of the wound, the skin itself contributes to 
a sustained release stopping the permeation almost completely when the barrier 
function of the skin is restored [9]. 
 
Figure 9. Ex vivo drug permeation studies. (a) Percentage of permeated betulin and (b) 
amount of betulin permeated from TE-loaded wound dressings. 
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5.4 Materials and Methods  
5.4.1 Materials 
PVA with molecular weights of 67 (low molecular weight, (LMW)), 130 (medium 
molecular weight (MMW)) and 146–186 kDa (high molecular weight, (HMW)) (87–89% 
hydrolyzed) was purchased from Sigma Aldrich (Steinheim, Germany). All other 
materials were obtained from the named supplier. Hydrogenated phospholipids, Lipoid 
GmbH (PL90 H, Ludwigshafen, Germany), Sunflower oil, Caesar & Loretz GmbH 
(Hilden, Germany), Birch bark extract, (Amryt AG, Niefern-Öschelbronn, Germany), 
Parafilm®, Bemis Company Inc., (Oshkosh, WI, USA), Whatman Nuclepore 
polycarbonate membrane filters, Sigma-Aldrich ,(Steinheim, Germany). Ultra-pure 
water (ELGA Labwater, Celle, Germany) was used as a solvent to prepare the aqueous 
solutions. Pig ears for ex vivo permeation studies were provided by the Department of 
Experimental Medicine, University of Tuebingen [54]. 
5.4.2 Preparing the Colloidal Dispersions 
The colloidal dispersion with particle sizes of 400 ± 49 nm which was utilized in this 
work consisted of 2.5% PL90H, 1.0% SO and 0.5% TE as the dispersed phase and 
water as the continuous phase optimized from our previous study. Briefly, the 
dispersion was prepared using a two-stage homogenization process where a pre-
dispersion is first formed using a rotor-stator system (Ultra Turrax T25, IKA, Staufen, 
Germany), at 9500 rpm with eventual homogenization using a high-pressure 
homogenizer (Emulsiflex C-3, Avestin, Mannheim, Germany) for 8 cycles at a pressure 
of 100 MPa [33].  
5.4.3 Preparation of Solutions and Electrospinning of Nanofibers 
From all molecular weights, PVA polymer solutions were prepared with varying 
concentrations (5, 7, 10, 12, 15 and 20 wt.%) by dissolving PVA in water at 90 °C under 
magnetic stirring. After PVA was completely dissolved, the solution was cooled to room 
temperature and used the following day. Subsequently, for electrospinning 
experiments, the colloidal TE dispersions were blended with the prepared PVA 
solutions in the ratio of 60:40 using a magnetic stirrer at 40 °C for 2 h to form a 
homogeneous solution. Besides, blends of colloidal dispersions/12 wt.% PVA solutions 
with different mass ratios (20:80, 40:60, 50:50, 60:40, 70:30 and 80:20) were prepared 
to test the influence of blend compositions on fiber morphology. Samples were then 
cooled down to room temperature prior to electrospinning. 
5.4.4 Electrospinning of nanofibers 
Electrospinning was performed using a conventional unit, Nanolab Instruments Sdn. 
Bhd. (Subang Jaya, Malaysia). Figure 10 shows a scheme of the electrospinning setup 
used to perform the experiments. A blunt-end needle (18-gauge) attached to a 5 mL 
plastic syringe was used, while the electrospinning conditions were a needle to 
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collector distance = 10 cm, voltage = 15 kV and flow rate = 0.5 mL/h. A drum rotating 
collector covered with non-sticky aluminium foil and a speed fixed at 1000 rpm was 
used to collect the fibers. All electrospinning studies were carried out at ambient 
temperature (23 ± 2 °C) and a relative humidity of 45%. 
 
Figure 10. Schematic representation of the electrospinning set up used to fabricate 
nanofibers. 
5.4.5 Rheological Characterization of the Spinning Solutions 
Rheological properties in the bulk were determined for all polymer solutions using a 
Physica MCR 501 rheometer (Anton Paar, Graz, Austria) with the cone-plate 
measuring system CP25-1 at a constant temperature of 25 °C. Rotational tests were 
performed in order to determine the viscosity of the solutions at a shear rate of 100 
s−1.The amplitude sweep tests were performed to estimate the viscoelastic properties 
expressed as storage modulus G′ and loss modulus G″. The frequency was set at 1 
Hz and the deformation was in the range of 0.01 to 1000 %. Both the storage modulus 
G′ and loss modulus G″ were determined in the linear viscoelastic range (LVE). 
5.4.6 Surface Tension and Conductivity 
Surface tension was measured at room temperature by the Du Noüy ring method with 
a TD1C LAUDA tensiometer (Lauda-Königshofen, Germany). For each solution, 
average values of parameters from at least three measurements are reported. 
Conductivity of solutions was also measured at 25 °C using a WTW Conductivity meter 
340i (Weilheim, Germany). 
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5.4.7 Qualitative Analysis of Electrospinning Process and Nanofiber 
Formation 
A qualitative evaluation was done on the performance of polymer solutions during 
electrospinning using a plugged digital camera (Digimicro Profi, DNT, Dietzenbach, 
Germany). The camera was attached to the electrospinning process and so it was 
possible to visualize what was happening at the tip of the needle, like the formation of 
jet or droplets and Taylor cone behavior. 
5.4.8 Characterization of Nanofibrous Scaffolds 
The fiber morphology of both the blank and the TE-loaded fibers was observed by 
SEM, using a Zeiss DSM 940 A, Carl Zeiss GmbH (Oberkochen, Germany). Prior to 
SEM observation, each of the fiber mats (0.5 × 0.5 cm) was placed on a conductive 
double-sided tape and sputtered with gold using Biorad E 5100 Sputter Coater (Bio-
Rad GmbH, Munich, Germany) at 2.1 kV and 20 mA for 240 s. Based on these SEM 
images, the average fiber diameters were determined from at least 30 measurements 
using ImageJ software (National Institute of Health, Bethesda, MD, USA). 
5.4.9 Ex vivo Skin Permeation and In vitro Drug Diffusion Studies 
Modified vertical Franz diffusion cells with a reservoir capacity of 12 mL (Gauer Glas, 
Püttlingen, Germany) were used to conduct ex vivo permeation and in vitro release 
studies. In the case of in vitro release studies, synthetic polycarbonate membranes 
(pore size diameter of 0.4 µm) were used. For ex vivo permeation studies, pig ears 
were received from the Department of Experimental Medicine, University Hospital of 
Tuebingen right after the death of the animals. The Department of Pharmaceutical 
Technology is registered for the use of animal products at the District Office of 
Tuebingen (registration number: DE 08 416 1052 21). In ex vivo permeation studies, 
the skin was prepared according to previous studies [55,56]. Briefly, fresh pig ears 
were washed with isotonic saline using cotton balls and after postauricular skin 
excision, wrapped in aluminium foil and stored at −30 °C until further use. On the day 
of experiment, the skin samples were thawed at room temperature, cut into skin strips 
of 3 cm width and pinned to a block of Styrofoam pre-covered with aluminium foil. 
Thereafter, “wounded” skin samples were prepared by a skin grafting method using a 
Dermatom (Dermatom GA 630, Aesculap AG & Co. KG, Tuttlingen, Germany). Here, 
the skin was “wounded” through initial removal of the 0.2 mm outermost layers of the 
skin using Dermatom. Subsequently, the remaining skin was dermatomed to a 
thickness of 0.4 mm, and punched to obtain discs of 25 mm in diameter using a circular 
hole punch (Eduard Gottfried Ferne, Remscheid, Germany) [9].  
Afterwards, the Franz diffusion cells equipped with synthetic membrane/porcine skin 
were filled with a mixture of ethanol and water, 50:50 (v/v), as the receptor medium. 
The diffusion area was 1.77 cm2. In all molecular weights, the final composition (wt.%) 
of PVA/colloidal dispersions (60:40) blends consisted of 7.2 wt.% PVA, 1 wt.% PL90H, 
0.4 wt.% SO and 0.2 wt.% TE. In both experiments, samples of 30.50 mg fiber mats, 
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exactly weighed, were loaded in the donor compartments and covered with parafilm to 
avoid solvent evaporation. The experiments were performed at 32 °C with continuous 
stirring at 500× g. 
The amount of betulin diffused through the membrane/skin was determined by 
withdrawing samples of 1 mL from the receptor chamber at a predetermined time 
interval and replacing them with an equal volume of fresh prewarmed receptor medium 
to keep the sink condition. The samples were analyzed directly for betulin content using 
high-performance liquid chromatography with ultraviolet detection (HPLC-UV). The 
experiments were conducted in triplicate. 
5.4.10 Betulin Permeation/Release Kinetics Assessment 
The release/permeation kinetic of betulin from TE/PVA scaffolds was fitted by zero-
order (Equation 1), first-order (Equation 2), Korsmeyer–Peppas (Equation 3) and 
Higuchi (Equation 4 [57]. After evaluating the regression coefficient (R2), the best 
mathematical kinetic model was obtained. In all cases, Mt is the amount of betulin 
determined in the receptor medium at the fixed times, and t is the time intervals. 
Zero−order model, where k0 is the zero-order release constant: 
Mt = k0t (1) 
First-order model, where K1 is the first-order release rate constant: 
In (1 − Mt) =−K1t (2) 
Korsmeyer−Peppas model: Mt = ktn, where K is the Korsmeyer–Peppas constant 
which is related to the characteristics of the delivery system and the encapsulated drug. 
The n is the diffusional exponent that shows the betulin release mechanism, where n 
= 0.45, a Fickian diffusion mechanism; 0.45 < n < 1, a non-Fickian diffusion mechanism 
(anomalous transport), in which both Fickian diffusion and Case-II transport occurs 
[58]. (3) 
 
Higuchi model, where k is the Higuchi constant: 
Mt = kt0.5 (4) 
5.4.11 HPLC Analysis 
The LC-20A prominence HPLC system (Shimadzu, Kyoto, Japan) was used for betulin 
analysis. The mobile phase was composed of acetonitrile and water with the addition 
of 0.1% (v/v) phosphoric acid. For efficient betulin quantification, gradient conditions 
were used according to the isocratic/gradient modes developed by Armbruster et al. 
[59]. The flow rate was set to 1.2 mL/min, the injection volume was 100 µL and the 
oven temperature was 40 °C. For HPLC separation, a Nucleosil 100-5 C18 EC 125/4 
column together with a precolumn Universal RP EC 4/3 (Macherey-Nagel, Düren, 
Germany) was used. The retention time of betulin was approximately 7.5 min and the 
detection wavelength was set at 210 nm. 
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5.4.12 Statistical Analysis 
The obtained data were acquired from repeated experiments, at least three times, and 
statistically evaluated in terms of the mean and its standard deviation (mean ± SD). 
Statistical differences were determined by one-way or two-way analysis of variance 
(ANOVA) using GraphPad Prism 6.0 (GraphPad Software Inc., La Jolla, CA, USA). 
Results were considered to be statistically significant at the level of p-value less than 
0.05. 
5.5 Conclusions 
This study broadens the knowledge on PVA-based electrospun fibers with a colloidal 
dispersion of a birch bark extract as the active principle for enhanced wound healing. 
The concentration and molecular weight of the polymer as the most decisive 
parameters have a significant effect on the rheological properties of the polymer 
solution and affect directly the resulting fiber properties. Overall, the viscosity of the 
prepared polymer solutions increased as the molecular weight and solution 
concentration increased. Incorporation of colloidal TE dispersions resulted in 
electrospun fibers of thinner diameters. The average fiber diameters in the whole 
studied design space varied between 143 and 2204 nm. It was also possible to control 
the release rate of betulin by just adjusting mainly the thickness of the electrospun 
fibers which can be adjusted by either, or both, the polymer concentration and 
molecular weight. TE was released much faster from fibers of LMW, while MMW and 
HMW performed better in terms of electrospinnability with more uniform fiber 
morphologies. We conclude that such developed scaffolds together with the positive 
benefits of birch bark extract present excellent dressing materials which can be tailored 
to the specific needs of enhanced healing of various types of wounds. 
 
  
 
134 
 
Author Contributions: Conceptualization, F.K.M. and R.D.; data curation, F.K.M.; 
funding acquisition, F.K.M. and R.D..; investigation, F.K.M.; methodology, F.K.M. and 
R.D.; project administration, R.D.; supervision R.D.; writing—original draft, F.K.M.; 
writing—review and editing, R.D. Both authors have read and agreed to the published 
version of the manuscript. 
Funding: This research was funded (PRC20170703) by the Phospholipid Research 
Center in Heidelberg, Germany. 
Acknowledgments: We would like to thank Lipoid GmbH for supplying us with 
phospholipids and Amryt AG for the kind donation of birch bark extract. 
Conflicts of Interest: The authors declare no conflict of interest. 
 
 
 
 
135 
 
5.6 References 
1. Boateng, J.S.; Matthews, K.H.; Stevens, H.N.; Eccleston, G.M. Wound Healing 
Dressings and Drug Delivery Systems: A Review. J. Pharm. Sci. 2008, 97, 2892–
2923, doi:10.1002/jps.21210. 
2. Aiken, C.; Chen, C.H.; Betulinic acid derivatives as HIV-1 antivirals. Trends Mol. 
Med. 2005, 11, 31–36, doi:10.1016/j.molmed.2004.11.001. 
3. Haque, S.; Nawrot, D.A.; Alakurtti, S.; Ghemtio, L.; Yli-Kauhaluoma, J.; Tammela, 
P. Screening and Characterisation of Antimicrobial Properties of Semisynthetic 
Betulin Derivatives. PLoS ONE 2014, 9, e102696, 
doi:10.1371/journal.pone.0102696. 
4. Dehelean, C.A., Soica, C.M.; Toma, C.-C.; Feflea, S.; Gruia, A.T. and Kasa Jr., P. 
Antitumoral activity of betulin, a compound present in birch tree, in formulations 
with cyclodextrin. Studia Univ. VG, Seria St. Vietii 2010, 20, 55–58. 
5. Dehelean, C.; Şoica, C.; Ledeţi, I.; Aluaş, M.; Zupkó, I.; Gǎluşcan, A.; Pinzaru, S.C.; 
Munteanu, M. Study of the betulin enriched birch bark extracts effects on human 
carcinoma cells and ear inflammation. Chem. Central J. 2012, 6, 137, 
doi:10.1186/1752-153x-6-137. 
6. Ebeling, S.; Naumann, K.; Pollok, S.; Wardecki, T.; Vidal-Y-Sy, S.; Nascimento, 
J.M.; Boerries, M.; Schmidt, G.; Brandner, J.M.; Merfort, I. From a Traditional 
Medicinal Plant to a Rational Drug: Understanding the Clinically Proven Wound 
Healing Efficacy of Birch Bark Extract. PLoS ONE 2014, 9, e86147, 
doi:10.1371/journal.pone.0086147. 
7. Metelmann, H.-R.; Podmelle, F.; Waite, P.D. Long-Term Cosmetic Benefit of 
Wound Healing by Betuline. Am. J. Cosmet. Surg. 2012, 29, 19–24, 
doi:10.5992/ajcs-d-11-00046.1. 
8. Steinbrenner, I.; Houdek, P.; Pollok, S.; Brandner, J.M.; Daniels, R. Influence of the 
Oil Phase and Topical Formulation on the Wound Healing Ability of a Birch Bark 
Dry Extract. PLoS ONE 2016, 11, e0155582, doi:10.1371/journal.pone.0155582. 
9. Färber, A.; Daniels, R. Ex vivo Skin Permeation of Betulin from Water-in-Oil Foams. 
Ski. Pharmacol. Physiol. 2016, 29, 250–256, doi:10.1159/000448689. 
10. Laszczyk, M.; Jäger, S.; Simon-Haarhaus, B.; Scheffler, A.; Schempp, C.M. 
Physical, Chemical and Pharmacological Characterization of a New Oleogel-
Forming Triterpene Extract from the Outer Bark of Birch (Betulae Cortex). Planta 
Medica 2006, 72, 1389–1395, doi:10.1055/s-2006-951723. 
11. Krasutsky, P.A. Birch bark research and development. Nat. Prod. Rep. 2006, 23, 
919–942, doi:10.1039/b606816b. 
12. Jäger, S.; Laszczyk, M.N.; Scheffler, A. A Preliminary Pharmacokinetic Study of 
Betulin, the Main Pentacyclic Triterpene from Extract of Outer Bark of Birch 
(Betulae alba cortex). Mol. 2008, 13, 3224–3235, doi:10.3390/molecules13123224. 
13. Scheffler, A. The Wound Healing Properties of Betulin from Birch Bark from Bench 
to Bedside. Planta Medica 2019, 85, 524–527, doi:10.1055/a-0850-0224. 
14. Weckesser, S.; Schumann, H.; Laszczyk, M.; Müller, M.; Schempp, C.M. Topical 
Treatment of Necrotising Herpes Zoster with Betulin from Birch Bark. Forschende 
Komplementärmedizin / Research in Complementary Medicine 2010, 17, 271–273, 
doi:10.1159/000320592. 
15. Schwieger-Briel, A.; Kiritsi, D.; Schempp, C.; Has, C.; Schumann, H. Betulin-Based 
Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A 
Prospective Controlled Proof-of-Concept Study. Dermatol. Res. Pr. 2017, 2017, 1–
10, doi:10.1155/2017/5068969. 
 
136 
 
16. Frew, Q.; Rennekampff, H.-O.; Dziewulski, P.; Moiemen, N.; Zahn, T.; Hartmann, 
B. Betulin wound gel accelerated healing of superficial partial thickness burns: 
Results of a randomized, intra-individually controlled, phase III trial with 12-months 
follow-up. Burn. 2019, 45, 876–890, doi:10.1016/j.burns.2018.10.019. 
17. El-Hadi, A.M.; Al-Jabri, F.Y. Influence of Electrospinning Parameters on Fiber 
Diameter and Mechanical Properties of Poly(3-Hydroxybutyrate) (PHB) and 
Polyanilines (PANI) Blends. Polym. 2016, 8, 97, doi:10.3390/polym8030097. 
18. Reneker, D.H.; Chun, I. Nanometre diameter fibres of polymer, produced by 
electrospinning. Nanotechnol. 1996, 7, 216–223, doi:10.1088/0957-4484/7/3/009. 
19. Zahedi, P.; Rezaeian, I.; Siadat, S.O.R.; Jafari, S.-H.; Supaphol, P. A review on 
wound dressings with an emphasis on electrospun nanofibrous polymeric 
bandages. Polym. Adv. Technol. 2009, 21, 77–95, doi:10.1002/pat.1625. 
20. Kai, D.; Liow, S.S.; Loh, X.J. Biodegradable polymers for electrospinning: Towards 
biomedical applications. Mater. Sci. Eng. C 2014, 45, 659–670, 
doi:10.1016/j.msec.2014.04.051. 
21. Zhong, S.P.; Zhang, Y.Z.; Lim, C.T. Tissue scaffolds for skin wound healing and 
dermal reconstruction. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2010, 2, 
510–525, doi:10.1002/wnan.100. 
22. IgnatovaМ.; Rashkov, I.; Manolova, N. Drug-loaded electrospun materials in 
wound-dressing applications and in local cancer treatment. Expert Opin. Drug 
Deliv. 2013, 10, 469–483, doi:10.1517/17425247.2013.758103. 
23. Jiang, T.; Carbone, E.J.; Lo, K.W.-H.; Laurencin, C.T. Electrospinning of polymer 
nanofibers for tissue regeneration. Prog. Polym. Sci. 2015, 46, 1–24, 
doi:10.1016/j.progpolymsci.2014.12.001. 
24. Gajra⃰⃰⃰⃰, B., Pandya, S. S., G. Vidyasagar, H. Rabari, R.R. Dedania, and 
S.J.I.J.o.P.R. Rao, Poly vinyl alcohol hydrogel and its pharmaceutical and 
biomedical applications: A review. Int. J. Pharm. Res. 2012, 4, 20–26. 
25. Gaaz, T.S.; Sulong, A.B.; Akhtar, M.N.; Kadhum, A.A.H.; Mohamad, A.B.; Al-
Amiery, A.A. Properties and Applications of Polyvinyl Alcohol, Halloysite Nanotubes 
and Their Nanocomposites. Molecules 2015, 20, 22833–22847, 
doi:10.3390/molecules201219884. 
26. Koski, A.; Yim, K.; Shivkumar, S. Effect of molecular weight on fibrous PVA 
produced by electrospinning. Mater. Lett. 2004, 58, 493–497, doi:10.1016/s0167-
577x(03)00532-9. 
27. Ngadiman, N.H.A.; Noordin, M.; Idris, A.; Shakir, A.S.A.; Kurniawan, D. Influence 
of Polyvinyl Alcohol Molecular Weight on the Electrospun Nanofiber Mechanical 
Properties. Procedia Manuf. 2015, 2, 568–572, doi:10.1016/j.promfg.2015.07.098. 
28. Augustine, R.; Hasan, A.; Nath, V.K.Y.; Thomas, J.; Augustine, A.; Kalarikkal, N.; 
Al Moustafa, A.-E.; Thomas, S. Electrospun polyvinyl alcohol membranes 
incorporated with green synthesized silver nanoparticles for wound dressing 
applications. J. Mater. Sci. Mater. Med. 2018, 29, 163, doi:10.1007/s10856-018-
6169-7. 
29. Saeed, S.M.; Mirzadeh, H.; Zandi, M.; Barzin, J. Designing and fabrication of 
curcumin loaded PCL/PVA multi-layer nanofibrous electrospun structures as active 
wound dressing. Prog. Biomater. 2017, 6, 39–48, doi:10.1007/s40204-017-0062-1. 
30. Aruan, N.M.; Sriyanti, I.; Edikresnha, D.; Suciati, T.; Munir, M.M.; Khairurrijal, K. 
Polyvinyl Alcohol/Soursop Leaves Extract Composite Nanofibers Synthesized 
Using Electrospinning Technique and their Potential as Antibacterial Wound 
Dressing. Procedia Eng. 2017, 170, 31–35, doi:10.1016/j.proeng.2017.03.006. 
 
137 
 
31. Hussein, Y.; El-Fakharany, E.M.; Kamoun, E.A.; Loutfy, S.A.; Amin, R.; Taha, T.H.; 
Salim, S.A.; Amer, M. Electrospun PVA/hyaluronic acid/L-arginine nanofibers for 
wound healing applications: Nanofibers optimization and in vitro bioevaluation. Int. 
J. Biol. Macromol. 2020, 164, 667–676, doi:10.1016/j.ijbiomac.2020.07.126. 
32. Mwiiri, F.K.; Brandner, J.M.; Daniels, R. Electrospun Bioactive Wound Dressing 
Containing Colloidal Dispersions of Birch Bark Dry Extract. Pharm. 2020, 12, 770, 
doi:10.3390/pharmaceutics12080770. 
33. Mwiiri, F.K.; Daniels, R. Optimized Birch Bark Extract-Loaded Colloidal Dispersion 
Using Hydrogenated Phospholipids as Stabilizer. Pharm. 2020, 12, 832, 
doi:10.3390/pharmaceutics12090832. 
34. Gao, H.-W.; Yang, R.-J.; He, J.-Y.; Yang, L. Rheological behaviors of PVA/H2O 
solutions of high-polymer concentration. J. Appl. Polym. Sci. 2009, 116, 1459–
1466, doi:10.1002/app.31677. 
35. Gao, H.; He, J.; Yang, R.; Yang, L. Characteristic rheological features of high 
concentration PVA solutions in water with different degrees of polymerization. J. 
Appl. Polym. Sci. 2010, 116, 2734–2741, doi:10.1002/app.31900. 
36. Esparza, Y., A. Ullah, Y. Boluk, and J. Wu, Preparation and characterization of 
thermally crosslinked poly(vinyl alcohol)/feather keratin nanofiber scaffolds. 
Materials & Design 2017, 133, 1–9. 
37. Hay, W.T.; Byars, J.A.; Fanta, G.F.; Selling, G.W. Rheological characterization of 
solutions and thin films made from amylose-hexadecylammonium chloride 
inclusion complexes and polyvinyl alcohol. Carbohydr. Polym. 2017, 161, 140–148, 
doi:10.1016/j.carbpol.2017.01.011. 
38. Sousa, A.M.; Souza, H.K.; Uknalis, J.; Liu, S.-C.; Gonçalves, M.; Liu, L. 
Electrospinning of agar/PVA aqueous solutions and its relation with rheological 
properties. Carbohydr. Polym. 2015, 115, 348–355, 
doi:10.1016/j.carbpol.2014.08.074. 
39. Rwei, S.-P.; Huang, C.-C. Electrospinning PVA solution-rheology and morphology 
analyses. Fibers Polym. 2012, 13, 44–50, doi:10.1007/s12221-012-0044-9. 
40. Bhattacharya, A.; Ray, P. Studies on surface tension of poly(vinyl alcohol): Effect 
of concentration, temperature, and addition of chaotropic agents. J. Appl. Polym. 
Sci. 2004, 93, 122–130, doi:10.1002/app.20436. 
41. Le Corre Bordes, D., Hofman, K., Bordes, N., Tucker, N., Huber, T.; Staiger, M. P. 
Electrospinning window: Solution properties for uniform fibres from 
electrospinnable biopolymers. In International Conference on Processing and 
Fabrication of Advanced Materials, Auckland, New Zealand, January 2017; pp.22–
25. 
42. Shin, J.; Kim, Y.; Lim, Y.M.; Nho, Y.C. Removal of sodium acetate in poly(vinyl 
alcohol) and its quantification by1H NMR spectroscopy. J. Appl. Polym. Sci. 2007, 
107, 3179–3183, doi:10.1002/app.27453. 
43. Haider, A.; Haider, S.; Kang, I.-K. A comprehensive review summarizing the effect 
of electrospinning parameters and potential applications of nanofibers in biomedical 
and biotechnology. Arab. J. Chem. 2018, 11, 1165–1188, 
doi:10.1016/j.arabjc.2015.11.015. 
44. Angammana, C.J.; Jayaram, S.H. Analysis of the Effects of Solution Conductivity 
on Electrospinning Process and Fiber Morphology. IEEE Trans. Ind. Appl. 2011, 
47, 1109–1117, doi:10.1109/tia.2011.2127431. 
45. Zhang, C.; Yuan, X.; Wu, L.; Han, Y.; Sheng, J. Study on morphology of electrospun 
poly(vinyl alcohol) mats. Eur. Polym. J. 2005, 41, 423–432, 
doi:10.1016/j.eurpolymj.2004.10.027. 
 
138 
 
46. Supaphol, P.; Chuangchote, S. On the electrospinning of poly(vinyl alcohol) 
nanofiber mats: A revisit. J. Appl. Polym. Sci. 2008, 108, 969–978, 
doi:10.1002/app.27664. 
47. Ramakrishna, S. An introduction to electrospinning and nanofibers. World 
Scientific: Toh Tuck Link, Singapore, 2005. 
48. He, M.; Zhang, B.; Dou, Y.; Yin, G.; Cui, Y.; Chen, X. Fabrication and 
characterization of electrospun feather keratin/poly(vinyl alcohol) composite 
nanofibers. RSC Adv. 2017, 7, 9854–9861, doi:10.1039/C6RA25009B. 
49. Cho, D.; Netravali, A.N.; Joo, Y.L. Mechanical properties and biodegradability of 
electrospun soy protein Isolate/PVA hybrid nanofibers. Polym. Degrad. Stab. 2012, 
97, 747–754, doi:10.1016/j.polymdegradstab.2012.02.007. 
50. Imani, R.; Yousefzadeh, M.; Nour, S. Functional Nanofiber for Drug Delivery 
Applications. In Handbook of Nanofibers; Springer Nature Switzerland AG, Cham, 
Switzerland,, 2018; pp. 1–55. 
51. Ritger, P.L.; Peppas, N.A. A simple equation for description of solute release II. 
Fickian and anomalous release from swellable devices. J. Control. Release 1987, 
5, 37–42, doi:10.1016/0168-3659(87)90035-6. 
52. Han, X.; Huo, P.; Ding, Z.; Kumar, P.; Liu, B. Preparation of Lutein-Loaded 
PVA/Sodium Alginate Nanofibers and Investigation of Its Release Behavior. 
Pharmaceutics 2019, 11, 449, doi:10.3390/pharmaceutics11090449. 
53. Nikmaram, N.; Roohinejad, S.; Hashemi, S.; Koubaa, M.; Barba, F.J.; 
Abbaspourrad, A.; Greiner, R. Emulsion-based systems for fabrication of 
electrospun nanofibers: Food, pharmaceutical and biomedical applications. RSC 
Adv. 2017, 7, 28951–28964, doi:10.1039/c7ra00179g. 
54. Zhang, Z.; Lunter, D.J. Confocal Raman microspectroscopy as an alternative 
method to investigate the extraction of lipids from stratum corneum by emulsifiers 
and formulations. Eur. J. Pharm. Biopharm. 2018, 127, 61–71, 
doi:10.1016/j.ejpb.2018.02.006. 
55. Lunter, D.J.; Rottke, M.; Daniels, R. Oil-in-Oil-Emulsions with Enhanced 
Substantivity for the Treatment of Chronic Skin Diseases. J. Pharm. Sci. 2014, 103, 
1515–1519, doi:10.1002/jps.23944. 
56. Lunter, D.; Daniels, R. In vitro Skin Permeation and Penetration of Nonivamide from 
Novel Film-Forming Emulsions. Ski. Pharmacol. Physiol. 2013, 26, 139–146, 
doi:10.1159/000348464. 
57. Suvakanta, D.; Murthy, P.N.; Nath, L.; Chowdhury, P. Kinetic modeling on drug 
release from controlled drug delivery systems. Acta Pol. Pharm.-Drug Res. 2010, 
67, 217–223. 
58. Ritger, P.L.; Peppas, N.A. A simple equation for description of solute release I. 
Fickian and non-fickian release from non-swellable devices in the form of slabs, 
spheres, cylinders or discs. J. Control. Release 1987, 5, 23–36, doi:10.1016/0168-
3659(87)90034-4. 
59. Armbruster, M.; Mönckedieck, M.; Scherließ, R.; Daniels, R.; Wahl, M.A. Birch Bark 
Dry Extract by Supercritical Fluid Technology: Extract Characterisation and Use for 
Stabilisation of Semisolid Systems. Appl. Sci. 2017, 7, 292, 
doi:10.3390/app7030292. 
 
 
 
139 
 
6 Supplementary data 
6.1 Influence of PL90H and oil content on drug release/Permeation 
In order to evaluate the influence of PL90H and SO on drug release or permeation 
through the skin, colloidal dispersions containing different compositions of these two 
components were produced. The PL90H content used was 1 wt.% and 3.2 wt.% while 
sunflower oil was 0.4 wt.% and 4 wt.%. TE was kept constant at 0.2 wt.%. The colloidal 
dispersions were prepared according to our previous study through high pressure 
homogenization process. Henceforth, the colloidal dispersions were blended with 12 
wt.% PVA solution from molecular weight of 146-186,000 in the ratio of 60:40 and 
electrospun into nanofibers. 
Table 1. Final composition (wt.%) of formulation blends for electrospinning. 
Component Sample 1 (S1) [%] Sample 2 (S2) [%] Sample 3 (S3) [%] 
PVA 7.2 7.2 7.2 
PL90H 1 3.2 3.2 
Sunflower oil 0.4 0.4 4 
TE 0.2 0.2 0.2 
Purified water ad 100 ad 100 ad 100 
The release and permeation profiles of different formulations composed of various 
amounts of PL90H and sunflower oil are presented in Figure 1 and 2. Betulin gradually 
released or permeated from all scaffolds. The S1 scaffolds incorporated with 1 wt.% 
PL90H released betulin at the significantly higher extent than those incorporated with 
3.2 wt.% PL90H (S2) and 4 wt.% sunflower oil (S3). The S3 showed the slowest 
release. For example, release rate of betulin from S1 scaffolds was about 44 %, 34 % 
from S2 and 28% from S3 after 72 h. At the same period, about 21% of the drug 
permeated from S1 scaffolds, followed by fiber mats of S2 with 14% and S3 scaffolds 
exhibited the slowest permeation of 8%.  
 
 
140 
 
 
Figure 1. In vitro drug release studies. (a) percentage of released betulin and (b) 
amount of betulin released (µg/cm2) from TE-loaded wound dressings. 
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Figure 2. Ex vivo drug permeation studies. (a) percentage of permeated betulin and (b) 
amount of betulin permeated (µg/cm2) from TE-loaded wound dressings. 
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Figure 3. SEM morphologies of (a) S1, (b) S2 and (c) S3 electrospun fibers with their 
diameter distributions. All scale bars represent 1µm.  
Clearly, the release and permeation of betulin depended mainly on the amount of 
PL90H / sunflower oil incorporated in the blend and a controlled release of betulin can 
be achieved by adjusting PL90H and sunflower oil content. The S1 blend had a 
permeation coefficient of 5 x 10-2 mg/cm2.h, S2 (2 x 10-2 mg/cm2.h) and S3 (1 x 10-2 
mg/cm2.h) which explains further slower betulin release with higher amounts of PL90H 
and sunflower oil. Notably, the S1 scaffolds incorporated with 1 wt.% PL90H had the 
thinnest average fiber diameters of 392 nm, followed by S2 with 524 nm and scaffolds 
with S3 had the thickest fibers of 617 nm (Figure 3) where betulin might have longer 
distance through which to diffuse from the polymeric matrix leading to a slower release 
[1]. It is also known that through emulsion electrospinning, core-shell nanofibers can 
be produced while designing controlled release drug delivery systems in that the drug 
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release rate can be modulated, for example, by just adjusting the oil phase and the 
water phase of the emulsions [2]. 
6.2 Solvent-Cast Films  
The 12% wt.% PVA solution was prepared from molecular weight of Mw 146-186,000 
by dissolving PVA in water at 90 °C under magnetic stirring for 5 h. The solution cooled 
to room temperature and used the following day. Subsequently, the polymer solution 
was blended with colloidal dispersions containing 2.5% Phospholipon 90H, 1% 
sunflower oil and 0.5% TE in the ratio of 60:40 using a magnetic stirrer for 2 h at 40 °C 
to form a homogeneous solution. The sample was then cooled down to room 
temperature prior to film casting. A modified film casting machine (Figure 4) was used 
to prepare the films. To fabricate the cast films with uniform thickness, the prepared 
solutions were cast onto a Teflon-coated glass plate (pre-heated at 32 °C, skin surface 
temperature) using a film applicator with a clearance gap thickness of 0.2 mm. The 
cast films were left to dry for 1 h before stored at 32 °C in a drying chamber (Heraeus 
Holding GmbH, Hanau, Germany) for 24 h [3, 4].  
 
Figure 4. Photograph of the modified film casting machine. 1. Teflon-coated plate, 2. 
Temperature and speed control unit, 3. Applicator and 4. Processing directions. 
The same characterization methods of electrospun fibers were also used for the cast 
films. Hence, produced films were evaluated with respect to morphology, drug release, 
wound healing, and compared to electrospun fiber mats. As can be observed from the 
scanning electron microscope (SEM) images in Figure 5, the electrospun fiber mat 
appeared white in colour compared to colourless cast film which could be attributed to 
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the incorporation of colloidal dispersions and an interaction favoured by the 
electrospinng process might have occurred. We also found that electrospun fiber mats 
had a porous structure and were more flexible than cast films. 
The release characteristics of Betulin from the TE-loaded electrospun PVA fiber mats 
and films were carried out using Franz diffusion cells. Comparing drug release profiles 
in Figure 6, the cumulative amount of Betulin released from electrospun fibers was 34 
% whereas from cast films was 41% after 72 h. The drug release from cast film was 
much faster than electrospun fiber mats. This could be contributed by the features of 
the nanofibers such as the core-sheath structures and fiber thickness which slowed 
the release of Betulin. Besides, drug in cast films is just entrapped in the PVA matrix 
rather than inside the fibers hence faster release. 
(A) Electrospun fiber mat (B) Cast film 
  
  
Figure 5. (A) Photographs of electrospun nanofibers (392 nm) and (B) cast film, 
12%PVA:2.5% PL90H:1% Sunflower oil:0.5%TE (60:40). 
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From the ex-vivo wound healing assays (Figure 7), TE-loaded cast films and 
electrospun fibe rmats significantly accelerated the wound healing process more than 
a TE-oleogel. However, electrospun fiber mats were superior to cast films in wound 
healing which could be attributed to the key role played by nanofibers such as favouring 
cell proliferation, mimicking the ECM etc. [5]. 
 
Figure 6. In vitro drug release studies of cast film and electrospun fiber mat 
(7.2%PVA:1%PL90H:0.4%Sunflower oil:0.2%TE in both formulations). 
 
Figure 7. Wound healing recovery from oleogel, electrospun fiber mats and solvent-cast 
films. (TE-formulation:7.2%PVA:1%PL90H:0.4%SO:0.2%TE and Cast film-placebo: 
7.2%PVA:1%PL90H:0.4%SO). statistically significant, * p < 0.05; ** p < 0.01 vs untreated 
control 
  
 
146 
 
6.3 References 
1. Akhgari, A., et al., The design and evaluation of a fast-dissolving drug delivery system 
for loratadine using the electrospinning method. 2016. 11(2). 
2. Nikmaram, N., et al., Emulsion-based systems for fabrication of electrospun nanofibers: 
food, pharmaceutical and biomedical applications. RSC Advances, 2017. 7(46): p. 
28951-28964. 
3. Gruetzmann, R. and K.G. Wagner, Quantification of the leaching of triethyl 
citrate/polysorbate 80 mixtures from Eudragit® RS films by differential scanning 
calorimetry. European Journal of Pharmaceutics and Biopharmaceutics, 2005. 60(1): 
p. 159-162. 
4. Heck, R., et al., Film-forming formulations containing porous silica for the sustained 
delivery of actives to the skin. European Journal of Pharmaceutics and 
Biopharmaceutics, 2016. 108: p. 1-8. 
5. Zahedi, P., et al., A review on wound dressings with an emphasis on electrospun 
nanofibrous polymeric bandages. Polymers for Advanced Technologies, 2010. 21(2): 
p. 77-95. 
 
